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ABSTRACT  
 
PUBLIC REPORTING OF HEALTHCARE-ASSOCIATED INFECTIONS: THE 
IMPACT OF PUBLIC POLICY ON HEALTHCARE ORGANIZATIONS AND 
PATIENT OUTCOMES 
Stephen Perez 
Julie Sochalski, PhD, RN, FAAN 
 Healthcare-associated infections (HAIs) are a significant source of morbidity and 
mortality in U.S. hospitals.  Policy makers have responded with a variety of state and 
federal policies to reduce infections by increasing the visibility and accountability of 
hospital performance.  One policy initiative that has gained momentum is state-level 
legislative mandates requiring hospitals to report HAI-related performance data, which 
often includes public release of this data.  These reporting mandates have produced 
mixed results, however, regarding their impact on healthcare organizational processes, 
patient outcomes or consumer decision-making.  
 This dissertation comprises three papers that explore the relationship between 
HAI public reporting, organizational climate and HAI infection rates.  The first paper 
presents a conceptual framework derived from an integrative review of the HAI reporting 
literature that proposes new pathways for testing these relationships. The second paper 
uses data from the Prevention of Nosocomial Infections and Cost-Effectiveness Refined 
(P-NICER) survey, specifically the Leading a Culture of Quality for Infection Prevention 
(LCQ-IP) instrument, to examine differences in infection prevention organizational 
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climate between hospitals in states with and without HAI reporting mandates.  Bivariate 
and multivariate analysis revealed no statistically significant associations between key 
climate domains supporting infection prevention and state reporting mandates, despite 
finding noted associations with other hospital characteristics. The final paper uses 
National Healthcare Safety Network (NHSN) surveillance data, from the P-NICER 
survey, to conduct a quasi-experimental longitudinal analysis examining the impacts of 
reporting mandates on Clostridium difficile (C. difficile) infections in U.S. hospitals. 
Poisson regression models yielded no statistically significant differences in incidence rate 
ratios for C. difficile at varying time intervals before and after implementation of 
reporting mandates. Sensitivity analysis showed similar findings, with no differences in 
rates of infections over time between hospitals in reporting and non-reporting states.  This 
dissertation provides a well-circumscribed analysis of varying organizational factors and 
patient outcomes thought to be impacted by mandatory HAI reporting. Findings are used 
to propose new directions for nursing research and public policy.  
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1.1 Introduction 
Healthcare-associated infections (HAIs) are a significant source of morbidity and 
mortality within the United States (U.S.) healthcare system.  The Centers for Disease 
Control and Prevention (CDC) defines HAIs as those infections which are acquired 
during the course of treatment and care at a healthcare facility, oftentimes causing some 
adverse reaction or outcome for the patient. 1 Although certain infections contracted or 
incubating outside of the healthcare setting can be transmitted through hospitals and other 
institutions, these are not considered HAIs and excluded from surveillance definitions.1  
HAIs can range in severity, from relatively mild cases of upper respiratory infections to 
life-threatening bloodstream infections, but all place a significant burden on patients, 
caregivers, and the larger health system.  Data from 2011 suggest approximately 722,000 
HAIs occurred in U.S. hospitals that year alone, resulting in 75,000 deaths2.  Estimated 
direct costs to the health system range from $28.4 to $33 billion dollars.3  Most recent 
surveillance data available from the CDC showed a national reduction in overall rates of 
HAIs since baseline data was collected in 2008, likely reflecting national efforts to 
implement evidence-based prevention efforts across healthcare settings.4 While this trend 
is encouraging for all concerned with patient safety, closer examination of state-level 
HAI data yield a slower decline and less consistent trends within specific states. 4  
HAIs can have multiple microbial etiologies and range from localized to more 
systemic or disseminated infections.  While all HAIs are of clinical importance to patients 
and caregivers within the health system, certain infections have long been targeted for 
reduction based both on their detrimental impact and their preventability when using 
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evidence-based interventions.  Infections of particular interest encompass: those that are 
related to surgical or other medical/procedural interventions; those that are caused by 
multidrug-resistant organisms (MDROs); and, infections that, at their initial emergence, 
were epidemiologically linked to healthcare settings.   Specifically, these infections 
include surgical site infections (SSIs), central line-associated bloodstream infections 
(CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated 
pneumonias (VAPs), blood stream infections (BSIs) caused by Methicillin-resistant 
Staphylococcus aureus (MRSA), and gastrointestinal infections caused by Clostridium 
difficile (C. difficile) .1,5  In a 2014 point-prevalence study by Magill and colleagues5, 
these infections were noted as collectively responsible for over 50% of HAI infections in 
2011, with the remaining half consisting of infections considered to be more varied in 
etiology, pathogenicity and cost.   
The financial impact of HAIs on healthcare settings is significant.  A recent study 
by Zimlichman et. al6 found per-case costs for infections are highest in CLABSIs at 
approximately $46,000 per patient; costs associated with CLABSIs in which MRSA was 
causative pathogen rose even higher. The same study found SSI costs contributing the 
most to overall HAI annual costs, responsible for nearly $3.3 billion dollars annually.6   
Although other etiologies and types of HAIs permeate the healthcare environment, these 
infections have specific surveillance definitions, continue to be costly to patients and 
health systems and have been deemed preventable through evidence-based 
intervention.1,6  A 2011 systematic review found nearly 65-70% of CLABSIs and 
CAUTIs were highly preventable within the healthcare setting.7   
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In addition to the costly outcomes from device-associated infections and surgical 
site infections, invasive MRSA and C. difficile HAIs have garnered increased attention 
and targeted prevention strategies over the past few years.  These infections are prevalent 
in healthcare setting, can be difficult to treat, cause significant complications in 
compromised individuals, and can be transmitted back and forth between the community 
and healthcare environments.  The burdens of these two infections in hospitalized 
patients can be immense with regard to complexity of treatment and prolonging the 
course of hospitalization, particularly in critically ill individuals and those with multiple 
co-morbid conditions.  Despite the availability of evidence-based guidance for prevention 
of these infections, transmission and healthcare-associated cases continue to persist in 
healthcare settings.5,8–11   
The past two decades have yielded growing concern over preventable HAIs 
among the public and policymakers.  HAIs have played an increasing  role in U.S. federal 
patient safety policy and have been a  national target for improvement since 2013, with a 
goal of total elimination by 2020.12  Federal and state-level lawmakers have used these 
infections as a means of monitoring performance and, in some cases, promoting 
improved performance among healthcare institutions.13   
 One policy intervention that has been widely used to promote improvements in 
the reduction of HAIs has been public reporting of hospital and statewide HAI-related 
data.  Beginning in the mid-2000s, state-level policy began to mandate the public release 
of HAI data in a variety of formats and for varying infections.  Originally CLABSIs were 
the most prominent infections to fall under reporting mandates, but data from additional 
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device-associated infections soon followed.14   More recent mandates have expanded to 
include the public reporting of MRSA and C. difficile data in addition to device-
associated HAIs.  These data are also used for newer federal initiatives that promote 
improvements through incentives for healthcare systems if they are able to reduce their 
incident infections on an annual basis.12,13,15  Healthcare-associated MRSA and C. 
difficile infections were recently added to these incentive programs as measures of patient 
safety and system improvement, reflecting state-level public reporting initiatives and the 
need to reduce morbidity and mortality resulting from these infections.  However, little is 
known about the efficacy of these incentive programs and whether the public reporting of 
MRSA and C-difficile HAI data decreases infection rates and improves patient outcomes.  
Studies evaluating the impact of publicly reporting HAI data have shown mostly 
mixed findings, consistent with broader research on the effects of releasing non-HAI 
healthcare data.16–21 Both qualitative and quantitative methodologies have been used to 
analyze the effects of public reporting mandates and the mechanisms by which these laws 
may stimulate improvements.  Yet while previous work has shown effects of the laws on 
healthcare organizations and infection rates, these effects have not been uniform across 
healthcare settings or outcomes.  This suggests the need for further research on the 
impacts of these laws and the mechanisms by which these laws promote improvement or 
change in organizations.  
The purpose of this dissertation is to explore the impact of HAI public reporting 
laws on patient outcomes and organizations.  This work will examine these impacts from 
multiple perspectives. A revised conceptual framework detailing how the laws affect 
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patient outcomes, consumers and organizations will be presented using evidence from 
current HAI public reporting literature.  This revision will build on previously proposed 
frameworks and examine their relevance to the current literature.  This revised 
framework will provide new guidance for inquiry supported by what is currently known 
and where there is paucity in the available evidence.  Public reporting mandates and their 
effects on patient outcomes, specifically MRSA blood stream infections (BSIs) and C. 
difficile infections, will be examined in the first of two studies.  No previous U.S. studies 
have looked at these infections in relation to these laws, despite their prevalence in 
healthcare institutions and their prominence in public reporting mandates. While this 
study focuses on patient outcomes, the third study will center on the impact of these laws 
on organizations.  The relationship of public reporting laws to infection prevention 
specific organizational climate measures will be examined by exploring responses to 
survey data designed to measure organizational climate specific to infection prevention.  
These responses will be examined in hospitals in states with and without public reporting 
to determine what, if any effects these laws may have on organizational climate.  
Findings from these inquiries will guide future research and provide new directions for 
policy evaluation and formative analysis.  
1.2 HAIs as Policy Priorities in the United States 
 In 1999, the Institute of Medicine (IOM) released what would become a sentinel 
work examining the issue of patient safety and preventable errors in the modern 
healthcare system.  To Err is Human: Building a Safer Health System quickly became a 
major impetus of advocacy and policy intervention to address the national growing 
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concern about patient safety issues within healthcare institutions.  The report detailed the 
complex issues of errors committed within the healthcare system that often resulted in 
grave outcomes for patients, and avoidable financial burdens on systems22.  Types of 
errors discussed in this report ranged from preventable medication errors to errors 
associated with the provision of medical care, including HAIs.  While IOM didn’t detail 
strategies for preventing HAIs specifically, they did propose several broader policy level 
recommendations to tackle the problem of HAIs and other preventable conditions within 
health systems.  Part of those policy recommendations included a stronger research 
infrastructure to understand why these issues exist.   Additionally a system of mandatory 
public reporting of these events inclusive of HAIs was proposed to foster accountability 
and provide incentives for strengthening quality of care.22    
 Shortly after the release of this report, issues of patient safety and HAIs gained 
more substantial standing in the policy priority environment.  Data from the early 2000s 
suggested a trend toward rising HAIs and a need for improved accountability and 
transparency23.  These needs were coupled with a new push for consumer empowerment 
and an ongoing national push toward improvement programs tied to financial 
incentives.24  Public reporting of these infections began in some states as early as 2002 
with a strong uptake among state legislative bodies and administrative agencies toward 
the end of the decade.14,25  Yet this increase outpaced the available evidence that these 
mandates improved care; a fact that did not go unnoticed by industry and infectious 
disease experts.24  Despite apprehensions from experts and health systems, the policies 
moved forward.   
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The U.S. Department of Health and Human Services (HHS) HAI Action Plan was 
launched in 2009 to highlight and combat the growing issue of HAIs across the country.  
This initiative originally focused on HAIs in the acute care setting but has since expanded 
to include community and outpatient settings and long-term care facilities.  Components 
of this initiative span research, outreach, incentivizing health systems, and technology.12  
All aspects are focused on collaborative efforts between the federal government, payors, 
and health systems to reduce the incidence of HAIs in the U.S. while identifying best 
practices and evidence-based innovation. Federal involvement in HAI reduction and 
mandated reporting increased with the passage of the Patient Protection and Affordable 
Care Act (ACA) .15  This legislation centered on reporting hospital-acquired conditions 
(HACs) and mandating a subsequent reduction in payment to lower performing hospitals 
in hopes of motivating them to improve care by leveraging these financial penalties.15  
The total HAC score used to determine penalty payments involved several patient safety 
and quality measures; by fiscal year 2017 (FY17), five measures included incident 
HAIs.15 Evidence from Lee et. al26,  shows that HACs were ineffective in stimulating a 
reduction in HAIs.  Utilizing a different approach, a policy intervention called Value 
Based Purchasing (VBP), also stipulated in the ACA, emphasized payment rather than 
non-payment for improved quality of care.  VBP purchasing focuses on incentivizing 
hospitals by evaluating performance and providing additional payments based on baseline 
measures and ongoing improvements.13  Early on in VBP implementation measures for 
incentive payments included some infection-related performance measures, but did not 
include C. difficile or MRSA.  In FY17, incident hospital-onset C. difficile and MRSA 
infections were added to the list of critical performance measures central to the VBP 
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program.  Even as other measures are slated for removal, all HAI-related measures 
appear to remain, signifying their importance as a policy priority.13 
As public reporting and associated policies continue to expand and become 
ingrained in the larger healthcare system, HAIs remain a key component.   However, as 
specific policies concerning public reporting of these infections continue to evolve, they 
remain diverse in their structure and implementation. 
1.3 Public Reporting of Healthcare Performance Data 
Public reporting of healthcare and health system performance measures has been 
a part of federal policy and guidelines since the mid-1980s.27  While data collection and 
dissemination varies by disease process, outcome, and reporting body, certain tenets of 
public reporting policy remain constant.  In a 2012 evidence report for the Agency for 
Healthcare Research and Quality (AHRQ), Totten and colleagues27 describe public 
reporting as “data, publicly available or available to a broad audience free of charge or at 
a nominal cost, about a health care structure, process, or outcome at any provider level 
(individual clinician, group, or organizations [e.g., hospitals, nursing facilities]) or at the 
health plan level” (p.3).    The same report speculates that the abilty of public reporting tp 
guide behavior lies in its capacity to influence the actions of both providers and 
consumers within the same healthcare system.  At best, evidence that public reporting is 
effective in this capacity appears to be mixed in the current literature..20,27–29   As 
Romano and colleagues30 note, stimulating change from public reporting of quality 
measures is a complex endeavor that relies on the ability of an organization to assimilate 
and use data to improve their own processes and the ability of society and consumers to 
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use reported data for effective decision-making.30   Yet, despite the rise in publicly 
reporting healthcare performance measures over the past three decades, empirical 
findings from examination of its impact on organizational processes, clinical outcomes 
and effectiveness in different types of health systems remains mixed.  Public reporting of 
HAI data, newer still to the policy landscape, was largely crafted without this empirical 
evidence and has faced challenges in implementation.24   Current research evaluating 
HAI reporting laws is subject to these same challenges since states may vary in their 
policy implementation and behaviors within health systems in ways that are not 
completely understood.     
1.4 Public Reporting of HAI-related Performance Data 
Public reporting of HAIs, like those measures previously discussed, has gained 
momentum over the past decade.  While hospitals have tracked HAI related data for 
many years, mandated reporting of data through state-level legislative initiatives has only 
recently gained policy traction.25 This primarily involves requiring hospitals to report 
their data to state government bodies. While public reporting of HAI data can be 
mandated or voluntary, most states in the U.S. (37 states as of 2013) now have some type 
of HAI-related public reporting legislation, with a significant amount of that data now 
available at the federal level as well.14  
HAI data collection in the U.S. is facilitated by the National Healthcare Safety 
Network (NHSN), a national HAI surveillance system managed by the CDC.  NSHN 
receives reported HAIs from healthcare institutions around the country who follow 
specific surveillance criteria for the identification and reporting of certain HAIs.  
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Aggregate data from this system is available to the public through federal channels (i.e., 
Hospital Compare Website), and allows for uniform definitions for infection surveillance 
as well as some risk-adjusted comparison.1,31  NHSN often uses the standardized 
infection ratio (SIR) as a measure of performance and progress around HAI 
prevention.4,32,33 Centers for Medicare and Medicaid Services (CMS) uses the same HAI-
related data published on their Hospital Compare Website in a variety of payment 
reduction plans including the HAC Reduction Program and incentive programs including 
VBP.13,15   
Since its inception, the public reporting of HAI data has been met with 
controversy related to the perceived increased burden on healthcare systems, 
inconsistencies in data used for reporting, and the paucity of evidence concerning the 
effectiveness of publicly reporting data with regard to HAIs.24,34,35  Since that time, some 
of these issues, primarily data inconsistencies, have been addressed with the use of the 
NHSN surveillance and reporting system.  However, questions persist around the 
accuracy and validity of publicly reported HAI data.35,36  
In preparation for compliance with state-mandated public reporting of HAI data, 
the CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC) 
published a systematic review of evidence evaluating public reporting in the literature in 
2006.24  The review included recommendations for evaluation of public reporting of 
HAIs, yet no studies to date had evaluated outcomes related to these mandates.24    
HICPAC recommended both process improvements and clinical outcomes be included as 
measures for evaluating the efficacy of publicly reporting HAI data.37  Recommendations 
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for clinical outcome measures centered on infections that cause significant morbidity and 
mortality and are known to be preventable when employing evidence based prevention 
efforts.  Specific considerations were given to the importance of selecting patient 
populations considered at-risk for these infections as well a means of validating reported 
data.  These recommendations were emphasized and clarified in updated guidance from 
HICPAC in 2013.38 Due to the increasing utility of publicly reported HAI surveillance 
data, HICPAC released new guidance to ensure that valid surveillance data is used 
properly.  Along with HICPAC’s praise for policymakers’ shift toward using surveillance 
data for public reporting (vs. administrative data or some combination of both), the 
guidance recommended strict adherence to NHSN surveillance definition with supported 
documentation, methods for data validation, and support from hospital administration 
emphasizing the authority of the hospital epidemiology or infection prevention staff.38  
A 2014 study by Reagan and colleagues14, showed that mandatory public 
reporting of C. difficile and MRSA varied across states. While one state, Missouri, began 
mandatory public reporting of MRSA infections in 2005, most states began reporting of 
C. difficile and MRSA after 2008.  Many did not implement mandatory reporting of these 
infections until 2013.14  By 2013, 20 states had passed laws mandating the reporting of 
MRSA HAI data, with nearly half of these states passing laws in 2012 or later.  This 
paper also detailed 19 states that had mandatory reporting of C. difficile HAIs.14  An 
additional study by Reagan and colleagues39 in 2015 examined specific public reporting 
laws pertaining to C. difficile.  While the study showed a gradual increase in mandated 
reporting of these infections since 2008, yet less than half of U.S. states were noted to 
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have C. difficile reporting laws.  Reporting requirements were both by state statute and 
administrative ruling, such as the incorporation of healthcare quality reporting into state 
law.39   Public reporting of these infections and others has gained momentum in states 
across the U.S.  The value of these laws in their impact of health systems and patient 
outcomes continues to be studied in the literature.  Yet, to the knowledge of this author, 
few studies have evaluated the effect of MRSA and C. difficile public reporting mandates 
on on infection rates in acute care settings.   Evaluation of these laws’ effects on 
preventable infections such as C. difficile and MRSA are key to understanding the impact 
of these public policies on patient safety.    
1.5 Conceptual Framework for the Public Reporting of Healthcare Outcomes  
Evaluating the impact public reporting has on healthcare organizations and 
outcomes, relies first on understanding how these policies may impact these health 
systems and their consumers.  In 2003, Berwick and colleagues40 proposed the most 
widely used framework for understanding the effects of public reporting on the healthcare 
system.  The authors illustrate two distinct pathways by which the measurement of 
quality in healthcare can stimulate improvement (Figure 1).  Pathway One, the 
improvement through Selection pathway, describes the mechanism by which consumer 
choice drives the need for change and improvement.  If publicly reported data alters the 
way consumers select their healthcare providers, this may stimulate improvement within 
that organization to prevent loss of market share.40  Pathway Two, improvement through 
Change in care, describes systems’ propensities toward internal drivers of change to 
improve outcomes, regardless of consumer choices and market.40  Intrinsic motivations 
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stimulate change in health systems when performance data is reported internally or 
externally.  However, Berwick et. al, contend that often these motivations are not enough 
to overcome the status quo performance-level in a health system.40  In these instances, the 
Selection pathway may act on the Change pathway to drive the motivation of 
organizations and individuals through the change process.  While this may contribute to 
changes in health systems, any measured improvements may be vulnerable to the 
variability in reporting policies and the ability of stakeholders to interpret data for 
decision-making .40   
Figure 1.1  Conceptual Framework Linking Quality Measurement and Improvement 
Figure 1. Conceptual Framework Linking Quality Measurement and Improvement: Pathways proposed by Berwick and 
colleagues40 linking performance measurement and improvement.  These pathways have been used in subsequent 
literature to describe the pathways by which public reporting of healthcare performance data could stimulate 
improvement and promote better patient outcomes. 
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Building off those pathways described by Berwick and colleagues40, Hibbard et 
al41 discerns a third pathway which centralizes the role of a health system’s reputation as 
pertinent to stimulating change from performance data.  The authors gave health systems 
data regarding their own performance and assigned each health system to either public, 
private (in-house), or no reporting groups.  Hibbard and colleagues41 determined that 
low-scoring hospitals also had more negative associations with public reporting, and 
found that reported data would detract more from their reputation than their market share.  
Findings also showed more quality improvement processes in the hospitals that publicly 
report than in the other two groups.41  The authors contented that since public reporting  
hospitals showed increases in quality improvement efforts in response to their 
performance data, intrinsic motivation and the previously described change pathway may 
be relatively weak.29  Thus they proposed the Reputation pathway be added to the 
framework proposed by Berwick and colleagues29  yielding to concerns about public 
reputation.   
Although these frameworks hypothesize that publicly reporting hospital 
performance data stimulates improvements in care and better outcomes, findings in the 
scientific literature have left some of these pathways untested.  Furthermore, these 
conceptual frameworks have not been examined considering more recent literature that 
explores the public reporting of performance data.  Studies evaluating how HAI public 
reporting laws impact health system stakeholders and patient outcomes have been 
published since these conceptual frameworks have been proposed. Yet many of these 
studies do not specifically test these pathways.  A revised conceptual framework, based 
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on a synthesis of the current HAI public reporting literature is needed to examine and 
update these complex pathways, and provide new directions for empirical testing.  This is 
particularly true for HAIs, given their priority throughout state and federal policy 
initiatives.  The first paper in this dissertation will propose this revised conceptual 
framework to describe the pathways by which publicly reporting HAI may impact 
consumers, health systems, and outcomes.  This framework will draw on the current HAI 
public reporting literature to guide the development of revised pathways and delineate 
opportunities for empirical testing.  
1.6 The Effectiveness of Public Reporting on Improving Performance and Patient 
Outcomes  
Empirical findings on the effectiveness of public reporting to impact patient 
outcomes, health system improvement, or consumer decision-making, remain mixed. 
Two large reviews showed mixed results when evaluating impact of public reporting on 
healthcare outcomes.  In 2000, Marshall and colleagues28 reviewed 21 studies, three of 
which examined direct clinical outcomes, all cardiovascular mortality measures.  
Findings in each of the three reviewed studies confirmed reductions in mortality after 
public reporting.  The authors believed that advocates for public reporting may see this as 
a small but valid justification in its use to drive improvements, despite possible 
alternative explanations that may have contributed to these findings.28  Also, the authors 
note that little evidence supports consumer use of publicly reported data in decision-
making, and the exact mechanism of system or organizational behavior change and 
improvement remains unknown.  A systematic review published in 2008 found more 
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conflicting evidence around public reporting’s effects on clinical outcomes than that 
which was presented in Marshall and colleagues’ work.20,28  Eleven studies examining 
hospital outcome data showed that while initial findings suggested improvements related 
to publicly reported data, additional studies showed similar declines in mortality data in 
states or systems without public reporting, particularly when mortality rates were 
adjusted for risk.20  This review found some effect of public reporting on the stimulation 
of quality improvement in hospital settings with more inconsistent effects on the selection 
of hospitals or providers.20  Both reviews show similar findings that suggest public 
reporting does stimulate process improvement yet may have a somewhat less appreciable 
effect on clinical outcomes.20,28  While these reviews found some associations between 
the reporting of outcomes and effects on systems processes, mechanisms by which public 
reporting serves as a driver for change remains poorly understood.   
A closer examination of public reporting literature regarding HAIs reveals similar 
mixed results.  An initial systematic review published in 2006 found very little evidence 
supporting organizational or patient impact as a result of the public reporting of HAI 
performance data.24  Since then, some studies have attempted to examine clinical 
outcomes and organizational change related to publicly reported HAI data.  In 2014, 
Black and Kim42 examined the changes in CLABSI rates in Pennsylvania before and after 
the implementation of public reporting laws.  They found that rates of CLABSI fell in 
both administrative and reported data sets (19% and 40% respectively). Yet the authors 
noted there may have been evidence of gaming as a result of reporting that may have 
clouded the validity of the finidngs.42   A retrospective cohort study evaluating public 
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reporting requirements and CLABSI SIRs showed no difference among facility level 
SIRs across states with varying strata and reporting requirements.16  Like research from 
Black and Kim (2014), Marsteller and colleagues (2014) evaluated the effect of public 
reporting on CLABSI rates and participation in a performance improvement program.  
Results showed greater reduction in CLABSI rates after mandatory reporting within the 
first year of reporting and higher rates of participation in the CUSP: Stop BSI program, a 
national collaborative aimed at reducing CLABSIs among participating institutions.43  
CLABSI SIRs and prevention practices in neonatal intensive care units (NICUs) were 
evaluated in a 2014 study by Zachariah and colleagues.  While this study showed greater 
than 95% compliance with prevention activities in mandatory reporting states compared 
to control states (p=.0002), no statistically significant relationship was found in CLABSI 
SIRs between the two groups.17   Rinke et. al (2015), evaluated effects of mandated 
reporting on CLABSI rates in critically ill pediatric patients using administrative data and 
found that regardless of reporting status all states experienced a decrease in CLABSI 
rates during the study period regardless of reporting mandates.44   A recent study by Liu 
and colleagues (2016) used longitudinal data to evaluate the impact of HAI reporting 
laws on CLABSI rates and found ongoing reduction in CLABSI rates due to 
implementation of the laws after controlling for secular trends in infection data and 
facility characteristics.  Additionally, the authors note decreasing trends in CLABSI rates, 
particularly in the 6 months leading up to the implementation of the laws when compared 
to the 25 months or more prior (incidence rate ratio [IRR] = 0.66 [p<.001] .19  The 
authors contend that this finding indicates that public reporting mandates stimulate 
changes in potential improvement processes even prior to their implementation19.   
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The only study to examine the relationship between public reporting of infection 
data and C. difficile infection was done in Canada by Daneman and colleagues and 
published in 2012.  Their study compared observed rates to predicted rates used to 
simulate C. difficile rates in the absence of public reporting.  Findings showed a rate of 
8.92 cases per 10,000 patient days in Ontario in the calendar year after public reporting, 
which was lower than the predicted rate of 12.16 (p<.001, 95% CI 11.35 – 13.04) cases 
per 10,000 patient days45.  Overall 26.7% (95% CI 21.4% - 31.6%) reduction in C. 
difficile cases was associated with public reporting45.  
As of 2014, 23 states have implemented MRSA public reporting mandates, and 22 
have implemented C. difficile mandates.4  While  findings from Canada support the 
positive impact public reporting may have on C. difficile infections, no studies evaluating 
reporting policy have been conducted to determine if similar effects are seen domestically 
regarding C. difficile rates.  Additionally, MRSA-related outcomes remain unexamined in 
the context of state-level public reporting laws. As previously discussed these infections 
are increasingly important in federal HAI-related policy and hospital quality initiatives.    
Yet, no studies have evaluated these effects longitudinally on MRSA and C. difficile 
infections in U.S. hospitals.    The second paper in this dissertation will use longitudinal 
data to evaluate the impact of state public reporting laws specifically on MRSA 
bloodstream infections (BSIs) and C. difficile infections.  Given their associated 
morbidity and mortality, and financial impact, additional study is needed to evaluate the 
role of reporting mandates in improving patient outcomes related to these diseases. 
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1.7 Pathogenesis and Clinical Outcomes of MRSA Bloodstream and C.difficile 
Infections 
C. difficile and MRSA BSIs are a preventable source of morbidity and mortality 
in hospitalized patients. This has led to ongoing concern among patients, policy-makers, 
clinicians and healthcare administrators. Policy mandates that require hospitals to report 
these infections aim at preventing their associated complications and improving 
outcomes.   
MRSA is the most common cause of skin and soft tissue infections in the 
community setting and is well-documented as a cause of invasive infection in the 
hospitalized patient9,46–48.   A Gram-positive, anaerobe, Staphylococcus aureus (S. 
aureus) is a frequent colonizer of the nares, pharynx, and skin of humans47,49.  Individuals 
with known colonization who progress to infection with S. aureus, invasive or otherwise, 
often do so with their colonizing strain of the bacteria47.  Persons with frequent exposure 
to the healthcare system, uncontrolled chronic disease, immune compromise, presence of 
invasive devices, and exposure to broad-spectrum antibiotics are most at risk for 
colonization and/or infection.  Methicillin resistance was noted in S. aureus nearly 
immediately after the introduction of the antibiotic in the early 1960s49.  S. aureus has 
multiple virulence factors which contribute to it pathogenesis and propensity for 
progression to invasive disease in compromised individuals11,47,50.  Some virulence 
factors precipitate development of sepsis through toxin-mediated disease, while others 
assist with binding and evasion of host defenses47,49.  Binding factors also contribute the 
development of biofilms which can adhere to implanted devices in hospitalized patients 
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and may be significantly resistant to antibiotic treatments47.  Studies of whether added 
virulence is propagated by methicillin resistance continue to yield mixed results11,47–49.    
The increased prevalence of MRSA infections within the healthcare setting is 
mediated by inpatient use of antibiotics47.  Methicillin resistance confers a decreased 
affinity to β-lactam antibiotics and broad spectrum antibiotic use can provide a selective 
advantage for MRSA in the hospital setting11. MRSA can be transmitted from healthcare 
provider to patient, or patient to patient, via normal contact associated with standard 
provision of care11.  Infection within the healthcare setting can affect multiple systems, 
but invasive disease often occurs as a BSI, commonly referred to as MRSA bacteremia.  
The sequelae of MRSA bacteremia are significant.   This manifestation of invasive 
disease is often associated with increased risk of death and prolonged hospitalization, 
particularly in older and critically ill adults50.  Disseminated MRSA infection in the blood 
precipitates hematogenous spread of the bacteria to other organs, often resulting in organ 
dysfunction, sepsis and death50.  
Like MRSA, C. difficile is an anaerobic, Gram-positive, bacteria. This spore-
forming bacillus is transmissible in humans via the fecal-oral route.  Spores are extremely 
resilient in the hospital environment and are not killed by conventional alcohol-based 
hand rubs; these are common products used for hand hygiene in healthcare settings51.  
Production of two exotoxins, toxin A (ToxA) and B (ToxB), is associated with its 
primary virulence factors and its resultant pathogenesis in the gastrointestinal system.  
These toxins’ direct effects and their associated immunologic responses can cause 
diarrheal disease ranging from mild, self-limiting infection to severe colitis requiring 
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surgical intervention, systemic decompensation, and death52. Over the past decade a 
novel emergence of a more virulent strain of C. difficile, 027/BI/NAP1, has predominated 
in healthcare settings and been associated with more severe disease and worse clinical 
outcomes of C. difficile infection (CDI)52,53.  Although some data suggests a decline in 
the 027 strain, additional lineages of C. difficile have arisen and are causing disease, 
including NAP07, PCR-Ribotype 078.  This particular strain has been associated with the 
production of a binary toxin, which may amplify the  effects of ToxA and ToxB and lead 
to enhanced pathogenicity8,51,53.  The most significant risk factors for CDI are recent 
antibiotic exposure, older age (> 65 yrs) and contact with a healthcare setting52,54,55.  
While asymptomatic colonization of susceptible patients in the healthcare settings can 
occur, the majority of testing and eradication efforts are centered on confirming CDI in 
those with symptomatic disease as they are most likely to spread the infection to other 
patients and contaminate their surroundings.  Both infections have experienced 
fluctuations in rates and prevalence both in the community and healthcare systems over 
the past two decades.  Despite an encouraging trend downward in infections, their 
presence in healthcare settings continues to be of significant concern. 
1.8 The Epidemiology of MRSA and C. difficile within the Healthcare Setting  
MRSA and C. difficile infections in U.S. healthcare institutions continue to be of 
concern for both providers and policy makers, despite national decreases in their rates 
since 2008. 4  This is likely because these infections have been deemed preventable 
within healthcare systems and yet still cause significant morbidity and mortality in 
hospitalized patient.  
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Since its discovery in the early 1960s, rates of MRSA-associated disease rose 
within healthcare settings and the community through the mid-2000s.48,49  As HAIs 
became a focal point of clinical and policy intervention, invasive healthcare-associated 
MRSA was targeted for enhanced prevention strategies.  From 2005 to 2008 a decline in 
invasive healthcare associated MRSA has been noted.56,57 A study from Kallen and 
colleagues in 2010 showed this decline was most prominent, -11.2% (95% CI -15.9 to -
6.3%) in MRSA (BSIs) .56   An additional study using the same data set but examining 
rates through 2011 showed similar improvements, yielding an overall reduction in 
hospital onset invasive MRSA of approximately 54% during the study period.57   
Similar findings are noted in a recently released HAI progress report from the 
CDC. This report analyzed data from 2014 and compared it to their national baseline data 
from 2008. SIRs are computed using risk adjusted models to compare both national and 
state-specific trends.    In the most recent comparison data, SIRs for MRSA BSIs in 
reporting hospitals decreased by 13% nationally from 2011 to 2014.4   Despite this 
national trend, state level SIRs have not uniformly seen a decrease.  Closer examination 
of state level data yields an increase in some state-specific SIRs when comparing 2014 
data to baseline SIRs calculated in 2011, suggesting that reductions are not ubiquitous 
across states and institutions4     Additionally data from the CDC’s Active Bacterial Core 
Surveillance program notes that the death rate from health-care associated MRSA 
infections remain nearly 5 times higher that of community acquired cases.58  The same 
data show that MRSA BSIs continue to account for more than two-thirds of all invasive 
MRSA infections deemed healthcare-associated.  These data show that despite overall 
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some overall reductions nationally MRSA BSIs continue to be a significant contributor to 
morbidity and mortality in the hospitalized patient.   
Like MRSA, C. difficile infections are a significant concern in the hospital setting.  
C. difficile is the most common healthcare-associated gastrointestinal infection and the 
most common cause of antibiotic-associated diarrhea in the U.S.5,55  Recent studies have 
indicated that C. difficile was responsible for more than 450,000 infections and 29,300 
deaths in the U.S. in 2011, increasing excess healthcare expenditures by $1.5 billion.6,8  
One modeling study by Desai and colleagues (2016) suggests that in 2014, an estimated 
439,237 incident C. difficile infections occurred in the U.S with roughly two-thirds 
originating in hospital or long-term care settings.  This same study yielded that roughly 
one-third of severe infections and deaths from C. difficile occurred in hospitalized 
patients.54  Additional findings from this study confirmed that adults over 65 continue to 
suffer from the largest burden of C. difficile infections, and higher proportions on total 
deaths from C. difficile in hospitalized patients occurs in those with immune compromise 
and chronic kidney disease.54   
Similar to data reported on incident MRSA infections, the CDC compiles reported 
data on hospital-onset C. difficile.  SIRs are used to compare hospital performance to 
national and state baselines and year-to-year performance.  As of 2014, C. difficile 
infections were down by 8% among reporting hospitals when compared to the 2011 
baseline. 4  However, between 2013 and 2014, an increase in these infections were noted 
suggesting a recent upswing in infections.  In fact, C. difficile infections were only one of 
two HAIs in this report to see an increase over the 2013 comparison; surgical site 
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infections related to colon surgeries were the other4.   Some state-specific trends in SIRs 
also showed  increases when compared to 2013 data, emphasizing that the issue of 
healthcare-associated C. difficile infection, is still a significant one.4 
 Decreasing rates of these infections and curbing thier transmission within 
hospitals are a focal point of U.S. federal and state HAI-related policy.   A wide range of 
evidence-based interventions are described in current guidelines that aim to achieve these 
outcomes. Yet while eliminating transmission of these infections within hospitals remains 
a prominent policy goal12, the implementation and response to these policies have led to 
inconsistencies in patient outcomes and infection rates.  As previously discussed, a 
national decrease in MRSA and C. difficile infections has been observed, but within 
states and likely within hospitals, rates do not always echo the national trend.     
One potential reason for these discrepancies is that healthcare organizations are 
unique entities and respond to policy initiatives in the context of their internal and 
external environments.40 As policies become more widespread, organizations must adapt 
and implement these policies within their own unique environment.  One framework for 
specific characteristics of healthcare organizations may contribute to patient outcomes is 
that of organizational climate.  While organizational climate has been examined in 
healthcare literature, little is known about its relationship to public reporting policy and 
whether these policies act to strengthen infection prevention climate in health systems.  
The third paper in this dissertation will use survey data to explore how a climate infection 
prevention may be impacted by these policies.  This pathway is important for 
understanding the true nature of how these public reporting laws impact organizations 
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and allows for new research on the relationship between policy, organizations and patient 
outcomes.   
1.9 Public Reporting, Organizational Climate, and Outcomes 
As some experts have noted, public reporting does not exist apart from larger 
structural components of organizations.30,40,59,60  Organizations respond to publicly 
reported health outcomes, yet these outcomes are impacted by a considerable 
organizational characteristics, processes and structures.  Thus, the effectiveness of public 
reporting to improve outcomes can potentially be mediated by these critical 
organizational factors.  One concept related to organizational functioning which could be 
impacted by public reporting is the organizational climate.   
Organizational climate is described in the literature as the perceptions regarding 
specific organizational attributes including leadership, accountability, communication 
and social norms, reported by persons within the organization.61,62    Stone and 
colleagues61describe organizational climate as a set of core structural domains and 
process domains that impact outcomes and processes of care.  They propose the 
Integrative Model of Organizational Climate as a means of describing the relationships 
between structural domains, processes and outcomes (Figure 2).  In this model that is not 
specific to HAIs, structural domains, including leadership and organizational 
characteristics encompass inputs such as communication processes and values of the 
organization.61  Process domains include quality emphasis, group dynamics, work design 
and supervision.  These processes mediate the relationship between larger structural 
domains and healthcare worker-related outcomes (i.e., satisfaction) and patient outcomes 
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(i.e. clinical outcomes or patient satisfaction) .61  The model was developed from surveys 
and data used in previous studies63 to describe key structures and characteristics of 
organizations.  Themes were analyzed and grouped into the domains and processes and 
the resultant model was tested with empirical evidence showing statistically significant 
associations between structural domains and healthcare worker outcomes, specifically 
intention to leave.  While clinical outcomes were not evaluated in this study, the authors 
note the value of this model lies in its capacity to support further investigations 
concerning organizational climate in healthcare.61    A later systematic review examined 
the relationship of organizational climate on both clinical outcomes and employee related 
outcomes using an adapted form of this model.62   In this review, MacDavitt and 
colleagues62 discuss conflicting findings regarding certain aspects of organizational 
climate and outcomes of care.  The authors propose that this may be due to varying 
measures of climate and clinical outcomes.   
Like the findings noted by MacDavitt et. al62, organizational climate literature 
related to HAIs has shown mixed findings.  Stone et. al, (2007) studied the impact of 
nurse working conditions on various patient safety outcomes including CLABSI and 
CAUTI.  Analyses showed slightly higher risk of CLABSI in units where nurses 
perceived a more positive organizational climate (adjusted OR 1.19; 95% CI, 1.05-1.36), 
but a lower risk of CAUTI (adjusted OR 0.61; 95% CI, 0.44-0.83) .64   A 2013 study from 
Salge and colleagues examining organizational context and longitudinal MRSA rates, 
found climates that encouraged the reporting of errors were associated with reductions in 
MRSA blood stream infections over time.   
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Figure 1.2 The Integrative Model of Organizational Climate 
Published by Stone et. al in 2004, this model describes the relationship between core structural and process domains related to 
organizational climate.  This model provides a framework for how organizational climate, can impact patient care related outcomes.   
 
Other factors from this study that were associated with decreased MRSA 
infections dealt more with infection control procedures and training than with 
organizational climate.65  A more recent study from nurse researchers in Colorado 
examined organizational context and used secondary data from the Leading a Culture of 
Quality Instrument for Infection Prevention (LCQ-IP) from the Prevention of Nosocomial 
Infections and Cost-Effectiveness Refined Survey (P-NICER) .66  Using the Quality 
Health Outcomes Model, the authors conducted latent variable modeling within a 
structural equation modeling framework (SEM) to examine the relationships between 
constructs within the model, organizational climate variables, a CLABSI-related 
29 
 
intervention (Central Line Bundles), and outcome (CLABSI events).  The final latent 
variable model suggested a relationship between high levels of adherence to the 
intervention and organizational context, but this did not extend to CLABSI outcomes.66   
Broader climate-related conceptual relationships have been proposed to explain 
why organizations respond differently to policy initiatives and attain varying results in 
improving patient outcomes.  Berwick et. al40contend that improving performance 
through the measurement and reporting of data relies heavily on an organization’s ability 
to improve processes and promote an environment conducive to change.  Core processes 
identified by Berwick include leadership, investment in time and change management, 
communication, and ongoing evaluation.40  Marshall, Romano, and Davies30discuss the 
impact public reporting can have on organizational culture by empowering change-
makers, strengthening the value of quality improvement, and improving accountability. 
They discuss how public reporting’s impact on social norms within organizations can 
have long-lasting effects, but only with  the understanding of the unique role internal 
structures and processes play in impacting behavior and outcomes.30   Yet despite these 
proposals, few studies target the effect of public reporting on these organizational-level 
processes.  These complexities require additional study to understand the relationship 
between public reporting, organizational climate and the impact on HAI-related patient 
outcomes.   
1.10 Significance of this Research 
The public reporting of HAI related data is now mandated in most states in the 
U.S.  Yet despite widespread adoption and implementation, mixed empirical evidence 
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exists that supports its influence on HAI infection rates.  Less still is known about which 
organizational characteristics may aid or hinder these laws in being effective.  This 
research fills existing gaps by providing a comprehensive approach to examining these 
concepts in the context of HAI-related performance data.  Paper one provides an updated 
framework for examining the pathways by which public reporting of HAI may impact 
organizations and, in turn, outcomes for patients and health systems.  The associated 
literature review offers a thorough analysis about what is known regarding HAI public 
reporting using an existing public reporting framework to organize the findings. 
The first study and second paper in this dissertation, examines the longitudinal 
relationship between public reporting and outcomes associated with C. difficile and 
MRSA blood stream infections.  While similar methodologies to previous studies was 
used, this is the first study to use longitudinal surveillance data to evaluate the effect of 
these laws on a healthcare-associated MDRO and C. difficile, one of the most 
burdensome HAIs in the United States.  Recent policy initiatives, including federal VBP, 
have included MRSA and C. difficile infections as prime measures for incentive 
programs during fiscal year 2017. Results of this retrospective study provides needed 
insight into the effects of these laws on infection rates within hospitals as well as lay the 
groundwork for policy evaluation and ongoing evaluation of these outcomes.   
Organizational contexts and climate may potentially play a significant role in how 
HAI public reporting impacts outcomes. The second study and third paper in this 
dissertation examined variables related to organizational climate as reported by health 
systems and their relationship to public reporting.  This exploratory study evaluated 
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associations between key domains of organizational climate and public reporting by 
examining comprehensive organizational climate data and specific climate-related factors 
associated with infection prevention and control within healthcare institutions.  This 
study is the first to examine these relationships. The findings lay the foundation for 
understanding if and how these reporting mandates are associated with organizational 
climate and provide a baseline for additional studies including those examining 
outcomes.   
These studies serve as an exploration into whether public reporting policies work 
to improve outcomes related to C. difficile and MRSA and begin to explore examine what 
factors contribute to these effects within the context of organizations.  They shed light on 
an important policy initiative and guide new thinking about how to evaluate these laws 
given their continued evolution and growing complexity.  
1.11 Specific Aims 
This dissertation aims to illuminate the relationship between public reporting of HAI-
related data and HAI outcomes, while exploring the relationship of specific organizational 
factors which may enhance or attenuate the impact of public reporting.   
Aim One: To develop a revised conceptual framework that describes the relational pathways by 
which the public reporting of HAI data impacts health system organizational variables, 
subsequent impacts on HAI rates, and consumer decision-making.   Innovation: In the existing 
literature, no conceptual frameworks for public reporting of HAI data have been developed for 
the purposes of guiding inquiry and policy evaluation. Impact: Development of a conceptual 
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framework specific to the public reporting of HAI data will help to guide evaluation of public 
reporting policy and new inquiry in public reporting and HAI research.    
Aim Two:  Using data from the National Healthcare Safety Network (NHSN), conduct a 
longitudinal secondary data analysis quasi-experimental study to determine the effect of 
mandatory HAI public reporting laws on Laboratory Identified MRSA blood stream infections 
and C. difficile infection (CDI) while controlling for other variables.  Hypothesis: Implementing 
state-based mandatory public reporting of healthcare-associated CDI and MRSA is associated 
with a decrease in rates of these MDROs within hospitals from those states.  Innovation: In the 
existing literature, no studies have evaluated the impact of state-mandated public reporting laws 
in Healthcare-associated CDI and MRSA rates in the United States using NHSN surveillance 
data.  Impact: Understanding the impacts of state-based public reporting policy on healthcare-
associated MDRO infection rates will help determine the efficacy of these broad policy-related 
interventions.  
Aim Three: Using cross-sectional data from the P-NICER Survey, conduct an exploratory data 
analysis examining the relationship between the presence of HAI public reporting mandates and 
organizational climate in U.S. hospitals. Innovation: There is a gap in the present literature 
regarding the relationship between HAI public reporting mandates and concepts central to 
organizational climate.  Impact: Examining this relationship will provide baseline data for future 
research to investigate the intricate relationship between reporting mandates, organizational 
climate and HAI related outcomes.   
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2.1 Abstract:  
Background:  Healthcare-associated infections (HAIs) are a significant burden in the 
U.S. healthcare system.  These infections are often considered preventable and multiple 
evidence-based guidelines that provide prevention strategies are widely available.  
However, despite the adoption and implementation of prevention practices, these 
infections continue to persist.  Policy makers have responded to the problem with 
national and state-level mandatory reporting legislation or statutes that require hospitals 
to report their data to an oversight body, often times for public dissemination.  Although 
there is some mixed evidence in the literature as to whether these mandates have any 
impact on hospitals and patient outcomes, less is known about the mechanisms by which 
these policies make their impact.  Previous conceptual frameworks have attempted to 
broadly describe specific pathways (Change, Selection and Reputation) by which 
mandated reporting of healthcare performance data affects outcomes and organizations, 
but no framework exists specific to HAIs.  Purpose: The aim of this paper is to propose a 
revised conceptual framework describing how mandated HAI reporting impacts 
outcomes and organizations, based on an integrative review of available literature that 
has specifically explored these relationships.  Research Design: An integrative review 
was conducted to determine the existing evidence in the literature that supports or refutes 
previously described HAI reporting pathways from pior conceptual frameworks. 
Methods: Inclusion and exclusion criteria were developed and a search of SCOPUS, 
PubMed, and CINHAL data bases using targeted search terms was conducted.  Abstracts 
were reviewed and final selections were made for inclusion in the review.  Findings from 
qualitative, quantitative and mixed methodological studies were grouped by previously 
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proposed mandated reporting pathways and findings were integrated to support or 
challenge previously proposed pathways.  New pathways were also proposed based on 
available evidence from the literature.  Results:  Nineteen publications were selected for 
inclusion in this review, spanning 18 empirical studies and 1 systematic review.  Impacts 
of mandatory reporting largely support the Change and Selection Pathways but also 
suggest new relationships and variables which should be included in the revised 
framework.  Additionally, the impact of the Reputation Pathway on consumer selection 
and organizations is significantly revised.  Conclusion:  This revised conceptual 
framework is the first to incorporate HAI-specific evidence regarding the impacts of 
public reporting on health systems, patient outcomes and consumers decision-making.  
The existing pathways supported or challenged by current evidence and the new 
pathways presented in this framework allow researchers to test the intricate effects public 
reporting policy may have on stakeholders and organizations within the healthcare 
system.  
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2.2 Introduction 
Healthcare-associated infections (HAIs) are a significant cause of morbidity and 
mortality in the United States (U.S.) healthcare system.  The U.S. Centers for Disease 
Control and Prevention (CDC) estimates that on any given day, approximately 1 in 25 
hospitalized patients in the U.S. experiences an HAI.1  Each year, these infections result 
in roughly 75,000 deaths.  Of the multitude of HAIs that can occur in a clinical setting, 
many of the costliest and most dangerous are those associated with medical devices, 
surgical procedures, multi-drug resistant organism (MDROs), and Clostridium difficile 
(C. difficile).1–3  Central-line associated bloodstream infections (CLABSIs), catheter-
associated urinary tract infections (CAUTIs), surgical-site infections (SSIs), and 
ventilator-associated pneumonias (VAPs), are device and procedure associated infections 
that continue to be a preventable source of complications leading to higher healthcare 
costs, prolonged length of stay, increased complexity of care, and excess mortality in 
acute care settings.3,4        
In response to the growing concern surrounding patient safety and preventable 
adverse patient outcomes including HAIs, policymakers have implemented multiple 
strategies to push healthcare institutions towards improving quality of care.5–7   One of 
the most-widely propagated interventions is the mandated reporting of healthcare facility 
performance data.6,8–10   These mandates typically have three components: the reporting 
of HAI-related performance data to an oversight body (often state health departments), 
the public release of that performance data, and the linkage of these performance data to 
facility identifiers, allowing the public to see which data belongs to which facilities.11  
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The linkage of facility identifier for release of information to the public is often a key 
component of these state mandates and driver of change in health systems.12,13  Public 
reporting has gained ground in the past two decades as a potential means of holding 
health systems accountable for outcomes, improving quality of care, and empowering 
consumers and payors to make informed decisions about where to obtain services.6,8,10  
Most states as of 2013 do include a public reporting component to their HAI reporting 
mandates.14  Evaluation of patient outcomes resulting from these polices has shown 
mixed results; nevertheless, they continue to be implemented throughout the U.S. and 
serve as a benchmark for federal incentive programs aimed at improving quality.5,7,8,15   
The aim of this paper is to develop a revised conceptual framework that 
characterizes the impact of HAI public reporting on healthcare systems, patient 
outcomes, and consumers based on existing evidence in the available HAI public 
reporting literature.  An integrative review of existing literature was used to examine 
these impacts and identify potential gaps in knowledge regarding specific pathways 
included in this revised framework.  This framework will serve as a foundation for 
further inquiries regarding the public reporting of HAIs and identify new directions for 
HAI public reporting research 
2.3 Public Reporting of HAI-related Performance Data 
HAIs have been a focus of public reporting for over a decade.14  McKibben and 
colleagues (2006) describe public reporting relevant to HAIs as “information provided to 
the public about the quality of health services” (p.143).  Since 2003, policies to mandate 
the public reporting of HAIs have been implemented in a majority of states.14,15  Over a 
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decade later, public reporting of HAI-related data continues to be a policy priority for 
legislators, federal administrators and patient advocates alike.  However, effects on 
various stakeholders within healthcare systems, including consumers, infection 
prevention departments and personnel, and administrators is not fully understood.  
Additionally, impacts on organizational processes and improvements as well as specific 
HAI outcomes, particularly infection rates, has been explored in the literature but 
continues to remain somewhat ambiguous.  
Public reporting of HAI data in the United States focuses primarily on infection-
related data at the level of the healthcare system; these data are often used to make 
meaningful comparisons and observations regarding trends in patient outcomes or quality 
of care.1,14,16  These policies can be legislatively enacted, implemented as part of an 
administrative statute, or mandated through participation in other public reporting 
programs.11,16  A study from Herzig and colleagues in 2014 found that as of the prior 
year, 37 states had implemented mandatory HAI public reporting, with significant 
variability in types events reported.14   Most state laws mandate that case-based 
surveillance data are reported by healthcare institutions to the National Healthcare Safety 
Network (NHSN), a national HAI surveillance system with oversight from the CDC.  As 
of 2014 however, all states have hospitals that report HAI data to NHSN in some capacity 
whether in fulfillment of state mandates or federal requirements1,14  These data are then 
made publicly available via federal channels, allowing for some risk-adjusted comparison 
of HAI-related outcomes.17  These risk-adjustments allow for comparison among 
institutions with varying characteristics that may impact HAI outcomes such as size, 
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geography, or case-mix.  The standardized infection ratio (SIR) is the main reported 
statistic used by the Centers for Medicare and Medicaid Services (CMS) and the CDC to 
publicly report HAIs. 18  This ratio examines the relationship between the number of 
observed infections to the number of expected infections based on a risk-adjusted model 
for device-associated HAIs, surgical site infections, MRSA bloodstream infections, and 
C. difficile gastrointestinal infections.1  Specific criteria are used to meet surveillance 
definitions required for consistent case-reporting across states and facilities in an attempt 
to circumvent issues of variation in data reported and noted issues with validation of true 
HAI cases.16,19  In addition to being publicly reported these data are also used for various 
incentive programs including the Hospital Value-Based Purchasing program (VBP).7   
Although these laws have now been implemented in some states for over a 
decade, at the time of their original inception little evidence was available support their 
effect on reducing HAI events and improving patient care.  In many cases policy 
mandates were outpacing evidence and HAI experts were left concerned that little 
empirical foundation existed with which the challenges of implementing these laws could 
be justified.15  However the impacts of non-HAI public reporting mandates had been 
explored in the literature.9  In addition, conceptual frameworks had been developed to 
hypotheses the unique pathways and relationships by which reporting performance 
improvement data may impact outcomes and stimulate change hospitals.  Berwick et.al20 
developed a conceptual framework describing the impact of performance measurement 
and data reporting on health system performance, consumer engagement, and quality of 
care.20–22  While this framework does not specifically address the public reporting of 
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infection data, it identifies proposed pathways by which publicly reported performance 
data may stimulate change in healthcare systems.   
2.4 Conceptual Framework for Quality Measurement and Improvement 
  In 2003, Berwick and colleagues20 published one of the most highly referenced  
frameworks for how quality measurement might stimulate improvement in providers and 
organizations (Figure 1). The paper describes the varying pathways by which measuring 
performance might affect the actions and decisions of consumers, clinicians, payors and 
other various actors within the larger healthcare system.   
  The Selection Pathway described in this framework involves choice in the hands 
of consumers, payors and referring clinicians.20  Decisions to select services are based on 
measurement of and access to performance data of the institution or provider in question.   
The threat of avoidance of lower performing institutions by informed payors and 
consumers motivates those organizations to improve practices.  Not surprisingly, this 
pathway relies on the presentation of understandable, valid data as well as the ability of 
healthcare consumers to correctly interpret and use this data for decision-making.20   
A second pathway identified by Berwick et. al20, the Change Pathway, describes a 
more intrinsically motivated health system.  This pathway relies on the ability of health 
systems and providers to receive performance measurement feedback and implement 
change based on those data. 
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Figure 2.1 Conceptual Framework Linking Quality Measurement and Improvement: 
Change and Selection  
Pathways proposed by Berwick and colleagues20  linking performance measurement and 
improvement.  This pathway has been used in subsequent literature to describe the 
pathways by which public reporting of healthcare performance data could stimulate 
improvement and promote better patient outcomes. 
 
Significant investment on the part of these systems to collect and report data, promote the 
use of performance improvement techniques, and incentivize improvements in care is 
needed to ensure this pathway works optimally in the healthcare system environment. 
Berwick and colleagues20contend that individual intrinsic drivers such as pride, caring, 
and desire-to-achieve can help stimulate the change pathway.  However, without an 
environment that supports and drives improvement initiatives, intrinsic drivers may fail to 
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move the dial on quality of care.20  The Selection Pathway is also a recognized source of 
motivation for the Change Pathway, although in Berwick, et.al’s work it remains an 
untested driver.20  The authors hypothesize that provider and administrator aversion to 
loss of market share, community criticism, and other negative motivators can portend a 
shift toward improvement through the Change Pathway.20   
The notion that selection could serve as a motivator for change was explored by 
Hibbard and colleagues which led to the proposal of a third pathway for public reporting 
to stimulate change within healthcare systems.21–23  Their study contrasted the effect of 
issuing public versus private reports to health systems on performance improvement 
practices.22  Findings from this work showed that those low-performing hospitals 
receiving publicized performance reports undertook more quality improvement activities 
than those hospitals receiving non-publicized reports.22  Hibbard and colleagues argued 
that these findings indicated a concern for reputation served as a motivator for change.  
Findings from a subsequent paper indicated that this motivation is even greater than 
concern for loss of market share.23  Hibbard contended that these findings support the 
relative weakness of the aforementioned Change Pathway to improve care through public 
reporting and that a Reputation Pathway may be have a stronger propensity to stimulate 
improvement practices.21  
In 2008, Fung and colleagues8 published a systematic review of studies that 
examine how public reporting of performance data improves quality of care.  They 
addressed the Berwick20 framework in their review of the literature.   Their findings 
showed that consumer selection of physicians and hospitals was affected by the 
54 
 
publishing of performance data, particularly in the specialty area of cardiac surgery.  
Health plan selection was also affected by reported performance, with several studies, 
both experimental and observational, showing a preference for selecting plans with 
higher performance ratings even though these plans may be higher cost and involve more 
restrictions.8  The effects of public reporting on the consumer selection of hospitals and 
individual providers was more mixed.  Fung et. al8 reviewed 9 studies examining the 
effects of public reporting on hospitals and market share; overall studies showed that 
releasing hospital performance data had little or no effect on hospital utilization or market 
share.  In studies examining provider selection  after publicly reporting performance data, 
some effect was noted, particularly with regard to cardiac surgeons and the New York 
State Cardiac Surgery Reporting System.8  Five studies examining this data found that 
physicians with better outcomes were more likely to see increases in growth for surgical 
charges, while those surgeons with higher mortality scores were less likely to be selected 
by Medicare enrollees.8  
In addition to selection, Fung et. al8 also examined the effects of reporting on 
clinical outcomes and process improvements.  While a minority of studies in the review 
showed an improvement on mortality indicators after public reporting, most had 
inconclusive findings or could not account for secular trends in decreasing mortality in 
non-reporting environments.8  Underlying trends in these outcomes, including regression 
to the mean, may be a key limitation in analyzing these data and isolating the effect of 
reporting mandates.  This suggests the presence of additional complexity in the pathways 
between reporting and impact, highlighting the need for further review of the literature 
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and empirical investigation. Quality improvement activity was the outcome most widely 
affected by public reporting.  Studies of hospital settings found that most healthcare 
systems responded to the publication of their performance data by initiating quality 
improvement efforts, including efforts in domains noted in the various reports.8  
To date the most widely examined public reporting conceptual framework and its 
pathways have not been revised to account for the breadth of available evidence 
regarding the effect of public reporting and HAIs.  The aim of this paper is to develop a 
revised public reporting framework that incorporates available literature concerning the 
effect of public reporting on HAI-related outcomes.  This framework will allow 
researchers and policy-makers to target inquiries and develop relevant evaluation 
methods that address the impact of these public reporting laws on HAIs.   
2.5 Methodology 
 An integrative review of the literature was conducted to examine the relationship 
between public reporting and HAIs.24    The integrative review methodology is well-
suited  for the  aim of this review.24,25   Whittemore and Knafl (2005) discuss the 
integrative review as uniquely inclusive of diverse research methodologies and allowing 
for results aimed at a wide array of purposes, including the development of concepts and 
the review of evidence.  Ganong25 underscores the utility of the integrative review for 
examining theoretical issues and posing new directions for needed research.  These 
reviews often are guided by the use of a previously determined conceptual framework 
related to the phenomenon of interest, guiding the sampling of publications and 
development of inclusion/exclusion criteria.  The methodology put forward by 
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Whittemore and Knafl24 was used to conduct all steps of this review.  
Since the aim of this review is to develop a revised conceptual framework from 
current evidence, prior work from Berwick20, Hibbard21, and their colleagues was used to 
guide the development of inclusion and exclusion criteria for the final selected studies 
(Table 1).  These previously discussed pathways and frameworks focus primarily on the 
impact of publicly reported performance data on various stakeholder groups within health 
systems.  Thus, empirical studies and published work were reviewed with the intent of 
evaluating the impact of public reporting on stakeholder groups as a primary outcome.  
Similar to those outlined by previous frameworks, stakeholder groups are defined for this 
review as consumers or patients (inclusive of broad patient outcomes), health systems or 
organizations, payers and provider groups.20,21  This strategy also reflects previous work 
published by the Agency for Health Research and Quality (AHRQ) in attempts to 
evaluate similar relationships.13   A 2012 review was conducted by Totten et. al13 for 
AHRQ, resulted in findings similar to those reported by Fung and colleagues8.  However, 
Totten et. al13 used a structured guide for reporting that specifies the Population 
(healthcare providers or consumers), Intervention (public reporting of data), Comparators 
(examining groups with different data reporting or no reporting), Outcomes 
(improvements in care or changes in processes), Timing (trajectory of reporting and 
outcome evaluation), and Setting (hospitals or other healthcare organizations).   This 
guide is useful in identifying studies that are structured to evaluate the impact of public 
reporting on key stakeholders in the healthcare system.    
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Table 2.1 Inclusion and Exclusion Criteria for Integrative Review of the HAI and 
Public Reporting Literature 
Inclusion Criteria Exclusion Criteria 
• Published between 2006 and 2016 
• Published in a peer-reviewed 
journal 
• English language publication 
• Studies with the following 
characteristics: 
o Editorials, commentaries and 
papers describing the policy 
landscape 
o Studies examining long-term 
care and outpatient setting 
o Primary outcome is data 
validation 
o Primary outcome is not 
evaluation of stakeholder 
impact 
 
Searches were conducted in Scopus, PubMed and the Cumulative Index of 
Nursing and Allied Health Literature (CINAHL) querying for publications in peer-
reviewed journals published between 2006 and 2016 and using specific search 
terminology (Table 2).  This timeframe was selected since official guidance for the public 
reporting of HAIs was published in 200526.  Initial search was completed in Scopus and a 
subsequent review of titles and abstracts (where available) was conducted to exclude 
those studies or publications that met the exclusion criteria (figure 2).  Relevance to 
exclusion criteria was ascertained by using abstracts to determine the purpose of the 
study, identify the outcome of interest, and identify the methodology used by the 
researchers.  After this initial review, a full text review was done of the remaining 
publications to ensure relevance to the conceptual framework sampling and pathways 
previously described.   This same process was completed with additional search terms 
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and strategies in Scopus, while also reviewing titles for duplicates from previous 
searches.  The total publication yield from the full text review in Scopus indicated the 
potential need for expanded search terms to include “HAI”, “healthcare-acquired” and 
“mandated”.  This was ascertained by a review of the references of selected papers from 
the Scopus review. These terms were subsequently applied to the additional searches.    
Once results from the Scopus search were finalized, PubMed and CINHAL were 
queried using the same criteria and expanded search terms, with attention to duplicative 
results from the Scopus findings (figure 2). The final articles selected for inclusion were 
then reviewed, grouped and analyzed by where they fit within the various public 
reporting pathways.  Again, references of the final selected studies were screened.  
Publications were analyzed for study design, relevance to previous frameworks, outcome 
of interest, strengths and limitations (appendix A).   
Special attention and analysis was given to each study’s contribution to what is 
known about the impact of public reporting on specific stakeholder groups and cohesion 
with previously proposed pathways.  Proposed pathways from prior conceptual 
frameworks were used to group the selected studies for analysis.  Those studies which 
examined potential relationships or variables most fitting of the Change Pathway were 
analyzed to determine if findings supported, challenged or posed new relationships or 
variables along that pathway.20  Similar methods were used for articles related to the 
Selection and Reputation Pathways. 20,21   
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Table 2.2 Search terms and initial yield for Integrative Review of the HAI and Public 
Reporting Literature (2006-2016) 
Database/Search Engine Boolean/Search Terms Total 
Retrieved 
Scopus Public reporting (all text) *AND infections (all text) 189 
Scopus Public reporting (all text) *AND healthcare-associated 
(all text) *AND infections (all text) 
43 
Scopus Mandatory reporting (all text) *AND healthcare-
associated (all text) *AND infections (all text) 
42 
PubMed Public (title/abstract) *OR Mandatory (title/abstract) 
*AND Reporting (title/abstract) *AND Infections 
(title/abstract)  
571 
PubMed Public (title/abstract) *AND Reporting (title/abstract) 
*AND Healthcare-associated (title/abstract) *AND 
Infections (title/abstract) 
45 
PubMed Mandatory (title/abstract) *AND Reporting 
(title/abstract) *AND Healthcare-associated 
(title/abstract) *AND Infections (title/abstract) 
24 
PubMed Mandatory (title/abstract) *AND Reporting 
(title/abstract) *AND HAI (title/abstract) 
29 
PubMed Mandatory (title/abstract) *AND Reporting 
(title/abstract) *AND Healthcare-acquired 
(title/abstract) *AND Infections (title/abstract) 
2 
CINAHL Public (title/abstract) *AND Reporting (title/abstract) 
*AND Healthcare-associated (title/abstract) *AND 
Infections (title/abstract) 
72 
CINAHL Mandatory (title/abstract) *AND Reporting 
(title/abstract) *AND Healthcare-associated 
(title/abstract) *AND Infections (title/abstract) 
46 
CINAHL Mandatory (title/abstract) *AND Reporting 
(title/abstract) *AND HAI (title/abstract) 
53 
CINHAL Public (title/abstract) *AND Reporting (title/abstract) 
*AND HAI (title/abstract) 
80 
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Results were organized and synthesized with regard to specific pathways examined by 
each article.20,21   Evidence from the review was then used to update existing pathways 
and propose a revised conceptual framework specific to public reporting in the context of 
HAIs and its impact on specific stakeholder groups.  
2.6 Results 
Nineteen studies were identified for inclusion in this review.15,27–44   Fifteen empirical 
publications and 1 systematic review of prior HAI public reporting literature were 
identified in the initial Scopus search.  This review was deemed suitable for inclusion 
because its primary aim was to determine the impact of public reporting on HAI 
outcomes.15  Subsequent PubMed searchers identified 3 additional studies after removal 
of duplicates and reviews of abstracts and full text where applicable.  Review of 
references of included publications was conducted, and one additional study was 
identified which was published as a research paper in the Northwestern University 
Pritzker School of Law, Law and Economics Research Paper Series.40  It was noted that 
this paper served as the source of data for a narrative case-study paper identified in the 
Scopus search and already included in the review.   
In consultation with the study team and after reviewing both texts, it was decided 
that the source paper from Black and Kim (2014) would be used as it contained data and 
results from the empirical study rather than a case description of challenges and findings.  
Studies were then grouped an analyzed in relevance to conceptual framework pathways 
and methodology.   
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Figure 2.2 Literature Search Framework and Inclusion of Studies for Review 
Phase 1: Scopus 
 
Phase 2. PubMed and CINHAL  
 
 
   
62 
 
In total 13 studies described their methodologies as quantitative, four as 
qualitative, one as mixed-methods, and one as a systematic review.  Key characteristics 
of studies were collected and evaluated using a template described in the integrative 
review literature (Appendix A).45  Five studies described a conceptual framework in their 
background or methods, including two that describe the specific pathways previously 
discussed.  However, only one of these studies attempted to carry these pathways through 
to the analysis and discussion portion of the publication.29   
The Change Pathway: Patient Outcomes, Providers, and Organizations 
Berwick and colleagues describes the process of change within organizations and 
individuals as guided and stimulated by performance measurement, yet the specific 
sources of motivation for change remain highly variable.20   In many of the studies that 
examine patient outcomes, the change pathway is invoked with some  noted associations 
between public reporting mandates and patient outcomes.    
Studies using quantitative methods to evaluate public reporting’s impact on HAI 
outcomes showed conflicting results in that some showed decreases in HAI infection 
rates and others did not.  These effects on C. difficile in Canada were noted when 
Daneman and colleagues conducted a longitudinal retrospective cohort study, comparing 
modeled rates of C.difficile without the presence of a mandate to observed rates of the 
infection after the implementation of a mandate.39  Results showed a 26.7% reduction 
(p<0.001) from the expected outcome in C.difficile one year after implementation of 
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public reporting.  This trend was seen across multiple institutions included in the study 
sample of administrative data.39    
A study from Black and Kim (2014) described CLABSI rates before and after 
public reporting mandates in Pennsylvania.40   Researchers used a difference-in-
difference study design, to assess the change in CLABSI rates in Pennsylvania and 
control states, before and after public reporting implementation.40  Comparing 
administrative inpatient CLABSI rates in Pennsylvania to that of control states, the 
authors noted that CLABSI rates fell by 24% in Pennsylvania during the reporting period 
compared to 3% drop in those states without reporting.40  Hospitals with the highest rates 
in Pennsylvania had more significant decreases during the reporting period.  Similar work 
from Pakyz and colleagues38 evaluated the effect of public reporting on CLABSI SIRs 
through a cross-sectional retrospective cohort study.  One-hundred and fifty hospitals 
were divided into three groups: those in states with public reporting meeting three legal 
requirements (data submission, reporting of data to the public and inclusion of facility 
identifiers), those in states with public reporting not meeting the three requirements, and 
those in states without public reporting.38  Findings showed no differences in SIRs among 
all three groups.38  Marsteller and colleagues36 used a similar study design to Black and 
Kim40 to examine the impact of public reporting on CLABSI rates with an additional 
outcome of participation in a national program aimed at reducing the rates of CLABSI in 
the inpatient setting (On the CUSP: Stop BSI program).  Findings indicated that program 
participation was higher in states where reporting mandates were enacted at the time of 
On the CUSP: Stop BSI program implementation, potentially suggesting that pending or 
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new mandates may be associated with participation in process improvement intitiatives.36 
Facilities in states with the voluntary or long-standing reporting requirements had higher 
rates at baseline and greater reduction in CLABSIs during the first 6 months of the 
program with incidence rate ratios (IRR) of 1.48 and 1.14 respectively (p=.002, 
p=.033).36  All groups initiating the process improvement intervention saw decreases in 
CLABSI rates.36  A more recent study by Liu and colleagues (2016) used a difference-in-
difference design to examine CLABSI rates in ICUs and associations with mandatory 
reporting.  With a longitudinal national sample of CLABSI data (n=244 hospitals, with 
1,902 ICU years) from NHSN, the study team concluded that when compared to 25 
months or more prior to the law’s implementation, notable decreases in CLABSIs were 
seen both in anticipation of the law (IRR = 0.66 , p<.001) and long after the laws went 
into effect (IRR=0.343, p=.009) .41   
Three studies involving data from the pediatric population contribute similar 
findings to previous literature.37,42   In a study evaluating clinical outcomes from public 
reporting in critically ill pediatric patients, Rinke and colleagues (2015) used data from 
the Kid’s Inpatient Database (KID) to determine the extent of public reporting’s impact 
on CLABSI rates.  Analysis yielded statistically significant reductions in CLABSIs in all 
3 reporting groups regardless of when or if reporting was initiated (never reporting vs. 
reporting began in 2006 vs. reporting began in 2009) .37  Differences in CLABSI 
reduction between groups were not statistically significant, except in the never reporting 
group which showed a greater reduction when compared to the group that began 
reporting in 2009 (OR=2.1, p<0.001) .37  Flett and colleagues (2015) examined CLABSI 
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public reporting and its impact on point-of-care indicators, specifically blood culture and 
antibiotic use in pediatric populations.  Despite anticipating lower blood culture rates and 
antibiotic utilization multivariable linear regression showed no difference in adjusted rate 
ratios (ARRs) before and after public reporting implementation for either indicator.42   A 
third study in the pediatric population by Zachariah and colleagues (2014) explored the 
relationship between mandated CLABSI reporting, process improvements and outcomes 
in the neonatal intensive care unit (NICU).  The authors found that when compared to 
control states, NICUs in states with mandates more often reported greater than 95% 
compliance with all prevention practices (p=.002) .43  However this did not translate into 
a difference in clinical outcomes as no statistical significance was found in CLABSI SIR 
differences between both groups (mandated reporting vs. no mandates).43 These findings 
were also unable to significantly link NICUs that reported greater than 95% compliance 
with prevention activities and an SIR less than 1.43    Finally, a 2006 systematic review by 
Mckibben and colleagues15 was conducted to evaluate existing evidence for support 
newly enacted public reporting mandates.  While the published report did include 
recommendations for implementing a public reporting program centered on HAI 
performance data, finding from the review showed little empirical evidence suggesting 
the effectiveness of public reporting to improve outcomes.15 
Significant associations between public reporting and lower infection rates are 
noted in some studies, but in general remain inconsistent across the body of literature. 
Studies that showed statistically significant effects were those that used quasi-
experimental methodologies for analysis.36,39–41   .  However, even studies that show a 
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decline in infection rates do not illuminate the pathways by which these laws impact 
these outcomes.   
A diverse sampling of methodologies was used in studies that describe the 
organizational impact of public reporting.  In the first study, Pegues34 described the 
University of California, Los Angeles (UCLA) Health System’s response to the 2009 
Health and Human Services Federal and state HAI Action plan.34  Pegues used the 
Context-Input-Process-Product model, to evaluate the state of HAI prevention prior, 
during, and after process improvements related to state and federal HAI policy, including 
public reporting.  Specifically, he described the inputs of public reporting mandates for 
HAIs as main driver for a host of HAI prevention strategies and process improvements. 34 
Specific needs around reporting prompted additional methods for data validation, unit 
and hospital-specific HAI data reporting strategies (dashboards), and stronger 
surveillance.  These changes improved practice by highlighting trends in HAI rates in 
specific hospital units, allowing for improved infection prevention with targeted 
evidence-based interventions predetermined by the hospital.34  A more expansive 
qualitative study by Uchida and colleagues33used semi-structured interviews of infection 
prevention personnel conducted in six hospitals throughout California.   Thematic 
analysis of responses yielded both positive realizations and specific concerns generated 
by public reporting.  Specifically, respondents believed that mandated reporting 
emphasizes the issue of HAIs in their respective health system and increases cognizance 
of HAI issues across the organization.33  Frustration among respondents was due to a 
perceived disconnect between reporting data to external stakeholders and tangible 
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improvements in HAI-related outcomes.  Specifically participants felt that public 
reporting could not be linked to specific outcomes in their patients, therefore the added 
burden of reporting was challenging to reconcile33 A larger study in California involving 
many of the same researchers from the previous paper used a mixed-methods longitudinal 
approach to evaluate the impact of new mandatory reporting law.31 Pre- and post-public 
reporting surveys were conducted among hospital infection prevention leadership, 
examining a wide range of issues from work processes to outcome measures. These 
surveys were followed by in-depth interviews with six hospitals to gather further 
information.  Statistically significant changes were noted between pre/post reporting 
mandates, specifically in reported adherence to evidence based protocols (use of barrier 
precautions [p<.01], and chlorhexidine usage [P=.02]), as well as a reported decrease in 
CLABSI rates (p<.01) and VAP rates (p=.02) .31  Themes of frustration with increased 
workload, data validation concerns, but also a heightened awareness and prioritization of 
infection prevention within organization were noted from qualitative interviews.31  In a 
similar study with a larger multi-state scope, Stone and colleagues32interview key 
stakeholders, including hospital and state administrators from states with and without 
public reporting mandates.  Results show that while public reporting is key to fostering 
collaboration and increasing organizational awareness, significant concerns still existed.32  
Yet interviewees noted that these public reporting laws are largely responsible for 
highlighting the importance of HAIs within hospital settings and garnering support for 
organizational initiatives to improve outcomes.32   An additional national study from the 
University of Pennsylvania also queried infection control personnel in leadership roles, to 
determine the impact of state mandated reporting on infection prevention processes.35 
68 
 
Thirty-one states, 22 of which had mandated reporting requirements, were represented 
across 110 hospitals.  Contrary to findings in other studies, respondents in states with 
mandatory reporting did not identify added process improvements or a perceived 
decrease in incidence of HAIs when compared to those in states with no reporting 
requirement31,35,43.  Despite issues of small sample size, low external validity, and lack of 
infection-related data, these findings do provide perspective on how mandated reporting 
outcomes are perceived and reported by healthcare professionals. 35   
A final study by McGuckin et al. (2013) described the opinions of hospital 
epidemiologists with regards to mandatory reporting.  Findings suggested that a majority 
of hospital epidemiologists found public reports generated at the state level to be useful 
(70%), and believed that they have a role in disseminating data (96%).30  An additional 
finding from this study is that the majority of the epidemiologists surveyed believed that 
consumers would likely have difficulty understanding HAI data and interpreting it for the 
purposes of healthcare decision-making.30  This finding highlights the proposed role of 
the consumer role in the HAI framework, particularly regarding the selection pathway, 
and yet suggests that consumers may not be well-suited to use these outcome data for 
decision-making.  While clinical outcomes and organizational improvement data are key 
to understanding the effects of public reporting on HAIs, a full picture of the impact of 
public reporting HAI data must include a broader scope of how this available information 
is used by consumers.  Consumer involvement in this decision-making is a central tenet 
to previously described frameworks20,21, however existing public reporting and HAI 
literature reveals a diminished comprehension of these data by consumers.  
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The Selection and Reputation Pathways: Data-driven, Consumer Decision-making  
Understanding the utility of HAI data from the consumer perspective is essential 
to determine the best methods for dissemination and support informed decision-making if 
a goal of policy-makers is to empower consumers to use this data for healthcare decision-
making.46 Four articles discussing consumer knowledge of publicly reported HAI data 
and how those data affect healthcare choices were included in this review.   
A study by McGuckin and colleagues described the results of a telephone survey 
across the U.S. examining public awareness of HAI reporting and its use in selecting a 
hospital for their care needs.44  28% of total respondents in states with HAI laws were 
aware of the reporting laws and the presence of publicly available data.   Only 14% of 
respondents cited HAI data as a one of their top 2 considerations when choosing a 
hospital, with most listing provider recommendation as their main driver for hospital 
selection.44   More education (p<.0001), higher income levels(p=.0007), and previous 
infection were noted in participants who appeared more engaged with and/or aware of the 
HAI data reported in their state (p<.0001). 44   
Two additional studies from researchers at the University of Massachusetts 
examined the presentation and interpretation of HAI data and how these attributes might 
affect healthcare decision-making in a local population.28,29  The first study was a cross-
sectional survey of residents from Worcester, Massachusetts, evaluating formatting and 
structure of publicly available HAI data.29  Eight versions of the reports, each differing in 
consistency of indicators, representation of the data, and the presence of confidence 
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intervals were mailed to participants, followed by the questionnaire.29  From the 201 
questionnaires returned and included in the study, researchers found that inconsistency in 
metrics (i.e. one hospital with highest overall safety score, yet not the lowest HAI or 
mortality rate) pushes consumers to select the aggregate score (safety score) as the 
predominant means of decision-making.29  Similar to the findings from McGuckin et al44 
higher levels of education were associated with higher understandability ratings, 
suggestive of some influence of education on engagement and comprehension of publicly 
reported data.29   
An additional study by Mazor and colleagues28 used semi-structured, in-depth 
interviews, to describe the views about publicly reported HAI data as experienced by 
participants and generate new recommendations for publicly reporting HAI data.  Data 
was shown to participants in three forms: a standard report from the State of 
Pennsylvania, a subsequent “improved” (p.414) report, using varying graphical 
representations and a composite score, and web-based reports28.  Findings from 59 
interviews suggested many participants were unfamiliar with HAI-related terminology 
but interested in the data and prevention strategies.  However, confusion over 
interpretation of data and results continued even after general explanations of HAI 
concepts.  Participants tended to prefer infection rates and mortality compared with other 
measures.28  Similar to their previous study, Mazor and colleagues noted that while HAIs 
were a concern for patients with regard to decision-making and hospital selection, other 
factors predominated including: insurance status, family and friend recommendations, 
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and prior experiences.28,29  Recommendations for improving data presentation included 
stipulations on content and formatting.  
A more recent study from Mansick and colleagues (2015) assessed the 
interpretability of HAI data presented on the Hospital Compare website.  Researchers 
conducted a survey with questions designed to evaluate various domains covered on the 
website including: written descriptions of the data with or without the SIR (Tasks 1 and 
2), identical SIR descriptions with numerical SIRs (Task 3), and only numerical SIRs 
(Task 4) .27  Corresponding tasks were used to gauge how well participants interpreted 
these data in each domain.  Overall, increased complexity of the data (written 
descriptions vs. only numerical SIR data) was associated with lower mean correct 
responses (Task 1: 72%, [95% CI, 66-79%] vs. Task 4: 38% [95% CI, 31%-45%]) 
meaning that as data becomes more complex, participants are less likely to interpret it 
correctly.27  Similar to findings from Mazor28,29 and McGuckin44, those with higher 
education levels had higher mean correct responses on more complex data 
interpretation27.   
A Revised Conceptual for HAIs and Public Reporting 
Considering these findings, a revised conceptual framework for assessing the 
impact of HAI public reporting policy is proposed (figure 3).  This revised framework 
incorporates existing pathways previously described, but proposes new relationships, 
identifies the strength of existing evidence, and puts forward new frameworks for inquiry.   
With respect to the larger framework, new pathways are designated by solid or dotted 
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arrows indicating direct paths between variables of interested.  Dotted arrows are 
consistent with pathways that may be hypothesized but lack evidence or support in the 
literature.  Solid lines indicate conclusive or more mixed findings supporting that these 
pathways do exist, but the mechanism and mediating factors may not be well understood.  
Central to this new framework is the notion that patient outcomes are highlighted as a 
primary target for public reporting mandates and are effected, although inconsistently, by 
public reporting policy.35–38,40–43  However, the pathways by which these outcomes are 
affected are not well described.  The bi-directional nature of this reporting/outcomes 
relationship is important since outcomes are fed back to organizations and consumers, 
potentially stimulating the Change and Selection pathways.  Yet the inconsistency in 
previous findings suggest additional mediating variables and pathways that likely play a 
role in impacting stakeholders.   
Consumer choice operates within the more nebulous concept of the Selection 
Pathway.   It has been established that consumer education level has a remote effect on 
their healthcare decision-making, but most have difficulty interpreting data specifically 
for that purpose.28,29,44  However, one common theme present was reputation, specifically 
how a hospital’s reputation was more likely to impact decision-making than HAI data 
alone.  Because HAI data may contribute to more global reputation and prior evidence 
shows that hospitals are concerned with public reporting’s effects on reputation, it is 
considered a potent mechanism by which data can affect consumer choice.21  This is 
different from the prior stand-alone pathway, and couches the Reputation Pathway within 
the larger concept of selection.  There is a paucity in evidence that selection by providers 
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(referrals) or payers (insurance companies) is affected by reported HAI data, however 
this may be seen in other public reporting literature.8  Likewise, any change undertaken 
by an organization to address its reputation resulting from publicly reported HAI data 
may affect outcomes and, subsequently, consumer choice, but that relationship is not 
well-understood.  Improved outcomes or perceived positive changes within the 
organization may stem from an organizational climate conducive to better HAI 
performance and garner a higher reputation in the community possibly enhancing 
selection.  However, the circular relationship between the Selection Pathway and the 
more intrinsic Change Pathway is not well explored in this group of studies.  
2.7 Discussion  
 This review examines a diverse, but inclusive body of literature specific to public 
reporting of HAI data and its impacts on specific stakeholder groups within the 
healthcare system.  The review encompassed the current state of HAI literature 
evaluating the impact of public reporting mandates on various stakeholder groups, while 
allowing for a wide range of methodologies and inquiry.  However, these methodologic 
variations, coupled with inconsistency in data sources, diversity of outcomes and 
stakeholder groups, produce an incomplete picture of the public reporting’s effects on 
outcomes, organizations and consumer choice.  Yet, the range of findings from these 
empirical investigations do help illuminate the public reporting pathways that drive 
change within health systems and affect consumers’ healthcare decision-making.  
This review shows similar findings to previous work regarding the conflicting 
evidence that the public reporting of healthcare performance data has a significant impact 
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on patient or clinical outcomes.8,15,47  The Change Pathway described by Berwick and 
colleagues20, relies on this conceptualized relationship between performance monitoring,  
Figure 2. 3 Revised Framework for Assessing the Impact of HAI Reporting Policy 
 
This framework, adapted from Berwick et. al, 20 and Hibbard, et. al,21, addresses the complexities in relationships 
between public reporting, outcomes, organizations and consumers.    Dotted arrows represent limited or lacking 
evidence for proposed directional pathways by which the larger encircled concepts may be affected by public 
reporting.  For example, public reporting has a notable impact on organizations, but the specific ways in which their 
impacted and how they affect outcomes is still not well documented.  Solid lines are indicative of more established 
relationships in the literature (i.e. findings showed hospital reputation impacted consumer decision-making, but how 
HAI data affects reputation is not well understood). Dotted lines are used to describe the impact of HAI data on 
consumer choice, largely because consumers report an overall lack of awareness around publicly reported data.  
75 
 
intrinsic change in organizations, and improving outcomes.  However, while some studies 
in this review showed significant HAI reduction associated with these laws, few could 
delineate mediating pathways or processes that may explain these reductions.36,39–41  
Sensitivity analysis conducted by Liu and colleagues41 showed a reduction in central line 
days and increasing work-time by infection preventionists in the months leading up to 
and well-after the laws were in place.  Interestingly, anticipation of the law seemed to 
influence outcomes as well, suggesting organizational change and preparation in 
anticipation of these laws is a possible explanation for their impact.36,41   Although any 
change in the organization would be pushed through to providers, when clinical decision-
making was evaluated, no evidence of reporting policies’ impact was seen on antibiotic 
use or blood culture rates suggesting the change pathway may be more complex that 
previously described when applied to HAIs.20,38   Although some studies have found a 
reduction in HAIs associated with these laws, the presumed effects of organizational 
change that potentially mediates this pathway is not well understood.  Essentially the 
“why’s and how’s” of the Change Pathway, remain elusive.   
These gaps in the literature are partially illuminated by the qualitative and mixed-
methods studies examined in this review.   Both Pegues34and Stone et. al31directly 
describe the development and implementation of process improvements to improve HAIs 
in response to public reporting mandates.  Perhaps even more importantly, four studies 
identify the improved awareness and heightened attention that public reporting brings to 
HAIs within an organization.31–34  The study by Stone and colleagues31 in 2011 also 
pointed to the importance of organizational climate-related concepts including teamwork, 
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accountability and communication.  These organizational climate findings were echoed in 
work by Uchida et. al33, and described in detail by interview respondents.  Findings 
pointed to the importance of effective communication and sustained collaboration.33  
While these studies may help to explain aspects of the Change Pathway, additional 
research is needed to describe fully the effects of these laws on both organizations and 
their outcomes.  Mediating processes and organizational contexts may play an influential 
role, and research examining these factors is essential.  Where these studies fall short 
however, is describing the proposed Selection Pathway with regard to provider and payor 
selection.  No effects of public reporting on provider or payor selection were identified in 
the HAI literature included in this review.  However, the Selection Pathway does appear 
to play a role in consumers’ use of the data, albeit with the caveat that understanding and 
utility of the data among consumers remains challenging.   
Results from this review contend that while consumers do acknowledge publicly 
reported data as a factor in hospital selection, interpretability of the data remains difficult 
and other factors predominate in healthcare decision-making. 27–29,44  HAI outcomes 
remain a lower priority for selecting a care provider or institution behind insurance status, 
prior experience, recommendations of family or a provider, and location.28,29,44  While 
HAI data do not appear to directly affect the Selection Pathway for consumers, the 
Reputation Pathway may be an important mediator.  Mazor, Dodd and Kunches29 
qualitative work from 2011 found that a hospital’s reputation was second only to personal 
experience when influencing consumers’ decision-making around hospital selection.  The 
larger concept of healthcare facility reputation may in fact be affected by publicly 
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reported HAI data and could alter consumer choice when selecting a hospital.  However 
given the difficulty consumers have shown in interpreting HAI data, the concept of 
reputation would likely be more global than nuanced, when using HAI data alone.27,29  
Three studies also pointed to the recommendations of healthcare providers as an 
important consideration for facility selection.28,29,44  Hospital reputation perceived by 
healthcare providers may be more affected by publicly reported healthcare data and 
contribute recommendation for one institution over the other.  This presumption has not 
been well-explored in the published HAI public reporting literature, and remains a 
hypothesized pathway by which reputation affects selection.  The available data suggests 
varying ways that consumers may approach the HAI data and select the hospital where 
they receive their care.  
A potential theoretical foundation for empirical investigation of the relationship 
between publicly reported HAI data and consumer choice is behavioral economics (BE) 
research. BE examines the impact of multiple emotional, psychological and social factors 
or constructs that can alter decision-making.  With respect to healthcare, BE posits that 
people do not make decisions based only solely on available knowledge that would signal 
the highest quality hospital, but are greatly affected by a host of social contexts, and 
attentional and cognitive restraints that cloud rational choice.48,49  Concepts of heuristics, 
framing, limited time and/or capacity to assess all available knowledge (bounded 
rationality) and loss aversion could provide testable pathways for exploring HAI data and 
consumer decision-making. 
Work from Mazor and colleagues29 discussed in this review, reports on the 
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potential importance of framing HAI data as a means of invoking consumers’ desires to 
avoid losses and seek gains.29  However, this concept remains largely unexplored in the 
HAI public reporting literature.  BE and its associated theories fit well within the revised 
public reporting framework developed from this review.  Decision-making can be guided 
by data if presented in an effective manner and behavior change can be perpetuated by 
thoughtful BE-focused initiatives.50  In future research that tests components of these 
pathways, interventions supported by BE principles may prove useful and more 
sustainable. As described previously, the Change Pathway remains somewhat undefined 
in this body of HAI literature.   
It is apparent that quantitative and qualitative methodologies are both needed to 
elucidate the specific mechanisms that affect hospitals as a result of public reporting.  
Organizational process improvements and climate characteristics are presented in this 
revised framework as potentially lying on the causal pathway between HAI data and 
outcomes.  Organizational climate and its associated constructs (i.e. leadership strategy, 
communication, and collaboration) serve this framework well as a structures for defining 
relationship between data reporting and outcomes.51  While the impact of these HAI-
related changes is difficult to link to outcomes, a specific relationship between 
implementation of public reporting and an improvement in outcomes was evidenced in 
quantitative studies.36,39–41  Outside literature has also had difficulty linking 
organizational climate components to outcomes, however some positive findings have 
been noted in previous investigations.51  Presumably organizational climate, as impacted 
by the presence or implementation of public reporting may be perpetuating outcomes 
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oriented around HAI performance.  More salient in this new framework is the knowledge 
that reported data may stimulate some change toward better outcomes, yet the exact 
mechanisms of how this happens and in what contexts these changes are implemented, 
remain largely unknown.   
A potentially valuable strategy for exploring the relationships between publicly 
reported HAI data, organizations, and outcomes is the use of implementation science (IS) 
research.  IS investigates how evidence-based practices are systematically implemented 
and sustained in practice and has been promoted as means of improving uptake of 
infection prevention practices.52  While IS incorporates many concepts and constructs, 
the goal of this research is to understand the challenges and successes specific to 
implementation and sustainability.  The discipline has embraced structured frameworks 
to guide these inquiries while incorporating larger contextual factors, such as broad 
policy mandates that contribute to organizational functioning.   The Consolidated 
Framework for Implementation Research (CFIR) proposed by Damschroder and 
colleagues53 could help to guide inquiry around the unique pathways by which publicly 
reported data stimulates and sustainable change within healthcare organizations.  Two 
constructs within the framework lend themselves particularly well to examining the effect 
of public reporting.  The Outer Setting is described as a set of factors that exert influence 
on the healthcare organization and affect its ability to implement and/or sustain evidence-
based practices.53  These factors may include relationships with the community or other 
healthcare facilities (i.e. reputation and perception), peer pressure, and external incentives 
or policies (i.e. public reporting mandates and benchmarking) .53   The Inner Setting 
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construct involves the complex relationships and characteristics that enable or slow the 
implementation of process improvements and evidence-based practices.  Some of these 
factors noted in the CFIR framework include communication structure and practices, 
leadership engagement and feedback mechanisms. 53  These factors are similar to those 
identified in this review as organizational factors that are often reported as being affected 
by public reporting mandates.  Since IS research accounts for these constructs as 
facilitators or barriers to successful process improvements, the models and frameworks 
within this emerging field are well-suited to examine the organizational effects of policy 
mandates.  However, public reporting remains distinct in that the mandate itself is not an 
evidence-based intervention, but more so meant to stimulate improvement-oriented 
changes within individual organizations.  Still, IS may prove useful in unpacking the 
intricate relationships between these laws and implementing sustainable improvement 
processes in organizations.   
This review is subject to limitations.  First, the limited time-period for study 
inclusion potentially missed other articles that fit within the sampling framework and 
discussed HAI outcomes of public reporting.  However, the bulk of HAI public reporting 
policies were implemented during this time, and previous reviews showed little evidence 
of HAI outcomes relative to public reporting laws in empirical research prior to 2006.8,9,15  
Second, commentaries, HAI data validation studies, and theoretical papers were excluded 
from this research, despite their contribution to the HAI public reporting body of 
literature.  While these studies impact the larger picture of public reporting controversy, 
they do not target specific components of existing frameworks, nor do they empirically 
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evaluate the impact on stakeholder groups. Additionally, over the past 4-5, years data 
validity has improved across states and institutions with the use of NHSN for publicly 
reporting HAI data.  The primary aim of this paper was to integrate findings from these 
studies to propose n revised conceptual framework that illuminates the pathways through 
which public reporting may influence influences HAI outcomes and processes. Yet the 
diverse methodologies, study designs, and outcomes made this body of literature less 
conducive to a systematic review methodology.  An integrative review methodology was 
specifically chosen for the purposes of synthesizing diverse empirical sources and 
conceptualizing a revised frame work for evaluating the relationships between HAI 
public reporting, outcomes and stakeholder groups.  However, this review and the 
subsequent framework may have missed critical pathways because they have not yet been 
empirically explored or published.  This remains a proposed framework and will need 
ongoing evaluation as new pathways emerge or existing pathways are tested. 
2.8 Conclusion 
The public reporting of HAI data impacts stakeholders through a multitude of 
potential pathways and mechanisms.  Prior to this work, no reviews had sought to 
examine the Selection, Change and Reputation Pathways in the context of HAI data and 
their impact on various healthcare system stakeholders and outcomes.20,21   This review 
contends that these pathways are important, but much more complex than previously 
assumed.  A revised framework for understanding these complexities is presented; it 
illustrates the directional components and key concepts that drive improvements and 
determine choice using publicly reported HAI data.   The framework also highlights BE 
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and IS as new foundations and directions for investigation by which researchers can 
examine causal pathways and conceptual relationships.  Despite the expansiveness of 
these laws, much is still unknown their effects on consumers, organizations and the larger 
policy environment.  More research is needed to determine how best to design, 
implement, and evaluate these policies to ensure they are meeting their intended goals, to 
improve patient outcomes and guide consumer choice.   
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Abstract 
Background: Healthcare-associated infections(HAIs) are a significant cause of morbidity 
and mortality in U.S. hospitals.  Blood stream infections (BSIs) with Methicillin-
Resistant Staphylococcus aureus (MRSA) and gastrointestinal infections caused by 
Clostridium difficile (C. difficile) are HAIs associated with increased risks for 
complication, prolonged-hospitalization and death in acutely ill populations.  As a result, 
policy-makers have implemented state laws that mandate the reporting of these infections 
to state officials, often for the purposes of publicly disseminating this information.  
Purpose: The purpose of this study is to determine the impact of state HAI reporting 
mandates on laboratory identified C. difficile infections and MRSA BSIs in U.S. 
hospitals. Research Design: This is a quasi-experimental longitudinal secondary data 
analysis was conducted using state public reporting law information and infection data 
from a national sample of U.S. hospitals. Methods: Bivariate analysis was completed to 
examine differences in characteristics of reporting hospitals and baseline infection data in 
hospitals in reporting and non-reporting states. Poisson regression was used to model 
temporal impacts of implementation of the law on hospital-wide, Hospital-onset C. 
difficile and MRSA BSI laboratory-identified event rates as compared to hospitals in the 
same month in non-reporting states.  Results:  Compared to pre-law implementation, no 
statistically significant difference was seen in C. difficile infection rates in the time after 
the law, when controlling for secular trends and hospital characteristics.  Sensitivity 
analyses revealed similar findings.  Outcomes related to MRSA BSIs were unable to be 
ascertained due to an inability of the model to converge.  Conclusions:  State mandates 
for HAI reporting are present in most US states.  Our investigation did not show a change 
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in infection rates relative to implementation of these laws.  More research is needed to 
determine the impacts of these laws over time.    
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3.1 Introduction 
Healthcare-associated infections (HAIs) continue to be a significant source of 
morbidity and mortality in the United States (U.S.).  Device-associated infections 
including central line-associated blood stream infections (CLABSIs), catheter-associated 
urinary tract infections (CAUTIs), and ventilator-associated pneumonia (VAP) continue 
to impose a significant burden to health systems and patients.  Approximately 722, 000 
HAIs occurred in 2011, resulting in some 75,000 deaths in the U.S.1, while healthcare 
costs attributable to these infections can be upwards of 33 billion doallrs.2  Device-
associated infections, including those previously mentioned, are often targets for 
improvement within the healthcare system because they are often perceived as a 
preventable source of extraneous health system expenditures and poor patient outcomes.3   
However non-device associated HAIs including those caused by Clostridium 
difficile (C. difficile) and Methicillin Resistant Staphylococcus aureus are also implicated 
in poor patient outcomes and excess financial burdens for payers and systems.2,4–6   
Recently the U.S. Department of Health and Human Services (HHS) has included MRSA 
and C. difficile measures as part of the Value Based Purchasing program (VBP) to 
provide incentive to hospitals that successfully decrease these infections.7  This is in 
accordance with the HHS HAI Action Plan8 and subsequent updated targets for MRSA 
and CLABSI reductions by 2020.  While guidelines for the prevention of healthcare-
associated MRSA9 and C. difficile infection10 are well established, policymakers have 
used mandated reporting of HAI-related performance measures as means of attempting to 
inform consumers and stimulate organizations to improve quality of care.  As of 2013, 37 
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states had some mandate for public reporting of HAI data including 20 states requiring 
the reporting of MRSA bloodstream infections and 20 requiring C. difficile reporting.11,12   
The aim of this study is to conduct a secondary longitudinal data analysis to 
determine the impact of public reporting mandates on MRSA and C. difficile rates in 
acute care hospitals across the U.S.  No previous studies have examined the impact of 
these laws on rates of these infections; this study will evaluate these effects and inform 
the design of health policy interventions for the reduction of HAIs.  
3.2 Healthcare-associated MRSA and C. difficile Infections 
Both MRSA and C. difficile infections are prevalent HAIs within health systems 
across the U.S.  While disease course and pathogenesis differ, both bacterial infections 
can lead to prolonged hospital stays and worsened clinical outcomes for patients.     
MRSA BSIs are associated with an increased risk of death particularly in older 
and critically-ill adults.13  Rates of MRSA-related disease rose in healthcare settings in 
the early 2000s; soon reducing its incidence became a priority for both policymakers and 
health systems.6,14  Invasive MRSA, particularly BSIs, declined starting in 200515 but 
continued to be a prominent source of HAI-related morbidity and mortality.  Kallen and 
colleagues15 showed a total reduction in MRSA BSIs (-11.2% [95% CI, -15.9% to -
6.3%]) from 2005 to 2008.  A study examining rates from 2005-2011 showed a total 
reduction in invasive MRSA of 54% during the study period yet noted a continued 
presence of the HAI with 14,156 healthcare facility-onset MRSA infections occurring in 
2011.16  Data from the U.S. Centers for Disease Control (CDC) notes that Hospital Onset 
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(HO) MRSA BSIs, have decreased nationally by 13% from 2011 to 2014.1  However, 
closer examination of the data yields some increases in certain states during the same 
period.  These variations indicate that some states have not seen the same HO-MRSA 
BSI reductions as others.    
Similar to MRSA BSI, C. difficile infections have also continued to pose a burden 
to healthcare systems across the country.  Recently, a study by Desai et. al (2016), 
estimated 439,237 incident C. difficile infections occurred in 2014, with roughly two-
thirds originating in healthcare settings.  Data from the CDC’s National Healthcare 
Safety Network (NHSN) showed an 8% reduction in infections in 2014 when compared 
to the 2011 baseline1.  However, comparison of 2013 to 2014 data showed increases in 
these infections despite the overall decreasing trend; C. difficile being only one of two 
HAIs to see an increase during this time.   
Despite some indication that these infections are decreasing within healthcare 
institutions, their financial impact on the system continues to be burdensome.  C. difficile 
infection contributed an estimated an $1.5 billion USD in expenditures in 201117.  A 
review of the literature conducted by Scott in 20092, found attributable costs to 
healthcare-associated C. difficile was between $5,042 and $7,179 USD per infection. 
However, the author noted that the study reviewed did not include operative costs should 
the patient have surgical complications from infections, potentially understating the true 
costs of complex C. difficile cases2.  A more recent modeling study from 2016 estimated 
the total cost of C. difficile infections within the healthcare system, including long term 
care facilities (LTCs) and long term acute care hospitals (LTACs), was $4.7 billion 
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accounting for 87.6% of total C. difficile related healthcare expenditures in the U.S.18  
Zimlichman and colleagues (2013) published a paper detailing the total burden of HAIs 
on the U.S. health system and found that CLABSIs due to MRSA had some of the highest 
costs at $58,614 USD ([95% CI, $16 760-$174 755]).  A 2010 study comparing costs 
associated with MRSA and Methicillin-Susceptible Staphylococcus aureus (MSSA) 
infection showed unadjusted median costs to be more than twice as high in hospitalized 
patients with MRSA versus MSSA infection (P <.001)19.  The authors found that MRSA 
infections were associated with higher costs across multiple strata including age, 
infection site, severity of comorbid conditions (Charlson indices); those with MRSA and 
a Charlson index of 4 or greater had mean adjusted costs roughly $25,000 higher than 
those with MSSA19.   Since these infections serve as a significant source of financial 
burden and patient morbidity within the health systems, over that past decade 
policymakers devised laws to mandate the reporting of these infections, often for public 
dissemination to promote health system accountability, aid in consumer decision-making 
and improve patient outcomes. 
3.3 Public reporting of MRSA and C. difficile in Healthcare Settings  
 Laws mandating the public reporting of healthcare-associated MRSA and C. 
difficile have been in place since 2005 and 2008, respectively11.  As of 2013, 20 U.S. 
states had laws mandating the reporting of these infections, although not all states report 
all HAIs uniformly.  A study by Herzig and colleagues11, showed that after initial laws 
were passed for the public reporting of these infections, an accelerating trend in the 
passage of these laws was noted.  Nearly half of the laws pertaining to MRSA were 
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passed during or after 2012, and those pertaining to C. difficile were passed in 2013.   The 
authors noted that this trend coincided with the implementation of Centers for Medicare 
& Medicaid Services’ (CMS’) Hospital Inpatient Quality Reporting Program(IQR)11, a 
program designed to provide hospital-related data to consumers and financially reward 
hospitals for reporting their quality-related data. The Hospital IQR program began 
requiring data submission for HO-MRSA BSI and HO-C. difficile infections in January 
of 2013.20  Similar to these national reporting policies, the majority of state mandates for 
HAI reporting include provisions for submission of data to an oversight entity (typically 
state health departments or NHSN), the dissemination of that data to the public, and the 
public reporting of facility identifiers that coincide with that data.21   
 While much has been written about C. difficile and MRSA BSIs in the healthcare 
setting, little is known about the effect of mandated reporting laws on these infections.  A 
widely-referenced framework that describes the relationship between reporting healthcare 
performance related data, indicate that the potential of these reporting laws to stimulate 
change and improve care is related to various pathways by which these laws impact 
behavior22.  Berwick and colleagues22 relate the impetus of monitoring and reporting to 
change behavior via a Change Pathway and Selection Pathway.  These pathways are 
reliant on intrinsic motivators within providers and organizations who want to improve 
care and outcomes and the stimulus of external stakeholders (consumers, payors, etc) to 
drive improvement by potentially effecting market-share and revenue.22  An additional 
pathway proposed by Hibbard et al.,23 posits that hospital’s concern for market share and 
reputation are actually stronger drivers of change than those pathways suggested in 
100 
 
previous frameworks.  This effect was most noted in hospitals which tended to perform 
more poorly on key quality measures when compared to their peers.23  
The current body of literature exploring the impact of mandatory reporting on 
infection rates has yielded mixed findings.  A recent systematic review and meta-analysis 
exploring clinical outcomes, primarily mortality, found that implementing public 
reporting was associated with a noted improvement in mortality across 10 studies (RR of 
0.895 [95% CI 0.79-0.92]).24  However this review only included one study with an HAI 
related outcome.  More HAI-centric literature has attempted to evaluate the impact of 
these laws, focusing primarily on CLABSIs.  A recent study by Liu and colleagues25 used 
longitudinal data to examine the impact of reporting mandates over multiple states.  The 
authors found a reduction in mean CLABSI rates both in anticipation of the laws and 
long after the laws’ implementation.  Similar findings were seen in a study by Black and 
Kim.26  CLABSI data from Pennsylvania was examined longitudinally with data from 16 
states with no reporting mandates used as a control.  The researchers found a statistically 
significant reduction in CLABSI rates, particularly in hospitals with higher baseline 
rates.26  A subsequent study by Marstellar et al.27 found hospitals in states that had 
pending or recent implementation of mandates had increased participation in a 
performance improvement program designed to aid in CLABSI reduction.  The authors 
did show a trend toward greater reductions in CLABSI rates in states with reporting 
mandates, but the differences were not statistically significant.  Additional studies 
examining the impact of these laws to reduce CLABSI rates have not shown an effect, 
including in point-of-care practices such as antibiotic and blood culture utilization 
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rates.28,29  To the authors’ knowledge, only one study has been published examining the 
effects of public reporting on C. difficile rates.24  Studies specifically evaluating the 
effects of mandatory reporting have shown some positive effects, but also more mixed 
findings.  While a host of studies have examined CLABSI rates and mandated reporting, 
the only study to date has examined the relationship between public reporting and C. 
difficile rates.  
A study from Daneman and colleagues30 evaluated the impact of hospital public 
reporting laws on C. difficile infections using longitudinal data from 2002 through 2010.  
Public reporting in this cohort began in September 2008, and the authors used the 
previous data to model age-specific predicted monthly C. difficile rates as if had no 
public reporting occurred30.  These 2008 modeled rates were then compared to 2008 
observed rates to determine the impact of public reporting during the study period.  The 
authors found a significant reduction in observed C. difficile rates in the post-intervention 
period compared to predicted rates (8.92 per 10,000 patient days compared to 12.16 per 
10,000 patient days, P<0.001 [95% CI 11.35-13.04])30.  The authors also noted a total 
reduction of C. difficile cases of 26.7% (95% CI 11.35-13.04) over the first year of post-
public-reporting implementation.    
While these findings show an effect of the Canadian public reporting laws, 
additional study is needed to determine the effect of reporting mandates in U.S. states has 
similar impacts on C. difficile.  Additionally, no studies have evaluated the impact of 
these laws on MRSA rates in U.S. hospitals.  Further investigation is warranted to 
understand if the impact of these laws seen in previous studies extends to MRSA BSIs, 
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and coincides with previous findings regarding C. difficile.  To address this need, our 
study aims to investigate the impact of state reporting mandates on both C. difficile and 
MRSA in U.S. hospitals.  
3.4 Methods 
This study used a quasi-experimental design to determine the effect of public 
reporting mandates on Hospital Onset C. difficile (HO-C. difficile) and Hospital Onset 
MRSA blood stream infections(HO-MRSA) in hospitals across the U.S.  This design 
allows for the examination of longitudinal trends in the pre-and-post policy intervention 
period.31 A difference-in-difference design is often used to compare changes in outcomes 
over a time period between two groups, one of which has experienced a particular 
treatment or intervention.31   This study design involves a variant in the traditional 
difference-in-difference in that varying implementation times by state are considered in 
the analysis.  Hospitals which submitted pre-and post-reporting mandate infection data 
were included to model the effect of the law on infection rates relative to pre-reporting 
infection rates in states with mandated reporting.  This methodology allows for the 
assessment not only of the impact of the law, but of how these effects may change in the 
time prior to and after the laws implementation. This model was adapted from a study by 
Liu and colleagues25 who examined the impact mandatory reporting on CLABSI rates in 
ICUs, the results of which were discussed previously.   
The study compared the rates of HO-C. difficile and HO-MRSA laboratory-
identified events (LabIDs) over time in hospitals in states without public reporting to 
those in states that implemented mandatory reporting during the study period.  Hospitals 
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were selected as the unit of analysis rather than intensive care units (ICUs) because 
hospitals reported facility-wide C. difficile and MRSA data with equal or greater 
frequency than individual ICUs in this data set as is in keeping with NHSN reporting 
structure.32  Additionally, this allowed the capture of infection data across the facility 
including infections reported outside of the ICU setting.  State-level public reporting 
status was determined through a review of the published literature and legislative 
documents. 11,12,33  This was set as the date of implementation for this analysis.   
Sample 
Infection and hospital level data used for this analysis comes from facilities 
participating the Prevention of Nosocomial Infections and Cost Effectiveness Refined (P-
NICER) survey, completed in 2011 study (National Institutes of Health, RO1NR010107: 
Stone, P.).  Sampling methods and specifics of survey development are described 
elsewhere.34  Briefly the P-NICER survey was conducted among infection prevention and 
control leadership in hospitals that participated in the NHSN.  Participation in NHSN at 
the time of the survey was voluntary if hospitals were not mandated to report infection 
data.  All non-VA hospitals were eligible for inclusion.  Researchers who developed and 
implemented the survey decided against recruitment outside of the NHSN reporting 
hospitals due to concerns around quality and validity of the data.34  Participation in 
NSHN allows for infection event reporting based on specific surveillance criteria as well 
as pre-defined outcome measures including guidance on determining infection rates, 
prevalence and risk-adjusted standardized infection ratios (SIR) .32,35  The P-NICER 
survey captured data on a variety of infection prevention related resources and practices 
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as well as organizational climate, public reporting and process improvements.34    A 
subset of participating hospitals joined the P-NICER NHSN research group and agreed to 
provide NHSN reported infection data from the C. difficile/MDRO reporting module, as 
well as data regarding CLABSIs.   
A total of 975 hospitals were represented in the sample (29% response rate) .34  
To determine the generalizability of survey results, the CDC compared characteristics 
between responders and non-responders and did find some differences in facility 
characteristics.34  Non-responders tended to be smaller facilities with fewer admissions 
and patient days; additionally, differences were noted in geographical region.  No 
significant differences were noted when comparing CLABI rates in respondents and non-
respondents which supports generalizability of survey results despite a moderate response 
rate.34   
At the time of the survey (2011) approximately 73% of facilities were located in 
states with mandated HAI public reporting.36  As part of the NHSN reporting program, 
hospitals fill out a plan designating measures and frequency of data reporting.  Hospitals 
that chose to participate in the various surveillance modules must use the pre-designated 
criterion for case definitions of HAIs and subsequent infection reporting.37   Both active 
and passive surveillance techniques are encouraged for each appropriate reporting 
module.  Hospitals are also required to complete an annual survey which collects 
information regarding certain facility characteristics, relevant annual denominator data, 
infection control practices, and microbiology laboratory practices38.  Surveillance-defined 
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infection data are submitted regularly along with the appropriate denominator data 
according to pre-specified reporting frequencies.32    
Outcome Variable 
The outcome variables of interest for this study were HO-C. difficile LabIDs and 
HO-MRSA blood stream infection (BSIs) LabID events weighted by patient days as 
defined in the MDRO and C. difficile reporting module in NHSN.32  HO-C. difficile 
LabID rates werecalculated as the number of HO-C. difficile LabID events per 10,000 
patient days whereas the number of HO-MRSA blood LabID rates are defined as events 
per 1,000 patient days as defined in the most NHSN reporting module32.  Rates per 
patient days for each hospital were evaluated at monthly intervals, the smallest unit of 
time at which data is aggregated and reported through the NHSN.  Typically in federal 
and state-based reporting, HO-C. difficile and HO-MRSA BSIs are reported as LabIDs, 
but are also reported as surveillance-defined infections separate from the LabID event.32  
These infection definitions are slightly different than the LabID event definition, relying 
on additional patient level information, including symptomology to meet the infection 
criteria. Because LabIDs for both HO-MRSA and HO-C. difficile rely on the presence of 
positive diagnostics rather than symptoms or case definition, reporting these events was 
meant to be less burdensome on the healthcare institution while providing an appropriate 
proxy for the incidence of surveillance-defined infections.32  HO-MRSA BSI LabIDs are 
reported for unique blood specimens that test positive for MRSA greater than 3 days after 
admission.  Similarly HO-C. difficile LabIDs are those positive test results (the presence 
of C. difficile organism and or its associated toxin) in unformed stool specimens greater 
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than 3 days after admission.32   The guidance from NSHN is clear that reporting for both 
these LabID results should be on specimens sent for the purposes of diagnostic testing 
only, to prevent inflated infection counts as a result of screening initiatives or other 
screening protocols.  The use of LabIDs as a proxy for infection surveillance-defined 
cases of C. difficile and MRSA BSIs can lead to some discrepancy between metrics.  An 
evaluation of data submitted to the New York State Health Department in 2009 showed 
the incident HO-LabID C. difficile rate to be 29% higher than that of surveillance-defined 
hospital onset infections, but overall case-status match for all C. difficile infection of 
81.3%.39  The authors also noted this effect was relatively consistent across hospitals 
included in the study (Pearson Correlation Coefficient = 0.84) and proposed the reporting 
of LabID events to be a sound and valid measure for the public reporting of C. difficile 
events.39  A similar study examining MRSA blood LabID reporting to surveillance 
defined MRSA BSIs showed larger discrepancies than in C. difficile, with concordance 
ranging from 61%-76% in HO-MRSA BSIs.40  The authors suggested that a majority of 
the discrepancy lies with the differences in onset definition; for surveillance defined HO-
MRSA BSIs any cases on or after day 3 are reported, whereas for HO-MRSA blood 
LabIDs those specimens positive  on or after day 4 are reported.40  To date, however, this 
definition has not changed in NHSN reporting and remains a key component in state 
reporting mandates.32  Additionally LabID events for both C. difficile and MRSA BSIs 
remain the metric mandated by other reporting initiatives including CMS’ Hospital IQR 
program and Value-Based Purchasing.  
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Statistical analysis 
 Descriptive statistics of sample hospital characteristics were conducted.  Testing 
for differences between groups was completed t-tests and χ2 for hospitals in reporting 
states and non-reporting states from 2008 to 2012.  Unadjusted trends in HO-C. difficile 
LabID rates and HO-MRSA blood LabID rates were calculated based on mean monthly 
rates for all hospitals and compared between reporting and non-reporting states.     
 To model the effects of public reporting mandates on HO-C. difficile and HO-
MRSA BSI LabID rates a Poisson regression model was selected.  This model is well 
suited for modeling count data and has been used previously to examine the effects of 
public reporting on incident HAIs25.  The Poisson model assumes that the mean and 
variance of the distribution from which observations are counted are equal and that the 
count data has the possibility of zero counts. 41  Separate models were developed for both 
C. difficle and MRSA count outcomes.  As hospital characteristics reported in the NHSN 
survey are largely independent of temporal trends (e.g. affiliation with an academic 
medical center and profit status), a hospital (unit-level) fixed effect was used to control 
for these potential covariates that might confound the relationship between reporting and 
infection rates.  A fixed-effect model was selected because it is robust to unobserved 
variables, particularly those may differ across units, but are unchanging within units over 
time.  Additionally, admission prevalence rates for these infections were assessed and 
noted to have an increasing trend over the study period and are likely not associated time-
invariant characteristics of the hospitals (figure 3).  Therefore, this prevalence rate was 
added as a covariate in the model.  Consistent with NHSN rate calculations, monthly 
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patient days as defined specifically for C. difficile and MRSA (exclusive of units 
designated with a separate CMS designation as inpatient rehabilitation facilities or 
inpatient psychiatric facilities and, for C. difficile only, infant-designated locations) for a 
given hospital at a given month was included and will serve as the offset in the model.   
The use of an offset allows the count data to be modeled as a rate and serves as the main 
exposure for modeled events.   
Indicators representative of the timing of implementation of the law in each 
hospital’s state serves as an interaction term for the presence of the law and being in a 
reporting state.  A series of binary 3-month indicators will be used to account for time 
differences relative to implementation of the laws during the study period and are 
represented in the model for each given hospital at a given month.  This will allow for the 
determination of the policy effect with relevance to the timing of implementation of the 
public reporting law, which vary from state to state. Implementation time (time when 
data submission was first required) was determined by review of existing literature and 
review of state HAI websites and/or published legislation.11,12  To account for trends in C. 
difficile and MRSA BSIs over the study period, monthly indicators were used as a fixed 
effect for calendar time.  The independent variable of interest is Li,s(t) in the model below 
where the term is defined as the time difference relative to the law in hospital i, in state s, 
during month t.  Dit serves as the offset and represents the log of patient days respective 
to facility i in month t, while βadmprevit is the term representing admission prevalence rates.  
The coefficient λ is the estimated mean difference in incident rates for the infection of 
interest relative to non-reporting states in the same time-period.  The proposed model is 
109 
 
as follows, where Yit is the LabID counts for facilityi at montht) has a Poisson distribution 
with a mean µit and βi and βm(t) are fixed effects for facilities and calendar time, 
respectively:  
Yit = βi + βm(t) + βadmprevit + γ log (Dit) + λLi,s(t) 
 Appropriateness of the Poisson distribution was assessed using the Chi-square 
goodness of fit test.  Robust standard errors were used to correct for overdisperssion in 
the model, a common problem in Poisson regression often resulting from correlation 
between responses as is possible here between repeated hospital unit measures over the 
study period.41   
The prevalence of zero values in the outcome data was assessed to determine the 
impact of excess zero counts on the need for further measures to address this.  Zero-
inflated Poisson regression was used with the same terms and covariates as the original 
model, but addressing the issue of excess zero counts, by assessing both the binary 
probability model of zero as the outcome and the Poisson probability delineating the 
outcome of infection (zero or a count) given an exposure (patient days).  In our model, 
we hypothesize the binary probability to stem from outside factors which may influence 
hospitals ability to report on C. difficile infections during the study period.  This may 
include lack of infrastructure or ability to conduct surveillance and report infections.  
This was assessed by examining data points to look for patterns which may indicate 
difficulty with reporting that would predispose the data to excess zeros outside of the risk 
for infection, particularly serial rates, infection counts, or exposures of zero in hospitals 
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throughout the study period. The Voung test for the preference for the zero-inflated 
model was conducted.   
A random effects model incorporating time as a continuous variable and including 
a hospital random effect was used as a sensitivity analysis.  “Reporting” and “non-
reporting” status was refined to include hospitals in states with reporting mandates now 
defined as “non-reporting” if they were in the pre-law period.  This allowed us to 
evaluate baseline IRR between reporting and non-reporting groups as well as the 
differences in slope, indicating change in infection rates over time between the two 
“reporting status” groups.  The random-effects estimator allows for modeling changes in 
rates in while accounting for correlation within states.42   
   Coefficients generated from the Poisson model are reported as incidence rate 
ratios (IRRs) for the relative time interval before or after implementation of the law and 
are interpreted as change in the mean rates of HO-C. difficile and HO-MRSA BSI 
LabIDs25,41.  Statistically significant differences from the referent category will be 
reported for those IRRs with a pre-determined p-value < .05.  All analyses were 
conducted using Stata statistical software version 14.2.43  
3.5 Results 
 Early in model determination and testing, we discovered that the data for HO-
MRSA BSI LabIDs would not converge in our analysis.  Subsequent testing and 
evaluation hypothesized that the count data within the data set was unable to generate 
findings given our proposed model, due to an abundance of zero counts and counts of 1 
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(Figure 1).  As a result it was decided that MRSA BSIs will be dropped from the analysis 
for this study and primary analyses and interpretation of results would center on HO-
C.difficile events.  
Over the study period, specifically from September 2008 to June 2012, 5,454 
hospital-months of C.difficile-related data were provided by 242 hospitals across the U.S.  
Of these, 219 hospitals with 4,328 hospital-month observations included complete data 
relative to our proposed model.  These complete cases were used as the final analytical 
sample.  Also during the study period, ten states had C.difficile reporting mandates with 
eight states implementing data reporting during the study period (Figure 2).   
Figure 3. 1 Frequency of MRSA HO-BSI LabIDs in the data set from 2008-2012. 
 
            MRSA, Methicillin-resistant Staphylococcus aureus; HO-BSI, hospital-onset blood stream infection; LabIDs, Laboratory-  
            Identified events.   
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Figure 3.2 State Public Reporting Mandates and Implementation Dates 
Year of Mandate State* Date Data Submission First Required 
2008 OH October 2009 
2008 PA January 2008 
2009 CA January 2009 
2009 NY July 2009 
2010 TN July 2010 
2011 RI January 2011 
2012 IL January 2012 
2012 ME January 2011 
2012 NM January 2012 
2012 OR January 2012 
*Guide to state abbreviations in Appendix B.  Dates of mandates and implementation/data submission     
ascertained from existing literature and review of state legislation or HAI reports11,12 
Distribution of facility characteristics of the overall sample were different 
between hospital-month observations in reporting and non-reporting states (Table 1).  
Proposed time-invariant characteristics including academic medical center affiliation, 
ownership status, and bed size all differed significantly between reporting and non-
reporting states (p<.001, p<.001, and p<.001 respectively).  Event level data also differed 
significantly between the two reporting groups with hospitals in states without mandates 
reporting fewer C. difficile patient days than hospitals in states with reporting mandates 
(3,840.57 vs. 5798.09, respectively [p<.001]).  Hospitals in non-reporting states also 
reported fewer counts of HO-C. difficile LabIDs than those in states with mandates (2.25 
vs. 4.78 respectively, [p<.001]).  Both community-onset rates and HO rates were lower in 
hospitals with reporting mandates in this sample, with HO rates from hospitals under a 
reporting mandate at nearly half the rate of those without mandates (7.23 vs. 13.48 
respectively, [p<.001]).   
Overall trends in HO-C. difficile LabID rates over the study period yielded 
decreasing rates of events in states with and without reporting mandates and in the total 
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sample (Figure 3).  Analysis of rates was complicated by hospital-months with very few 
patient days reported, causing significantly elevated rates, in some instances >1000 
events per 10,000 patient days. To account for this, the analysis of rate trends was 
conducted across all three groups (reporting, non-reporting, and total sample) after 
removing observation months with patient days less than or equal to 25.  Removing these 
the observations diminished the rate extremes seen in the initial evaluations without 
eliminating smaller hospitals (bed size <100) in the sample.  Removing extremely high 
rates made comparison in trends smoother, yet still allowed for a wide range of hospitals 
size representation while still discerning differences in  
Table 3.1 NHSN Survey Reported Facility Characteristics by C. difficile Reporting 
Status, 2008-2012 
NHSN Survey Characteristics Non-Reporting Reporting Totals p-value† 
Number of Hospital Months of Data 
(mean, SD) § 
616.02, ± 8.64 613.521, ± 9.31 614.068, ± 9.22 
 
p<0.01 
Affiliation with Academic Medical Center 
(hospital months, %) 
    
Yes 439 (41. 53) 1,732 (46.53) 2,171 (45.43) 
p<0.01 No 618 (58.47) 1,990 (53.47) 2,680 (54.57) 
 1,057 3,722 Total = 4,779 
Ownership (hospital months, %)     
Non-profit 672 (63.58) 2,391 (63.39) 3,063 (63.43) 
p<.001 
For profit 113 (10.69) 474 (12.57) 587 (12.16) 
Government 23 (2.18) 167 (4.43) 190 (3.93) 
Not-reported 249 (23.56) 719 (19.06) 968 (20.05) 
Physician Owned 0 (0.0) 21 (0.56) 21(0.43) 
 1,057 3,772 Total = 4,829 
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Table 3.1 NHSN Survey Reported Facility Characteristics by C. difficile Reporting 
Status, 2008-2012 (continued) 
NHSN Survey Characteristics Non-Reporting Reporting Totals p-value† 
Bed Size (hospital months, %)     
<=25 82 (7.76) 215 (5.70) 297 (6.15) 
p<.001 
26-100 270 (25.54) 522 (13.84) 792 (16.40) 
101-200 280 (26.49) 1,003 (26.59) 1,283 (26.57) 
201-500 319 (30.18) 1,498 (39.71) 1,817 (37.63) 
501-1000 106 (10.03) 527 (13.97) 633 (13.11) 
> 1000 0 (0.00) 34 (1.57) 34 (1.06) 
Not reported 0 7 (0.19) 7 (0.14) 
 1,057 3,806 Total = 4,829 
Number of C. difficile Patient Days  
(mean, SD) 
3840.57, ± 4155.91 5798.90, ± 5067.12 5483.82, ± 4983.70 p<.001 
Number of HO-C. difficle LabIDs (mean, 
SD) 
2.25, ± 3.74 4.78, ± 6.01 4.38, ± 5.78 p<.001 
*Rates of HO-C. difficile LabIDs per 
10,000 patient days (mean, SD) 
13.48, ± 80.46 7.23, ± 6.47 8.19, ± 32.21 p<.001 
C. difficile Community Onset Prevalence 
Rate per 100 admissions (mean, SD) 
2.85, ± 14.29 0.50, ± 1.71 0.86, ± 5.88 p<.001 
†P-values in bold indicate statistical significant at α<.05.  All continuous variables tested for normality using Shapiro-Wilk W test for 
normality.  All values p<.001.  Differences in reporting/non-reporting continuous variables evaluating using Wilcoxon Rank Sum test.  
Differences in categorical variables testing using Chi-square test.  HO-C.difficile LabID rate adjusted for patient days ≥ 25 days. 
NHSN, National Healthcare Safety Network; HAI, Healthcare-associated infection; C. difficile, Clostridium difficile; MRSA, 
Methicillin-resistant Staphylococcus aureus; SD, standard deviation, HO, Hospital Onset. *Rates exclusive of facilities that reported 
less than 50 (73 observations) C. difficile patient days as defined by NHSN.  
 
trends.  Additionally, trends were evaluated beginning with data from July 2009, as 
observations prior to those were largely count values of zero and represented on 0.5% of 
the total hospital-month sample.  Overall larger declines were seen in non-reporting states 
during the study period when compared to hospitals in reporting states and the overall 
sample.  A much more minimal trend was noted in reporting states with mean rate for 
HO-C. difficile LabIDs lower in the third quarter of calendar year 2009 (6.70 events per 
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10,000 patient days) compared to the second quarter of calendar year 2012 (5.41 events 
per 10,000 patient days).  Evaluation of community-onset prevalence rate yielded an 
increasing rate over the entire sample during the study period (Figure 4).  
Figure 3.3 Mean HO-C. difficiile LabID rates by Month 
 
 
Effects of State HAI Mandatory Reporting Laws 
 Zero-inflated Poisson regression models with unit-level indicator variables for 
hospital fixed effects were used to determine the change in mean rates relative to the 
implementation of state reporting mandates.   
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  Figure 3. 4 Mean Community-Onset Prevalence Rate for C. difficile Infection 
 
       Community-Onset Prevalence defined as C. difficile LabID identified on hospital day 3, or earlier. 
 
The Vuong test yielded a p-value of <.002, indicating a preference for a zero-inflated 
model given this data set.  IRRs were interpreted as change in mean rates in the modeled 
time interval as compared to the reference group, 30-to-28 months prior to the law’s 
implementation.   
 With the exception of 3-to-5 months after the law, all IRRs from post-
implementation time-periods were less than 1.0, indicating a decreasing trend in HO-
C.difficile LabID rates when controlling for secular time trends and hospital 
characteristics.  However, in both the pre-and-post time periods, all but one of the rate 
ratios were not statistically significant (Table 2).  Similar trends were noted prior to the 
law’s implementation, specifically at 18-to-16 months before the law (IRR 0.568, p = 
0.034).  This interval period is associated with a 43% lower mean rate in HO-C. difficile 
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LabIDs compared with 30 to 28 months prior to the law’s implementation.  An IRR of 
0.452 was noted with in the farthest time distance interval from the law, 51-to-53 months 
post-implementation although this was not statistically significant.  Hospitals in non-
reporting states had an average mean rate 3.6 times higher than those in reporting states 
30 to 28 months prior to the law (IRR 3.578, p<0.001).  This difference is also reflective 
of the findings in the bivariate analysis presented in Figure 3.  
Sensitivity Analysis  
 In addition to the zero-inflated Poisson regression a standard Poisson regression 
with hospital and time fixed effects was modeled to ascertain the robustness of the zero-
inflated Poisson model.  Results of the panel data modeled with the standard Poisson 
yielded similar results with overall trends to decreasing IRRs after the implementation of 
the law, but none of them with statistically significant differences.  The 18-to-16-month 
time interval prior to the law did remain statistically significant with an IRR of 0.616 
indicating a 39% lower mean rate in this time-period compared to 30-to-28 months 
before the law.   
 An additional sensitivity analysis was conducted by fitting a random effects 
model interacting hospital month, as a continuous variable, with reporting status.  
Reporting status here was refined and modeled as all hospitals in non-reporting states and 
hospitals in the pre-reporting period as “non-reporting” status.  The model was used to 
determine the difference between the rate of infection increase from month-to-month in 
reporting compared to non-reporting groups.  Results from the model indicate that over 
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time the infection rate of the non-reporting status group changes at the same rate 
compared to the non-reporting group, although these results were not statistically 
significant (IRR 1.002, p = 0.304).    
Table 3.2 Results of Zero-Inflated Poisson Regression: Effects of HAI Mandates in 
Reporting States 
Month Time Interval IRR Robust Std. Err. P-value* 95% Confidence Interval 
Reference -30 to -28 Months 
Prior to Law Implementation 
 
27 to 25 months prior 1.100 0.286 0.714 0.660,  1.832 
24 to 22 months prior 0.885 0.233 0.642 0.529,  1.481 
21 to 19 months prior 1.020 0.250 0.936 0.630,  1.650 
18 to 16 months prior 0.568 0.152 0.034 0.337,  0.956 
15 to 13 months prior 1.035 0.292 0.904 0.594,  1.799 
12 to 19 months prior 0.993 0.263 0.978 0.590,  1.670 
9 to 7 months prior 0.851 0.263 0.601 0.464,  1.560 
6 to 4 months prior 0.942 0.267 0.834 0.541,  1.641 
3 to 1 months prior 0.912 0.266 0.752 0.515,  1.614 
0 to 2 months after  0.989 0.264 0.968 0.586,  1.670 
3 to 5 months after 1.168 0.367 0.621 0.631,  2.164 
6 to 8 months after 0.866 0.288 0.665 0.451,  1.661 
9 to 11 months after 0.864 0.305 0.678 0.433,  1.724 
12 to 14 months after 0.836 0.295 0.612 0.419,  1.668 
15 to 17 months after 0.877 0.328 0.726 0.421,  1.827 
18 to 20 months after 0.816 0.307 0.589 0.390,  1.706 
12 to 23 months after 0.851 0.338 0.685 0.391,  1.854 
24 to 26 months after 0.816 0.329 0.614 0.371,  1.798 
27 to 29 months after 0.830 0.350 0.659 0.364,  1.896 
30 to 32 months after 0.791 0.335 0.581 0.345,  1.816 
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Table 3.2 Results of Zero-Inflated Poisson Regression: Effects of HAI Mandates in 
Reporting States (Continued) 
Month Time Interval IRR Robust Std. Err. P-value* 95% Confidence Interval 
33 to 25 months after 0.869 0.390 0.754 0.361,  2.093 
36 to 38 months after 0.845 0.381 0.709 0.350,  2.044 
39 to 41 months after 0.978 0.472 0.963 0.380,  2.517 
42 to 44 months after 0.834 0.561 0.788 0.223,  3.119 
45 to 47 months after 0.616 0.442 0.500 0.151,  2.517 
48 to 50 months after 0.957 0.643 0.948 0.256,  3.573 
51 to 53 months after 0.452 0.471 0.446 0.059,  3.487 
non-reporting 3.578 0.768 0.000 2.350,  5.449 
Zero-Inflated Poisson Regression was used.  IRRs are exponentiated coefficients controlling for time and hospital fixed effects as well 
as community onset prevalence rates (IRRs not shown).  Depended variable modeled above is the count of HO-C.difficile LabIDs per 
10,000 patient days as the exposure (offset) variable in the model. IRRs, Incident Rate Ratios; HO-Hospital Onset; C. difficile, 
Clostridium difficile; Robust std. err, Robust Standard Errors.  *p-values in bold are statistically significant at the α=.05 level.  
3.6 Discussion  
 To our knowledge this is the first study that models the longitudinal effects of 
public reporting laws on C. difficile infection events in U.S. hospitals.  While the effects 
of these laws on average rates, failed to reach statistical significance in the model, 
important trends were noted in the findings.  Additional methodological implications for 
analyzing the impact of these laws were also apparent from study results. 
 Similar to previous work examining HAIs, lower average rates of HO-C.difficile 
LabIDs were noted in the months after the laws’ implementation.25,26,30  Declining rates 
of HO-C. difficile infection both during and after the study period have been observed in 
other literature, as are the noted increasing trend in community-onset C. difficile 
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infection, which in this sample, is noted on hospital admission or shortly after.1,44 
Although not statistically significant, the general trends appreciated in the data may 
reflect the effect of these laws, particularly as this model controlled for the secular time 
trend in HO-C. difficile rates.  The only lower rate that was statistically significant in 
reporting institutions was noted in the time frame of 16-to-18 months prior to the laws’ 
implementation.  Upon a more granular review of the data, it was noted that data which 
reached this far back in time was from the same reporting state and institution as that 
which populated the reference time interval (30-to-28) months prior to the law).  This 
effect is likely an incidental finding of a single institution being compared to its own 
previously reported data, albeit possibly in anticipation of the law.  While the model did 
control for correlation between repeated hospital observations, its possible that in 
addition to the impending law a time-variant extenuating factor or unobserved covariate 
affecting that institution was implemented.  These may include additional C. difficile 
prevention programs including CDC supported state C. difficile collaborative groups or 
other more local initiatives taken irrespective of the presence of state mandate.12  
Interestingly, the IRR for HO-C. difficile LabIDs 50-to-53 months after implementation 
of reporting mandates indicates a long-term reduction in these infections when compared 
to mean pre-law rates. This may be an indicator that the strength of these laws is more in 
their ability to impact hospitals over the long term, rather than stimulating immediate 
change. Similar findings were noted in previous studies25,27 when examining CLABSI 
rates in relation to state reporting mandates.  Although the C. difficile study by Daneman 
et. al, did not report findings beyond 20 months post-reporting, they too reported 
prolonged reductions in observed cases compared to predicted cases as result of reporting 
121 
 
mandates.30  Although our finding was not statistically significant, it may suggest that 
these laws have long-standing impact which warrant further longitudinal investigation 
Review of this data yielded many zeros counts, some across the same institution 
for the entirety of the longitudinal observations.  These zero values included both patient 
days and outcomes, suggesting that hospitals may have had difficulty reporting infections 
or reporting the proper metrics associated with NHSN surveillance.  While support for 
implementation of NHSN reporting exists, many hospitals may still have struggled with 
or questioned surveillance definitions, data validation and implementation of reporting 
infrastructure, causing incorrect reporting or missing.  These struggles have been 
described in other literature45,46 and may reflect a difficulty with implementation of 
public reporting.  These effects may represent one possibility for the over representation 
of zeros in the data, justifying the need for the Zero-Inflated Poisson model.   
There may be several reasons why little statistically significant effect was seen on 
HO-C. difficile LabIDs resulting from state HAI reporting mandates.  First these affects 
may be attenuated by other additional policy interventions including federal policies.  
During the study period, the CMS Hospital IQR was in effect and reporting of C. difficile 
infections was slated to begin in January of 2013.12  These larger federal policy initiatives 
may have stimulated additional process improvements during the study period that 
contributed to declining rates of C. difficile in hospitals and made the effect of state 
mandates difficult to isolate.  Additionally, C. difficile infections may have been affected 
by prior state reporting mandates for other HAIs.   Before the enactment of reporting laws 
specific to C. difficile, multiple states had mandatory reporting of CLABSIs which may 
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have stimulated additional efforts at curbing HAI infection rates.  Any novel process 
improvements or programs that are put in place for the management of specific HAIs 
may stimulate additional improvement in other HAI rates.  Prior studies45–47 have shown 
that any public reporting mandates tend to affect hospitals as a whole, rather than just 
focusing on one particular outcome, and it may be that these effects are difficult to 
separate from specific effects of a singular HAI reporting mandate.   
Implications for Policy and Future Research 
HAI reporting mandates have gained momentum over the past decade and have 
been evaluated in the literature regarding their impact on health systems, process 
improvements, and outcomes.  However, many of the studies attempting to delineate an 
impact on specific infection rates have yielded mixed results.  Ours is the first study to 
examine the effect of specific C. difficile reporting mandates in U.S hospitals, and does 
illuminate specific policy implications.  
 While the findings in this study didn’t isolate a statistically significant effect on 
C. difficile outcomes, it does show a potential trend toward reductions in these infections 
Yet, it may still be difficult to ascertain how and why these effects occur.  Some studies 
have attempted to examine specific process improvements and organizational impacts 
resulting from these mandates in hopes of better understanding the relationships between 
reporting mandates and decreased infection rates.  Many of these studies have also 
yielded mixed findings noting that process measures may or may not be affected by these 
policies.27,28  However, these impacts may not readily translate to changes in infection 
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rates.48  While mediating factors were not a focus of this study, understanding the role of 
process improvements and point-of-care changes may be an important component of how 
these laws affect hospitals, and ultimately outcomes, and should be examined in future 
research.   
The methodological considerations of this study lend themselves well to future 
mandated reporting policy research.  Adapted from a model put forward by Liu and 
colleagues48, our model aimed to isolate the effects of the law on C. difficile infections at 
varying time distances before and after its implementation.  This approach is valuable in 
that it allows investigators to examine trends in the effects of the law, particularly if 
reductions in infection rates persist, plateau or diminish over time.  The importance of 
these findings for policy makers lies in the understanding that broad policy initiatives, 
such as state reporting mandates, may have stronger impacts in time points leading up to 
or immediately after the law as has been seen in previous studies.25,27  This analysis may 
also yield longer term policy impacts that may have sustained effects on outcomes over 
many years.  These considerations are key to crafting and evaluating broad policy 
mandates.  If its established that the effect of reporting mandates are likely to be strongest 
in the months surround their implementation, then focused research on how, specifically, 
health systems respond to those within that critical period is essential.  If the converse is 
true, indicating more long-term impacts from these state mandates, understanding 
sustained patterns of change and how these laws have re-shaped hospitals would be 
essential as well.  In either case, defining the outcomes associated with these laws is as 
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important as understanding what is likely a multifactorial response by hospitals to their 
implementation.  
3.7 Limitations 
There are several limitations to this study.  As previously discussed, the data set 
likely did not have sufficient diversity in counts for its HO-MRSA BSI LabID for the 
proposed model to converge, leading to the inability of the authors to model the laws’ 
effects on this outcome.  While MRSA findings would have been complementary to the 
findings related to C. difficile ultimately the difference in these two infections did not 
represent a new or different process under investigation that was specific to MRSA.  Our 
sensitivity analyses confirmed the C. difficile results noted in the final model.  However, 
it is likely that data limitations were also applicable to the C. difficile analysis, primarily 
in the lack of available pre-reporting data.  Reporting of C. difficile to NHSN began in 
March of 2009.  This may have contributed to a lack of pre-data and inaccuracies in 
reported data as hospitals scaled up reporting programs.  While some pre-reporting data 
was present, a larger panel of observations may have allowed us to detect a stronger 
effect of these reporting mandates relative to their implementation time.   Although this 
was self-reported data and based on surveillance criteria it is possible that count and 
denominator data was not accurate for every observation in this data set.  This could 
contribute to the underestimations in assessing the differences between pre-and-post-
implementation rates.   Some states do have data validation structures in place, but this 
likely would have limited our analysis and, thus, we did not focus only on observations 
from those states.  Also, the data used in this analysis is from 2008 to 2012, representing 
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a span of five years between data collection and this study.  Ongoing changes in the 
epidemiology C. difficile coupled with additional state reporting mandates and new 
federal policy initiatives may diminish relevance to the current HAI policy environment.  
However, the majority of C. difficile reporting mandates were implemented during the 
study time-period or within one year of the final observation months.12  This allowed for 
modeling of the effects of those laws during the critical time before, during and after 
implementation.   The number of hospitals included in this study is a subset of 
participants in the P-NICER survey.34  While external validity is a potential limitation, 
the original authors of the survey noted that comparison between respondents and non-
respondents yielded similar CLABSI rates between the two groups, despite difference in 
other hospital characteristics.34  Finally, while our model controlled for secular trends in 
infection rates and time-invariant hospital characteristics, additional process 
improvements and programs implemented during the study period across differing 
hospitals may have confounded effects of the state mandates on our outcome measure.   
3.8 Conclusion 
 Most US states now have HAI reporting mandates in place.  This study is the first 
to examine the impact of these laws on C. difficile infections in US hospitals.  Findings 
may suggest a trend toward a reduction in rates, particularly after the law’s 
implementation, although these changes were not statistically significant.  Additional 
research is needed to examine trends in infections associated with these laws and by what 
mechanisms are these laws impacting hospitals to improve HAI related patient outcomes.   
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 Abstract 
Background: Over the past decade, various policy initiatives have been implemented to 
reduce the burden of healthcare-associated infections (HAIs). Mandating hospitals to 
publicly report HAI performance data is a key legislative policy aimed at stimulating 
improvement and reducing HAIs. Yet, little is known about how these state level 
reporting mandates galvanize the organizational changes in hospitals needed to reduce 
HAIs.  The organizational climate of hospitals is the perception culture and specific 
domains such as leadership, communication, and social norms.  Purpose: The purpose of 
this study is to examine the relationship between state HAI public reporting mandates and 
specific domains of organizational climate. as they relate to infection prevention. 
Research Design: This cross-sectional study uses organizational climate variables from 
the Prevention of Nosocomial Infections and Cost-Effectiveness-Refined (P-NICER) 
Survey.  Infection Prevention organizational climate composite scores are developed 
from the previously validated Leading a Culture of Quality for Infection Prevention 
(LCQ-IP) instrument nested within the P-NICER survey. Methods: Bivariate analysis 
was used to compare hospital characteristics in both reporting and non-reporting states. 
Multiple linear regression is used to determine the effect of public reporting mandates on 
organizational climate scores for the following climate-related concepts: Psychological 
Safety, Prioritization of Quality, Supportive Work Environment, and Improvement 
Orientation.  These effects are examined while controlling for hospital level 
characteristics. Results: There was no statistically significant difference in mean 
136 
 
organizational climate composite scores between hospitals in states with and without 
public reporting mandates.  However, facility bed size and the presence of an infection 
control director did have statistically significant associations with composite scores.  
Additionally, hospitals in public reporting states reported a slightly higher sense of 
urgency related to HAIs compared to those not in public reporting.  Conclusion: 
Although no statistically significant effect of public reporting was seen on organizational 
climate composite scores, other key hospital and infection prevention program 
characteristics did show an effect. Policy makers and researchers would benefit from 
understanding more about how organizational climate domains are impacted by these 
factors.  New directions for empirical investigation are needed to better understand their 
significance in improving HAI-related outcomes.  
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4.1 Introduction 
Healthcare-associated infections (HAIs) are a significant source of morbidity and 
mortality in hospitalized patients in the United States. The U.S. Centers for Disease 
Control and Prevention (CDC) estimates that approximately 722,000 HAIs occur 
annually and contribute 75,000 deaths.1  Device-associated infections including central 
line-associated blood stream infections (CLABSIs) and others often cause severe 
complications in patient.  Similarly, infections caused by Clostridium difficile (C. 
difficile) and multidrug resistant organisms (MDROs) such as Methicillin-Resistant 
Staphylococcus Aureus (MRSA) contribute to poor patient outcomes and prolonged 
hospitalizations.2,3   
Mandated public reporting of HAI-related outcomes has gained momentum as a 
policy initiative over the past decade.4  These policies are directed at improving hospital 
performance and empowering consumers to make informed choices about their care by 
mandating hospitals to report HAI performance data to various state and federal 
stakeholders.  The evidence of their effectiveness in stimulating a reduction in HAIs 
remains mixed.  Policy makers and healthcare facilities understand that, along with public 
reporting, additional factors intrinsic to an organization , such as organizational climate, 
can play a role in changing behavior and improving performance around patient safety 
and HAIs.5–7   
Organizational climate, or shared perceptions of various features and attributes of 
an organization and its functioning, has at times been associated with improved outcomes 
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and processes for staff and patients.8  Yet, little is known about the relationship between 
mandated public reporting of HAI performance data and specific domains of 
organizational climate as they related to infection prevention (IP) within the hospital 
setting.  The aim of this study it to explore the relationship between state-mandated 
public reporting of HAI-related data and IP organizational climate.  Understanding these 
relationships will guide future research to examine the pathways by which organizational 
climate domains impact the outcomes of HAIs within the structure of public reporting 
policy.   
4.2 Background 
HAIs in U.S. hospitals continue to be a significant source of morbidity and 
mortality, as well as a prominent policy issue for various stakeholders concerned with 
patient safety and quality of care.1,9  These infections are estimated to contribute to 
75,000 deaths per year in this country and cost health systems in excess of $28.4 to $33 
billion dollars annually.1,10  Over the past decade, growing patient safety and quality of 
care concerns have led to HAI performance data being used in payment incentive 
programs and reimbursement.9,11  These efforts center on infections associated with 
medical devices including central venous catheters, indwelling urinary catheters and 
ventilators, as well as surgical site infections and those caused by C. difficile and MRSA.  
Evidence has shown that more than half of device-associated infections could be 
prevented with the use of current evidence based guidelines, yet some organizations 
continue to struggle with reducing infection rates despite efforts to implement prevention 
initiatives.1,12  Infections such as those attributable to C. difficile and MRSA are not 
139 
 
readily attributable to devices but are known to be transmitted within the healthcare 
environment.  Both infections can cause serious complications in the hospitalized patient 
and contribute to excess financial burdens on institutions.   
The past two decades have yielded growing concern over preventable HAIs.  
These infections garner attention in the mainstream media and serve as drivers for 
policymakers and administrators to address key issues around patient safety and quality 
of care.  HAIs play a central role in U.S. federal patient safety policy and have been a  
national target for improvement since 2013, with a goal of total elimination by 2020.9  
Federal and state-level lawmakers have used these infections as a means of monitoring 
performance and driving improved performance among healthcare institutions.11   
 One policy intervention that has been widely used to promote the reduction of 
HAIs has been public reporting of hospital and statewide HAI-related data.  Beginning in 
the mid-2000s, state-level policy began to mandate the public release of HAI data in a 
variety of formats and for varying infections.  Public reporting of healthcare and health 
system performance measures has been a part of federal policy and guidelines since the 
1980s.13  In a 2012 evidence report for the Agency for Healthcare Research and Quality 
(AHRQ), Totten and colleagues13 describe public reporting as “data, publicly available or 
available to a broad audience free of charge or at a nominal cost, about a health care 
structure, process, or outcome at any provider level (individual clinician, group, or 
organizations [e.g., hospitals, nursing facilities]) or at the health plan level” (p.3).   
Public reporting of HAIs has gained momentum over the past decade.  While 
hospitals have tracked HAI-related data for many years, mandated reporting of data 
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through state-level legislative initiatives has only gained traction over the past decade.14 
This primarily involves requiring hospitals to report their HAI data to state government 
bodies. Public reporting of HAI data can be mandatory or voluntary; most states in the 
U.S. (37 states as of 2013) now have some type of state-level HAI-related public 
reporting legislation, with a significant amount of that data reported at the federal level as 
well.4 HAI data collection in the U.S. is facilitated by the National Healthcare Safety 
Network (NHSN), a national HAI surveillance system managed by the CDC.  NSHN 
receives reported HAIs from healthcare institutions around the county who follow 
specific surveillance criteria for the identification and reporting of certain these 
infections.  Aggregate data from this system is available to the public through federal 
channels (i.e., Hospital Compare Website), and allows for uniform definitions for 
infection surveillance as well as some risk-adjusted comparison.15,16  Centers for 
Medicare and Medicaid Services (CMS) uses the same HAI-related data published on 
their Hospital Compare Website in a variety of payment reduction plans, including the 
HAC Reduction Program, the Hospital Inpatient Quality Reporting Program and 
incentive programs such as Value Based Purchasing.11,17   
These policies are directed at improving hospital performance and empowering 
consumers to make informed choices about their care by mandating hospitals to report 
performance data to various state and federal stakeholders.  The evidence on their 
effectiveness in stimulating a reduction in HAIs remains mixed.  Studies evaluating the 
impact of public reporting of HAI data have shown mostly mixed findings18–20, and most 
of these studies focus only on a singular infection: CLABSIs.  Some studies have shown 
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a longitudinal reduction in CLABSI rates across various populations related to the 
implementation of these laws.20–23  However other studies employing other 
methodologies have shown no effect of these laws, particularly with regard to CLABSI as 
well as point-of-care practices.18,19,24,25   This mix of findings is consistent with the larger 
body of research examining the relationship between public reporting and patient 
outcomes.26–28 The inconsistency in these findings suggest that larger systemic and 
organizational factors impact their implementation and efficacy in promoting patient 
safety and improvement.   
Berwick et. al,7 contend that in order for the reporting of performance data to 
improve organizational processes and quality of care, the environment within 
organizations must be conducive to change.  Some key characteristics of these 
organizational environments include leadership, investment in time and change 
management, communication, and ongoing evaluation.7  Similarly, Marshall, Romano, 
and Davies29 describe the impact that public reporting can have on organizational culture 
by empowering change-makers.  The authors argue that strengthening the value of quality 
improvement and improving accountability are key factors impacted by publicly 
reporting data. Additionally, they discuss the impact of public reporting on guiding 
quality of care social norms within healthcare organizations.29  They describe these 
effects as potentially long-lasting, but only in the context of organizational factors that 
promote behaviors that emphasize patient safety and improving patient.29  Few studies 
have examined the effect of public reporting on these organizational-level processes and 
characteristics.  Thus policy makers and healthcare entities may fail to appreciate that 
142 
 
both public reporting and key organizational factors can play a role in changing behavior 
and improving patient safety and HAI performance.5–7 These key organizational factors 
have been captured in measures of organizational climate. Organizational climate, or 
shared perceptions of various features and attributes of an organization and its 
functioning, has been found to be associated with improved outcomes and processes for 
staff and patients.8  Yet, little is known about the relationship between mandated public 
reporting of HAIs and organizational climate in hospitals.   
In the Institute of Medicine’s 2000 report To Err is Human,30 the report’s authors 
determined that organizations must understand why and how preventable errors or 
adverse events happen within healthcare systems.  Causes of adverse events were 
multifactorial and were not solely attributable to individual healthcare providers.30  The 
authors contend that specific conditions including the working environment, guidance 
around acceptable performance, and proper communication all contribute to 
improvements in quality of care and reduction of errors.30  In subsequent literature the 
notion of organizational climate has been discussed as the perception of the culture 
within an organization including characteristics such as leadership, communication, and 
norms.8  It has been argued that since climate is a representation of perceptions of an 
organization, it can be more easily measured and evaluated than that broader notion of 
culture.8  Climate may be an effective way to capture various leadership and process 
domains within an organization and assess their impact on the overall functioning or 
outcomes within that organization. Stone and colleagues31 put forward an Integrative 
Model of Organizational Climate (Figure 1) which incorporates structural and process 
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domains and their relationship to outcomes in both healthcare workers and patients.  
These domains comprise a host of interrelated concepts including leadership, 
communication processes, work environment, innovation and collaboration.31  The effect 
of these structural domains on outcomes is mediated by process domains that directly 
impact worker related outcomes and patient outcomes.  In 2007, MacDavitt8 and 
colleagues published a systematic review evaluating the domains described in this model 
and their impact on patient outcomes.  Findings from the review suggested that some 
organizational climate domains including work environment, collaboration, and the 
availability of technology were associated with lower mortality, but these results were not 
consistent across studies.8   
 Although the Integrative Model of Organizational Climate was not specifically 
developed for infection prevention (IP), many of its domains are components of 
comprehensive IP programs. The impact of public reporting mandates on organizational 
climate domains related to IP programs has been explored, primarily in qualitative 
studies.  Stone and colleagues32 conducted interviews as part of a mixed-methods study to 
evaluate these impacts on hospitals in California.  They found an overall increase in 
infection prevention awareness and priority within hospitals as a result of these 
mandates.32    
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 Figure 4.1 The Integrative Model of Organizational Climate 
This model provides a framework for how organizational climate, can impact patient care related outcomes by 
associating core structural domains with potential mediating processes that affect measurable outcomes.  Developed 
by Stone et. al31   
  
A study from Uchida and colleagues33 using the same data, but centering on quality 
improvement factors, broadly describes the state of IP in California hospitals using 
qualitative interviews of nurse leaders, hospital epidemiologists, infection prevention 
directors, and other administrators across six hospitals.  Results of the analysis 
specifically identified the emergence of mandatory public reporting as a primary theme 
among respondents, with a subtheme that indicated that public reporting had led to a 
heightened awareness of infection prevention within the hospital.  A separate, theme of 
organizational climate emerged related to IP and highlighted the importance of increased 
collaboration and teamwork for HAI prevention.33  Participants also reported additional 
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IP climate components such as improved communication within the hospital and renewed 
emphasis on quality of care.33  In a later qualitative study by Stone et. al,34 interviews 
with multiple stakeholders across the country to examined the impact of federal and state 
policy on health departments and hospitals specifically with regard to infection 
prevention efforts. Participants included infection preventionists, state health department 
officials, hospital administrators and epidemiologist.  Findings were similar to previous 
work regarding the impact of reporting mandates, but less so in differentiating between 
state and broader federal mandates.34  Participants noted that these laws increased 
collaboration between hospitals and health departments, and intensified  the focus on 
HAI reduction in hospitals.34    
It’s clear from this prior work that these policy mandates strengthen the 
importance of HAI prevention in healthcare organizations, but less is known about their 
association with key organizational climate domains that relate to IP programs.   It 
remains unclear whether these laws impact patient outcomes by impacting key 
organizational climate domains which then contribute to improved enhanced infection 
prevention.  While previous studies are valuable in their contribution to the public 
reporting and HAI literature, they do not explore the specific relationship between public 
reporting mandates and IP organizational climate domains. Given the number of states 
that have implemented reporting mandates, understanding the association between public 
reporting and the climate of organizations is crucial to exploring potential pathways by 
which these laws improve outcomes.  This study used survey data assessing IP 
organizational climate domains to examine this issue.  We proposed that higher 
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organizational climate scores will be associated with the presence of public reporting 
mandates.  This study serves as a foundation for understanding the impact of public 
reporting mandates on specific IP organizational climate concepts and build on previous 
work that has explored this relationship in a more qualitative fashion.    
4.3 Methodology  
The data for this study came from the Prevention of Nosocomial Infections and 
Cost-Effectiveness-Refined (P-NICER) survey (National Institutes of Health, 
RO1NR010107: Stone, P.), a component of a mixed-methods study capturing the 
complexities and structure of infection prevention programs in the U.S. and subsequently 
informing the development of the survey tool.32,35,36  A subset of the P-NICER survey, 
the Leading a Culture of Quality for Infection Prevention (LCQ-IP), was developed and 
validated for the purposes of measuring organizational climate variables related to HAIs 
and IP.37 The primary analysis in this study will examine the association of the validated 
IP organizational climate domain composite scores and the presence of state public 
reporting mandates.   
4.4 Sample   
All non-Veteran’s Administration hospitals who reported to NHSN during the 
study period were eligible for participation in the P-NICER study.  One infection 
prevention director or leader from each participating institution was invited to participate 
in the web-based survey in 2011.  A modified Dillman technique was used for 
recruitment as well as lottery-based incentives to promote participation.36  A total of 1064 
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hospitals were represented in the survey (29% response rate) with 975 of hospitals 
providing complete data on the organizational climate measures.37 Hospitals completing 
the survey were invited to participate in the P-NICER NHSN research group.36  This 
group agreed to provide researchers with access to device-associated infection data as 
well as C. difficile and MRSA data reported to NHSN for the previous 6 years (2006-
2011).36  Additionally, data from the NHSN survey detailing hospital demographic 
characteristics was also made available through NHSN and hospital size, location, and 
ownership status.   
4.5 Independent and Control Variables 
The primary independent variable was the presence of a state public reporting 
mandate.  The presence of a state reporting mandate at the time of survey participation 
and data collection was ascertained by using published literature detailing the presence of 
public reporting mandate by time of passage for any type of HAI.4   Any hospitals located 
in a state with an HAI-related reporting mandate in effect in 2011 was counted as having 
a mandate.  
 Control variables included hospital demographics and characteristics previously 
known to impact HAI related outcomes19,36,38 and may be related to organizational 
climate.   These include location (Northeast, Midwest, South, West, other), ownership 
status (for profit, not for profit/other), medical school affiliation (major, graduate, limited, 
non-teaching), size (bed size ≤200, 201-500, 501-1000, >1000) and specific IP program 
characteristics including the presence of an infection prevention director (yes/no), 
presence of a hospital epidemiologist (yes/no) and number of infection preventionists on 
148 
 
staff (continuous).  Facility affiliation and facility ownership status were pulled from 
additional NHSN survey data submitted by a subset of respondents.  
4.6 Dependent Variables 
The P-NICER survey captured a breadth of organizational level data including 
information regarding processes and climate as it relates to the prevention of HAIs.  
Imbedded within the P-NICER survey was the LCQ-IP survey.  This was adapted from 
the Leading a Culture of Quality (LCQ) instrument which was designed to assess quality 
oriented climates by evaluating 9 quality related components.37 The subsequent LCQ-IP 
was validated in a separate analysis that identified specific to organizational climate 
domains as they relate to infection prevention.  The organizational climate factors related 
to infection prevention included 19 questions, grouped into 4 domains: Improvement 
Orientation, Psychological Safety, Prioritization of Quality, and a Supportive Work 
Environment (Figure 2).  Psychometric nalysis determined the LCQ-IP instrument to be 
psychometrically sound and a reliable measure of infection prevention organizational 
climate among respondents (Chronbach α for 19-item instrument = .926).37  
Infection prevention organizational climate composite scores from the LCQ-IP 
are the dependent variables in this analysis.  These composite scores are reflective of the 
IP organizational climate domains and are summed from a groups of variables found to 
be related and representative of the larger IP climate domains from the previous 
psychometric validation study(Figure 2).37  Responses to the individual organizational 
climate components within each domain were measured on a Likert scale (1=strongly 
disagree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree) and are coded so a higher 
149 
 
score indicates a more positive organizational climate (Figure 2). Composite scores for 
each domain are the sum of the individual components related to the climate domain 
(Figure 2). Values for composite scores for larger climate-related domains are treated as 
continuous variables for this analysis.   
4.7 Statistical Analysis 
Descriptive statistics were used to describe facility level demographics and 
characteristics including geographic distribution, bed size, ownership status and medical 
school affiliation. Differences in mean organizational climate composite scores for the 
sample were analyzed between hospitals in public reporting and non-public reporting 
state using the Wilcoxon rank-sum test to account for non-parametric data    
Bivariate analysis was used to assess differences in demographics and 
characteristics of hospitals with and without public reporting mandates.  Additionally, 
key structural components of IP programs including personnel and leadership, as well as 
participation in HAI quality improvement initiatives were examined.  Evaluation of 
categorical variables (coded as either present or absent) was conducted using a Fisher’s 
exact test, while Wilcoxon Rank-sum tests were used to evaluate the differences in the 
means of continuous variables and mean composite scores.  The null hypothesis of H0=0, 
indicating no difference in these characteristics between institutions in reporting and non-
reporting states, was rejected at a pre-determined alpha level ≤ 0.05.  
A subset of the 975 hospitals with complete organizational climate data was used 
to examine the relationship between public reporting laws and organizational composite 
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scores.  This subset (n = 662) is inclusive of all respondents who provided full data on all 
organizational climate variables and covariates. Stepwise linear regression was used to 
assess the association between public reporting mandates and IP organizational climate 
composite scores while controlling for covariates.  The association between public 
reporting and composite score variables was modeled inclusive of control variables in a 
stepwise fashion using backward elimination with covariates inclusion set at α < .05.  
Coefficients for those states with reporting laws were evaluated as the change in 
organizational climate score when reporting mandates are present.  While these models 
are inclusive of hospital characteristics selected a priori, they do not account for state 
variation in HAI reporting law or timing of implementation, both of which may impact 
organizational.  Since the association between the presence of the law and the hospital 
organizational was the primary outcome of interest, hospital characteristics were the 
covariates of focus in the model.  All statistical analyses were conducted using Stata 
statistical software version 14.2.39 
4.8 Results 
In all, 1064 hospitals across 50 states and Puerto Rico participated in the survey.  
Hospitals in the District of Columbia were not represented in the sample.  At the time of 
the survey, 34 states had HAI public reporting mandates while 17 did not (Table 1).  The 
majority of respondent hospitals in this sample (76%, n=811) were located in states that 
had public reporting mandates in place in 2011 (Table 2).  Respondents’ hospitals were 
geographically distributed around the country, but were primarily in the South (36%) and 
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Midwest (28%), and rather than the West (16%) and Northeast (19%).  Most hospitals 
identified as suburban or rural (74%) and smaller to mid-range in bed size (85%).   
Figure 4.2. List of LCQ-IP Organizational Climate Composite Scores and Individual 
Variables 
Concept Variable 
Prioritization of Quality Prioritization of Quality Composite Score 
 The health care-associated infection prevention goals and strategic and strategic plan of 
our organization are clear and well-communicated 
 Results of our infection prevention efforts are measured and communicated regularly to 
staff 
 There is good information flow among departments to provide high-quality patient safety 
and care 
 People here feel a sense of urgency about preventing health care-associated infections 
 Employees are encouraged to become involved in infection prevention  
 Members of this organization are able to bring up problems and tough issues 
Psychological Safety Psychological Safety Composite Score 
 The climate in the organization promotes the free exchange of ideas. 
 Staff will freely speak up of they see something that may improve patient care or affect 
patient safety. 
 I feel free to express my opinion without worrying about the outcome. 
 In general, people in our organization treat each other with respect. 
 If you make a mistake in this organization, it tends to be held against you. 
 People in this organization are comfortable checking with each other if they have 
questions about the right way to do something. 
 The people in this organization value others’ unique skills and talents. 
 Members of this organization are able to bring up problems and tough issues. 
Supportive Work Environment Supportive Work Environment Composite Score 
 Senior leadership here has created an environment that enables changes to be made  
 Where I work, people are held accountable for the results of their work 
 The quality of work suffers because of the amount of work staff are expected to do 
 Most people in this organization are so busy that they have very little time to devote to 
infection prevention efforts (reverse coded) 
 Employees are encouraged to become involved in infection prevention. 
Improvement Orientation  Improvement Orientation Composite Score 
 I can think of examples when problems with patient infections have led to changes in our 
procedures or equipment 
 I know of one or more health care-associated infection prevention initiatives going on 
within our organization this year 
 I have a clear understanding of the organization’s mission, vision and values. 
Responses to the individual organizational climate variables were measured on a Likert scale (1=strongly disagree, 2=disagree, 
3=neutral, 4=agree, 5=strongly agree) and are coded to indicate a higher score consistent with a more positive organizational 
climate. 
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4.8 Results 
In all, 1064 hospitals across 50 states and Puerto Rico participated in the survey.  
Hospitals in the District of Columbia were not represented in the sample.  At the time of 
the survey, 34 states had HAI public reporting mandates while 17 did not (Table 1).  The 
majority of respondent hospitals in this sample (76%, n=811) were located in states that 
had public reporting mandates in place in 2011 (Table 2).  Respondents’ hospitals were 
geographically distributed around the country, but were primarily in the South (36%) and 
Midwest (28%), and rather than the West (16%) and Northeast (19%).  Most hospitals 
identified as suburban or rural (74%) and smaller to mid-range in bed size (85%).   
Table 4.1. States with Public Reporting Mandates Enacted before or in 2011 
Public Reporting 
Mandate (2011, n=34) 
AL, AR, CA, CO, CT, DE, FL, HI, IL, IN, MA, MD, ME, MN, MO, NC, NH, NJ, NV, 
NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WV 
No Public Reporting 
Mandate (2011, n=17) 
AK, AZ, GA, IA, ID, KS, KY, LA, MI, MS, MT, ND, NE, NM, SD, WI, WY 
Data in the above table gathered from empirical evidence presented in Herzig, et. al in 2014.4  See 
Appendix B for guidance on state abbreviations.  
 
 Bivariate analysis of respondent hospitals in reporting states versus non-reporting 
states yielded significant findings regarding the hospitals’ participation in national IP 
improvement initiatives and characteristics of individual hospital infection IP (Table 2).  
Participation in an infection prevention improvement campaign outside of those 
stipulated in the survey (On the CUSP Stop BSI Initiative and IHI 5 million Lives 
Campaign) was noted to be different between hospitals in public reporting and non-public 
reporting states (p = .05).  Additionally, statistically significant differences were seen in 
specific components of facility IP programs.  The mean number of full-time hospital 
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epidemiologists (physicians) was 0.41 in hospitals in reporting states compared to 0.31 in 
non-reporting states (p = 0.04).  While the mean number of infection preventionists (IPs) 
in these hospitals did not differ between the two groups, IPs with specialty certification 
appeared to be more prominent in hospitals with public reporting laws, however this 
difference failed to reach statistical significance with mean in reporting hospitals vs non-
reporting 1.01 and 0.83 respectively, (p = .06).   
4.9 Organizational Climate Findings 
  Four composite scores were created from 19 variables previously 
psychometrically validated to measure organizational climate specifically related to IP.37  
When compared between hospitals in reporting and non-reporting states, mean composite 
scores for all four organizational climate domains did not differ significantly between the 
two groups (Table 3).  Mean scores for both reporting and non-reporting hospitals were 
well above the mid-range, indicating more positive IP organizational climates across the 
all respondent hospitals.   Analysis of individual components within each composite 
score yielded similar findings except for the question asking respondents if people in 
their hospital system feel a sense of urgency about HAIs.  Overall hospitals in public 
reporting states reported a slightly higher mean score than those without mandates, (3.7 
vs. 3.5 out of 5, p = 0.03).  
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Table 4.2. Demographics and Characteristics of Respondent Hospitals 
Demographic/Characteristic Public Reporting (% or 
SD) 
Non-public Reporting (% or 
SD) 
Total (%) [p-value] 
Total Hospitals 811 (76) 253 (24) 1,064 
    
Location    
Northeast  197 (24) 0 (0) 197 (19) 
South 288 (35) 99 (39) 387 (36) 
Midwest 189 (28) 106 (42) 295 (28) 
West  129 (16) 44 (17) 173 (16) 
Other (AK, PR, HI) 8 (1) 4 (2) 12 (1) 
Total 811 253 1,064 [p < .0001] 
Setting    
Urban setting 224 (28) 52 (21) 276 (26) 
Suburban  278 (34) 63 (25) 341 (32) 
Rural  304 (38) 136 (54) 440 (42) 
Total 806 251 1057 [p <.0001] 
Bed Size    
≤200 beds 413 (53) 151 (61) 564 (55) 
201-500 285 (36) 73 (29) 358 (35) 
501-1000 76 (8) 24 (10) 100 (9) 
>1000 beds 8 (1) 0 (0) 8 (1) 
Total 782  248  1030 [p = .06] 
 
                                         Participation in IP Improvement Projects 
Participation in the CUSP Initiative1    
Yes 267 (33) 96 (38) 363 (34) 
No 544 (67) 157 (62) 701 (66) 
Total 811  253  1064 [p = 0.08] 
    
Participation in IHI Five Million Lives 
Campaign2 
   
Yes 272 (34) 81 (32) 353 (34) 
No 539 (66) 172 (68) 711 (66) 
Total 811  253  1,064 [p = .356] 
    
Participation in any other similar program     
Yes 199 (25) 78 (31) 277 (26) 
No 612 (75) 175 (69) 787 (74) 
Total 811  253  1,064 [p = .03] 
    
                               Infection Prevention Program Structure 
Mean number of Full-time Hospital 
Epidemiologists -MD Only (SD)  
0.41 (±0.734) 0.31 (±0.693) 0.38 (±0.729) 
[p = 0.04] 
Mean number of Infection Preventionists 
(SD) 
1.94 (±1.56) 1.79 (±1.23) 1.91 (±1.48)  
[P = 0.36] 
Mean number of Infection Preventionists 
Certified in Infection Control (SD) 
1.01 (±1.22) 0.83(±0.99) 0.974 (±1.71)  
[P = 0.06] 
Hospital has an Infection Control Director    
Yes 560 (69) 188 (74) 748 (70) 
No 249 (31) 65 (26) 314 (30) 
Total 809  253  1,062 (p = .07) 
1Denotes participation in On the CUSP: Stop BSI Project, CUSP = Comprehensive Unit-based Safety Program. 2Denotes participation IHI 
Five Million Lives Campaign, IHI = Institute for Healthcare Improvement. IP = Infection Prevention. All means compared using Wilcoxon 
Rank-sum test. Normality assessed for continuous variables using Shapiro-Wilks test, all p<0.001. All other comparisons made using 
Fisher’s exact test.  
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Table 4.3. Mean LCQ-IP Composite Scores 
                                              LCQ-IP Composite Scores: Mean (N=975) 
 Public Reporting Hospitals Non-Public Reporting Hospitals Total 
Composite 
Mean 
Mean Prioritization of Quality Composite 
Score (range 7 – 30) 
23.92 (±3.66) 23.66 (±3.50) 
23.86 (±3.62) 
[p = 0.26] 
Mean Psychological Safety Composite 
Score (range 8 – 40) 
31.47 (±4.50) 31.11 (±4.86) 
31.38 (±4.59) 
[p = 0.60] 
Mean Supportive Work Environment 
Composite Score (range 5 – 25) 
17.88 (±3.23) 17.86 (±3.29) 
17.87 (±3.28) 
[p = 0.97] 
Mean Quality Improvement Orientation 
Composite Score (range 3 – 15) 
13.29 (±1.56) 13.23 (±1.52) 
13.28 (±1.56) 
[p = 0.62] 
 All scores tested for difference using Wilcoxon Rank-sum test. Normality assessed for continuous variables using Shapiro-Wilks test, 
all p<0.001. LCQ-IP = Leading a Culture of Quality – Infection Prevention.   
 
Four separate multiple linear regressions were conducted to determine the 
relationship between HAI public reporting mandates and each IP organizational climate 
composite score.  Analyses of fully-specified models showed no statistically significant 
impact of public reporting mandates on organizational composite scores, however other 
hospital characteristics emerged as associated with organizational climate (Table 4).  In 
the Improvement Orientation composite score, an average decrease of more than 0.5 
points in the mean score was noted in hospitals who reported being located a in rural 
setting and those within the 500 - 1,000 bed range (p <0.001 and p=0.04, respectively).  
Larger facility size was also associated with a decrease in mean Supportive Work 
Environment composite scores, by an average of 1.20 (p = .001) and 4.38 (p=0.01) 
points in hospitals with 500 – 1,000 beds, and more than 1,000 beds, respectively.  A 
similar association was seen in Prioritization of Quality composite scores in hospitals of 
the same size.  Conversely no association with size was seen on mean Psychological 
Safety composite scores.    
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Refined models determined by stepwise regression with backward elimination 
showed that the structure and characteristics of the hospital’s IP program had statistically 
significant associations with specific organizational climate composite scores (Table 5).  
Many of the statistically significant covariates were held in the refined models.  The 
presence of an infection control director had a consistent finding across three composite 
scores: Prioritization of Quality, Psychological Safety, and Supportive Work 
Environment.  Number of infection preventionist staff was also associated with an 
average increase in the Supportive Work Environment composite score, suggesting a 0.37 
average increase in the mean score for every one infection preventionist on staff.   In 
addition to the size of the facility, higher mean Improvement Orientation and 
Prioritization of Quality composite scores were modestly associated with the number of 
infection preventionists certified in their specialty. 
4.10 Discussion 
 This study estimates the association between HAI public reporting mandates and 
perceptions of infection prevention organizational climate in hospital settings.  Overall no 
statistically significant differences in organizational climate composite scores were noted 
in the association between states with and without public reporting mandates.  While no 
effect of state-level mandates were seen, it is possible that some of the effects of these 
specific laws were masked by federal reporting mandates and incentive programs 
specifically targeting HAIs.  Inpatient Hospital Quality Reporting, Value Based 
Purchasing and the HACS Reduction Program are federal initiatives aimed at reducing 
HAIs.   
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Table 4.4. Multiple Regression Coefficients for LCQ-IP Composite Scores (Full Model) 
 Prioritization of Quality  
(p-value, 95% CI) 
Psychological Safety  
(p-value, 95% CI) 
Supportive Work Env 
(p-value, 95% CI) 
Improvement 
Orientation 
 (p-value, 95% CI) 
Composite Range (SD) 7-30 (±3.62) 8-40 (±4.59) 5-25 (±3.28) 3-15 (±1.56) 
Public Reporting 
Mandate (Yes) 
0.051 
(0.883; [-.63, .73]) 
0.420 
(0.35; [-0.45, 1.29]) 
-0.023 
(0.942; [-0.64, 0.59]) 
-0.172 
(0.246; [-0.46, 0.11]) 
Setting     
Urban (Ref) - - - - 
Suburban -0.595 
(0.145; [-1.40, 0.21]) 
-0.194 
(0.709; [-1.21, 0.83]) 
0.050 
(0.891; [-0.67, 0.77]) 
-0.249 
(0.151; [-0.59,0.09]) 
Rural 
-0.842 
(0.071; [-1.76, 0.07]) 
-0.945 
(0.112; [-2.11, 0.22]) 
-0.068 
(0.871; [-0.89, 0.75]) 
-0.770* 
(<0.001; [ -1.16, -
0.38]) 
Bed Size§     
≤200 beds (Ref) - - - - 
201-500 -0.095 
(0.801; [-0.84, 0.65]) 
-0.165 
(0.732; [-1.11, 0.78]) 
-0.419 
(0.216; [-1.08, 0.25]) 
-0.001 
(0.993; [-0.32, 0.31]) 
501-1000 
-1.379* 
(0.048; [-2.74, -0.01]) 
-0.427 
(0.630; [-2.17, 1.31]) 
-1.994* 
(0.001; [-3.22, -0.77]) 
-0.609* 
(0.040; [-1.19, -
0.027]) 
>1000 beds 
-3.761* 
(0.049; [-7.51, -0.01]) 
-2.934 
(0.229; [-7.72, 1.85]) 
-4.377* 
(0.011; [-7.74, -1.01]) 
-0.583 
(0.473; [-2.18, 1.01]) 
IP Program 
Characteristics 
    
Infection Control 
Director (Yes) 
0.883* 
(0.005; [0.27, 1.49]) 
1.188* 
(0.003; [0.41, 1.97]) 
1.058* 
(<0.001; [0.05, 1.61]) 
0.176 
(0.182; [-0.08, 0.43]) 
Number of Full-time 
HE 
0.225 
(0.228; [-0.14, 0.59]) 
0.003 
(0.991; [-0.46, 0.47]) 
-0.029 
(0.863; [-0.36, 0.30]) 
0.078 
(0.326; [-0.08, 0.23]) 
Number of IPs 
0.326 
(0.159; [-0.09; 0.57]) 
0.150 
(0.482; [ -0.27, 0.57]) 
0.463* 
(0.002; [0.168, 0.76]) 
-0.021 
(0.771; [-0.16, 0.12]) 
Number of IPs with 
CIC? 
0.236 
(0.080; [-0.04, 0.69]) 
0.113 
(0.634; [-0.35, 0.58]) 
-0.027 
(0.870; [-0.35, 0.30] 
0.236* 
(0.003; [0.08, 0.39]) 
IP Improvement 
Initiatives 
    
IHI Campaign (Yes) 
0.541 
(0.08; [-0.06,1.14]) 
0 .294 
(0.45; [-0.47, 1.06]) 
0.104 
(0.70; [-0.43, 0 .64]) 
0.209 
(0.114; [-0.05, 0.47]) 
On the CUSP Program 
(Yes) 
0.428 
(0.16; [-0.175, 1.03]) 
-0.251 
(0.53; [-1.03, 0 .52]) 
0.225 
(0.47; [0.32, 0.76]) 
0.207 
(0.115; [-0.05, 0.47)] 
Other Similar Program 
(Yes) 
-.138 
(0.66; [-.75, 0.48]) 
-0.002 
(0.99; [-0.79, 0.78]) 
-0.097 
(0.73; [-0.65, 0.45]) 
0.286* 
(0.034; [0.02, 0.55]) 
*Regression coefficients significant at the p ≤ .05 level. Categorical variables not shown did not reach statistical 
significance in the model.  IP = infection prevention, CIC = Certification in Infection Control, HE = hospital 
epidemiologist, CUSP = Comprehensive Unit-based Safety Program, IHI = Institute for Healthcare Improvement. Not 
shown are coefficients for geographic location, medical school affiliation/type, facility ownership, all of which had no 
statistically significant coefficients. §Wald Test conducted to determine significance of bed size as a group 
(Prioritization of Quality Composite, F = 2.66, p =.047; Supportive Work Environment Composite, F=4.43, p = .0043) 
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Table 4.5. Stepwise Multiple Regression Coefficients for LCQ-IP Composite Scores 
(Final Model) 
 Prioritization of 
Quality  
(p-value, 95% CI) 
Psychological 
Safety  
(p-value, 95% CI) 
Supportive Work 
Env 
(p-value, 95% CI) 
Improvement 
Orientation 
 (p-value, 95% CI) 
Composite Range (SD) 7-30 (±3.62) 8-40 (±4.59) 5-25 (±3.28) 3-15 (±1.56) 
     
Public Reporting 
Mandate (Yes) 
0.051 
(0.883; [-.63, 
.73]) 
0.233 
(0.574; [-0.57, 
1.04]) 
-0.027 
(0.942; [-0.60, 0.54]) 
-0.125 
(0.370; [-0.39, 0.15]) 
     
Setting 
 
-0.379* 
(0.046; [-0.75, -
0.01]) 
 
-0.521* 
(0.012; [-0.96, -
0.09]) 
- 
-0.34* 
(p<0.001; [-0.50, -
0.18]) 
     
Bed Size§ - - 
-0.637* 
(0.008, [-1.11, -
0.17]) 
- 
     
IP Program 
Characteristics 
    
Infection Control 
Director (Yes) 
0.940* 
(0.002; [0.35, 
1.53]) 
1.023* 
(0.007; [0.27, 1.77]) 
0.981* 
(<0.001; [-0.45, 
1.51]) 
- 
 Number of Full-time 
HE  
- - - - 
Number of IPs - - 
0.379* 
(0.001; [0.17, 0.59) 
- 
Number of IPs with 
CIC? 
0.314* 
(0.015; [0.06, 
0.57]) 
- - 
0.183* 
(0.001; [0.08, 0.29]) 
     
IP Improvement 
Initiatives 
    
IHI Campaign (Yes) - - - - 
On the CUSP Program 
(Yes) 
- - - - 
Other Similar Program 
(Yes) 
- - - 
0.301* 
(0.024; [0.04, 0.56]) 
*Regression coefficients significant at the p ≤ .05 level. Model was refined using stepwise regression technique with 
backward elimination and model re-fitting for variables meeting the predetermined α ≤ .05. Categorical variables not 
shown did not reach statistical significance in the model.  IP = infection prevention, CIC = Certification in Infection 
Control, HE = hospital epidemiologist, CUSP = Comprehensive Unit-based Safety Program, IHI = Institute for 
Healthcare Improvement.  
 
This finding may also be explained in part by the sample of survey respondents.  
This was primarily a survey of IP departments and leadership, who responded to 
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organizational climate items from their unique perspective.  Since organizational climate 
is a perception of specific organizational features and domains, these IP professionals 
may have more positive perceptions of measures specific to IP organizational climate. 
This effect has been seen in other literature, specifically regarding infection prevention 
staff’s increased favorable perception of senior management’s engagement in patient 
safety compared to non-infection prevention quality improvement staff; an effect that was 
higher in infection prevention directors versus non-directors.40  Overall, organizational 
climate composite scores were noted to be high with no difference between reporting 
groups.  This could be reflective of respondents enhanced perception of their own 
organizations’ IP infrastructure. Moreover, while the findings of regression analyses 
presented here indicate no statistically significant association between overall composite 
scores and reporting mandates, other hospital characteristics were noted to be associated 
with organizational climate.  
 Size of the facilities was significantly associated with lower IP organizational 
climate scores in three domains: Prioritization of Quality, Supportive Work Environment 
and Improvement Orientation.  The greatest effect sizes of coefficients were seen in the 
Prioritization of Quality and Supportive Work Environment scores.  These scores include 
measures designed to assess the communication within organizations regarding quality 
and strategic plan, as well as open dialogue concerning problems or concerns.  The 
Supportive Work Environment composite score is comprised specifically of measures 
that address issues of accountability, amount of work tasked to staff and the ability of 
leadership to promote an environment conducive to change.  While it’s possible that 
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larger hospitals may face more challenges surrounding the concepts addressed by these 
measures (i.e. issues of distant leadership, stifled communication, obstructed chain of 
command), more research is needed to determine reasons for these associations.  
Leadership and communication have been noted as integral climate domains that 
promote a high quality of care, particularly with regard to IP.41–43  The association of 
hospital size with these IP organizational climate composite scores may indicate an 
important consideration for leadership of larger institutions.  Administrators in these 
hospitals may benefit from taking additional steps to ensure that their organizational 
climate promotes change, strong communication structures and accountability for 
infection prevention efforts.   
 Infection prevention program characteristics, particularly the presence of an 
infection control director, also impacted three composite scores in the final model.  The 
Psychological Safety score was associated with the largest statistically significant 
increase (β=1.023, (p=0.007; [95%CI, 0.27, 1.77]) in institutions with a director present.  
This composite score addresses personnel feeling safe to express concerns over patient 
care, a climate that promotes open communication and a respect for persons within the 
institution.  It’s possible that the presence of an infection control director promotes more 
open communication and facilitates the discussion of problems or issues related to IP 
within the organization. While current literature contends that leadership plays an 
important role in building an organization where infection prevention is supported and 
promoted41; the specific role the infection control director plays in promoting a more 
positive IP organizational climate has not been well-established in the IP literature.  It is 
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likely this role is critical to a well-functioning IP program and safe work environment, 
yet more research is needed to determine the mechanisms behind how this role 
contributes to these to an improvement IP organizational climate.  
 While all individual measures within each composite score were tested for 
differences between hospitals in public reporting and non-public reporting states, only the 
measure discussing a sense of urgency around HAIs was noted to be significantly 
different between the two groups (3.7 vs. 3.5 respectively, p = 0.03).  While this indicates 
a somewhat higher agreement with a sense of urgency around HAIs in hospitals in public 
reporting states, whether this difference is meaningful remains difficult to interpret.  
However this finding is consistent with previous qualitative work examining the impact 
of HAI public reporting mandates on organizations.32–34,44  These findings suggest that 
perhaps a primary role of public reporting mandates is to highlight the importance of 
HAIs and motivate organizations to begin examining methods to improve HAI-related 
outcomes.  
   The IP organizational climate composite scores were inclusive of key domains 
discussed in the Integrative Model of Organizational Climate including leadership, 
communication processes, employee recognition and workload.31  Although the LCQ-IP 
tool wasn’t built to test this model, it did explore specific domains that the Integrative 
Model posits may contribute to clinical outcomes.  Those scores that were most impacted 
by hospital characteristics concerned measures related to leadership, communication and 
accountability.  These domains from the LCQ-IP are similar to those from the Integrative 
Model suggesting that the impact of IP organizational climate may be tested using this 
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framework.  The Integrative Model of Organizational Climate does not account for 
factors such as public reporting that are external to the health system, thus it may not be 
useful in testing the role these policies play in impacting organizational climate.  Despite 
being helpful in delineating the pathways between larger climate domains and clinical 
outcomes, an additional or separate framework may be needed to account for what, if 
any, role public reporting may play in shaping IP organizational climate.  While public 
reporting was not associated with IP organizational climate in this study, it has been 
shown to be associated with climate  domains in previous work.32–34,44  Additionally it 
has been noted that the impact of public reporting of healthcare performance data may 
play stronger role in institutions where these domains have a stronger presence and can 
potentiate a more constructive and collaborative environment.7,29,44    How these 
pathways contribute to HAI outcomes in the setting of IP organizational climate domains 
warrants further study.   
4.11 Study Limitations  
 This study did have some limitations.  The cross-sectional data does not allow for 
causal inference; thus, it is not well suited to determine a causal effect of public reporting 
on organizational climate. Also, this data is from 2011 and public reporting mandates 
have changed considerably since that time, including the addition of more comprehensive 
reporting policy, standardized reporting mechanisms, newer federal policy aimed at 
improving HAI performance.  Additional examination could be conducted to determine if 
timing of the laws (recent implementation vs. less recent) has an impact on organizational 
climate.  While the sample size was considerable for the purposes of this study, the 
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original P-NICER survey had a response rate of 29%.  The addition of NHSN related 
covariates further limited the sample to only those respondents who provided NHSN 
survey data in addition to the P-NICER survey data.  As a result, a smaller subset of 
respondents was used to for regression analysis, potentially impacting ability to see 
statistically significant effect sizes.  Also, it is likely that additional covariates exist that 
were not included in the model potentially contributing to confounding.  A sensitivity 
analysis would be helpful in determining the impact of missing covariates particularly 
with regard to the full sample and the analytical sample. Finally sampling bias and self-
report may be an issue with the P-NICER survey, given that IP professionals may be 
more willing to respond if they are affiliated with specific types of institutions. The 
authors who first reported on results of the P-NICER survey discussed a CDC 
comparison of respondents to non-respondents.45  While no differences were noted in 
intensive care unit (ICU) CLABSI rates there were significant differences noted in 
hospital characteristics.  Specifically, non-respondent hospitals tended to be smaller with 
fewer patient days, fewer beds and admissions.45  While size of the facility was noted to 
be associated with organizational climate in this study, smaller hospitals appeared to be 
well-represented in our sample. Furthermore, organizational climate responses appeared 
consistent across comparisons and participants appeared to be well distributed across 
different geographic regions and facility characteristics so external validity appears 
sound.   
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4.12 Policy Considerations and Future Research 
 Although public reporting was not shown to be associated with IP organizational 
climate in this study, findings did confirm that these policies stimulate a sense of urgency 
around HAIs in hospital settings.  While the intent of these policies is to improve care 
and aid in consumer decision-making, they do not provide guidance as to how healthcare 
systems should make the changes necessary to facilitate these outcomes.  This allows for 
flexibility within institutions to determine the best methods for improving care and 
decreasing HAIs. It reasons then, that hospitals and other healthcare institutions may be 
affected by these mandates in different ways.  The results of this study are not meant to 
suggest that public reporting laws are ineffectual in impacting hospitals’ organizational 
climate; only that additional investigation is needed to address the complexity of their 
impacts on health systems.  Empirical study should continue to investigate how these 
public policies drive change in organizational climate.  If certain organizational climate 
domains are identified as being related to public reporting policies, the relationship 
between those domains and outcomes may be investigated.   
Qualitative methodologies have been successful in illuminating these concepts in 
previous literature32–34, and may be a beneficial strategy to investigate the large scope of 
these laws and the intricate ways health systems respond to their implementation.  
Organizational climate and its impact on patient outcomes has been studied in the 
literature with mixed findings using quantitative methodologies, however few have 
focused specifically in IP organizational climate.8  An innovative study from Gilmartin 
and Sousa46 used structural equation modeling to determine the association between 
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organizational climate, process improvements for CLABSI prevention and CLABSI 
outcomes. Their findings indicated that organizational climate was associated with 
CLABSI prevention activities, but not CLABSI outcomes, however the authors stress that 
more research is needed.46 While quantitative methods may be helpful in illuminating the 
relationship between climate and outcomes, mixed methodological studies may be 
helpful in both understanding the effect of policy on climate and the subsequent effects of 
climate on outcomes. Studies that examine how organizations change in response to these 
laws as well as how these changes impact outcomes would help to paint a fuller picture of 
the wide-ranging effects of these laws on health systems.   
Additionally, understanding how different hospital personnel perceive IP climate 
and their perceptions of publicly reported HAI data would shed important light on how 
these laws are assimilated not only by IP staff, but by other stakeholders within hospitals.  
Additional study of how physicians, nurses, and others view IP organizational climate 
and HAI data may help policy makers understand the how these mandates perfuse 
through healthcare systems and gauge their effect on key stakeholders.  This knowledge 
would highlight where these policies have their strongest effect in affecting decision-
making and improving quality of care.   
U.S. state and federal policy continues to promote public reporting of HAIs and 
other healthcare quality measures; law makers must understand the full scope of how 
these laws impact health systems.   This knowledge may help drive new policy that 
promotes or incentivizes hospitals to build programs that strengthen their IP 
organizational climate in the hopes of achieving gains in patient outcomes related to 
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HAIs.  If the public reporting alone is not enough of a stimulus to propagate change and 
improvement, policy-makers should consider other potential drivers that strengthen to 
organizational climate domains.  Policies that incentivize building a climate conducive to 
HAI improvements may prove to be a powerful adjunct to public reporting policy, or may 
prove more valuable to patients and organizations over the long term.  
4.13 Conclusion 
 In this study, organizational climate as measured here, did not differ between 
hospitals in states with and without mandatory HAI reporting. However important 
findings were seen concerning the effects of specific hospital characteristics including 
bed size and structure of IP programs that do have an impact on IP organizational 
climate.  Hospital size and IP program characteristics did show some association with IP 
Organizational climate composite scores in the survey.  However, more research is 
needed to determine the exact mechanisms behind these relationships.  Policy-makers 
should consider the structure of IP programs and hospitals in addition to organizational 
climate when formulating or implementing policy around HAIs and public reporting.   
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5.1 Introduction 
 
 Healthcare-associated infections (HAIs) continue to be a significant source of 
morbidity and mortality in the U.S. healthcare system.  Infections contracted during 
interactions with healthcare facilities or as a result of specific treatment interventions are 
considered to be healthcare-associated and may arise from multiple etiologies.1  These 
infections can cause serious complications and prolonged length-of-stay in inpatient 
settings and can complicate treatments and cause additional morbidity in both inpatient 
and outpatient settings.  Recent estimates from the CDC suggested that as recently as 
2011, 722,000 HAIs occurred annually and were responsible for approximately 75, 000 
deaths in the United States.2   Financial estimates place the monetary burden of HAI 
events as costing health systems anywhere from $24.8 to $33 billion dollars.2,3  Over the 
past decade, attempts to curb rates of HAIs has centered on both the implementation of 
evidence-based process improvements and promotion of broad policy initiatives and 
patient safety programs.   In many respects, these efforts may be considered successful, in 
that recent data from the U.S. Centers for Disease Control (CDC) show a general 
decreasing trend in HAIs in HAI incidence since 2008.4  However, a more granular view 
of the data suggests these trends are not consistent across all states and all healthcare 
systems.4  These fluctuations in trends indicate that there is still significant room for 
progress and additional policies or interventions that may be aimed at improving HAI 
outcomes.  While it may be difficult to attribute specific gains to any particular policy or 
evidence-based intervention, understanding the mechanisms behind larger HAI policy 
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initiatives is the first step to evaluating how policy may impact organizations and, 
ultimately outcomes.   
 One policy-level approach to addressing the issue of HAIs over the past decade 
has been the wide-spread passage of legislation mandating healthcare facilities report 
HAI-related data to specific state-level overseers, typically health departments.5  
Although commonalities exist across most state-level reporting mandates, these laws do 
vary from state-to-state particularly in terms of which specific HAIs must be reported, 
whether the data is reported to the public, and whether the data is required to be 
submitted with facility identifiers indicating which facilities are associated with specific 
outcomes.6  Each of these provisions carries the propensity to affect how hospitals and 
other healthcare entities respond to HAIs, particularly if they change their practices in 
response the external pressure of reporting these metrics.  Yet it is often contended that 
the mandate to report HAI data for release to the general-public is what may play the 
largest role in generating specific responses from hospitals aimed at improving HAI 
outcomes.7–10     
 State HAI reporting mandates and their public reporting components have often 
been met with controversy and skepticism.  As of 2013, 37 states had legislative 
mandates for reporting HAI-related performance data.5  Many of these laws, particularly 
those mandating the report of device-associated infection data (central-line associated 
blood stream infections [CLABSI] and catheter-associated urinary tract infections 
[CAUTI]), were enacted in the mid or late 2000s5, even in the face of little evidence 
supporting their ability to reduce infection rates or empower consumers to use to the data 
for decision-making.11  Since that time additional studies have attempted to evaluate the 
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impact of these laws on patient HAI-related outcomes, organizational process 
improvements, and consumer decision-making.  The empirical evidence from these 
studies has yielded mixed results concerning the potential impacts of these mandates and 
HAIs continue to negatively impact patient outcomes, despite the persistence of these 
laws. 
 The aim of this dissertation is to illuminate the impacts of state HAI reporting 
mandates by examining their relationships to organizations and infection rates.  
Specifically, this dissertation was written as three papers, each contributing a new 
understanding and evaluating hypothesized relationships between these mandates and 
hospitals or infection-related outcomes.  The first paper proposes a revised conceptual 
framework that builds on findings from existing literature to discern the various pathways 
by which reporting mandates may stimulate change in provider or system behavior, 
process improvements, outcomes and consumer decision-making.  The second paper is a 
quasi-experimental longitudinal data analysis that examines the impacts of state public 
reporting mandates on Clostridium. difficile (C. difficile) infections over time.  The third 
paper is an exploratory data analysis that examines organizational climate and its 
relationship to state reporting mandates using cross-sectional survey data from the 
Prevention of Nosocomial Infections and Cost-Effectiveness-Refined (P-NICER) 
survey12.  Each of these papers approaches the phenomenon of mandated reporting from a 
varying perspective: the impact on outcomes, the impact on organizations and the 
conceptual pathways which may guide those impacts. 
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5.2 Key Findings  
 Findings from each component of this dissertation contribute to the larger body of 
knowledge surround HAI public and mandatory reporting.  These papers represent a 
different aspect of reporting that has larger implications for healthcare systems, patients 
and policy.  
 The first paper in this dissertation proposed a revised conceptual framework to 
describe the relational pathways by which the reporting of HAI data impacts health 
systems, consumers and infection-related outcomes.  Prior pathways describing the 
impacts monitoring performance data7 and public reporting8 were used to guide the 
analysis and served as a foundation on which to build the revised framework.  The 
intricate relationships between these laws, key stakeholders and outcomes is illuminated 
by current evidence in the literature and analyzed using an integrative review 
methodology to develop and propose a revised conceptual framework.  The 19 studies 
reviewed, spanned a breadth of HAI reporting mandates and their associated impacts on 
healthcare organizations, consumers, and infection related outcomes.  Studies with 
diverse methodologies including qualitative, quantitative, mixed-methods and one 
systematic review were included in the analysis.  Key components of existing conceptual 
frameworks were used to organize the analysis and present findings.  Building from 
existing frameworks 3 key stakeholder groups were the focus of the literature review.  
Studies centering on HAI reporting impacts on consumers, healthcare organizations and 
providers were analyzed.  Findings were synthesized and compared to existing 
conceptual frameworks.  The author then determined whether empirical evidence exists 
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to support these existing relationships and if needed proposed new directional pathways 
that describe the hypothesized impacts of reporting based on the findings of the review.  
The Change pathway, first described by Berwick and colleagues7, centers on the 
intrinsic ability of organizations to respond to their own performance data and implement 
change to improve outcomes.  In this pathway, motivational drivers of change include 
desire-to-achieve and caring, yet are still subject to the environments in which these 
changes are slated to occur.  Studies examining the change pathway delineated mixed 
findings regarding patient outcomes and process improvements as a result of public 
reporting.13–22  With regard to infection related outcomes, multiple studies do show an 
effect of public reporting in reducing infection rates14,16,17,23, particularly related to 
CLABSIs.  Yet while these studies showed reductions in infection rates or events, the 
mechanism by which these laws generate these changes remained unclear.  A study by 
Marsteller and colleagues14 was able to link participation in process improvements to 
pending or recent reporting mandates, which in turn, was associated with decreased 
CLABSI rates.  A paper from Liu et. al23, also hypothesized on the potential impacts of 
public reporting on healthcare systems, finding that reducing central line days and 
strengthening surveillance programs may be an effect of these laws that contribute 
diminished CLABSI rates.  However additional studies were unable to find similar results 
with regards to both point-of-care processes, including antibiotic utilization, or infection 
rates.18,24  Qualitative studies showed more specific impacts of HAI reporting mandates, 
particularly their effects on organizational climate, infection prevention infrastructure and 
process improvements.  Studies examining California hospitals showed that after the 
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implementation of reporting laws, increased adherence to various infection prevention 
measures were noted as well as a general sense of increased infection prevention 
visibility and importance within the system.21,25  However, study participants also noted 
frustration with HAI laws due to variability in reporting requirements between state and 
federal agencies and increased workload.  Improved processes were described as a direct 
response to both federal and state reporting requirements in two other California 
hospitals, noting specifically that while challenges remain, reporting mandates had 
stimulated improvements in infection prevention infrastructure and implementation of 
evidence-based prevention practices.19 In addition to process improvements, 
organizational climate factors such as leadership, accountability, communication, and 
support also emerged.20  These factors were noted by respondents as being key 
components of broader responses to mandatory reporting within healthcare organizations.  
Two additional pathways, the Selection Pathway and the Reputation Pathway, 
have also been proposed as drivers of change as a result of public reporting.7,8  These 
pathways acknowledge the potential impact of reporting mandates and publicly reported 
data on consumers. However studies examining these potential pathways largely showed 
that publicly reported HAI data is not a prominent factor when consumers make decisions 
about their healthcare often outweighed by provider recommendations, geographic 
location or insurance status.22,26–28  Additionally most consumer respondents across all 
studies had difficulty interpreting HAI data, particularly in the face of numerical or 
statistical complexity and variable outcome metrics.   These findings suggest that while 
consumer selection may be a proposed pathway for public reporting mandates, additional 
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evidence is needed to examine the mechanism by which it affects consumer decision-
making.  Interestingly consumers often ranked provider and family recommendation as a 
contributing factor to their healthcare decision-making.   
Findings from this review showed largely mixed support for the current pathways 
proposed by Berwick et. al7, and Hibbard8.  A revised conceptual framework was 
proposed that used evidence from the literature to support existing pathways and propose 
new pathways and relationships between public reporting and various stakeholders within 
the healthcare system.  In the revised framework, publicly reported data does have a 
direct impact on patient outcomes related to HAIs.  Studies presented in this review have 
shown this relationship both for clinical outcomes and process improvements.14–17,23  Yet 
the exact nature of the relationship between reporting and outcomes remains somewhat 
undefined.  Improvement processes and organizational climate were noted in these 
studies to be key factors related to HAI reporting laws, yet evidence for how these 
components impact outcomes is not readily appreciable across findings.  Thus, the 
framework describes a direct association of reporting mandates on HAI outcomes, but 
also a potential mediating impact through organizational processes and climate.   
While consumer choice had less supportive data describing potential relationships 
within the Selection Pathway, evidence from this review suggests that the Reputation 
Pathway may play a greater role in selection than previously discussed.  Findings from 
consumer-focused studies showed that consumers more often rely on recommendations 
from family and care providers for healthcare decision-making than publicly reported 
HAI performance data.22,26–28  In this regard the Reputation Pathway may mediate the 
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Selection Pathway, if reported HAI data does in fact affect the reputations of healthcare 
organizations.   
Despite these new hypothesized relationships further study is needed to determine 
how and to what magnitude these pathways impact outcomes, organizations and 
consumer decision-making.  Understanding these relationships is crucial not only in the 
broader context of discerning public policy impacts on patient outcomes, but to ensure 
these policies are being implemented effectively and rationally to improve patient care.   
To contribute to the body of literature and further discern the impacts of HAI 
reporting mandates on clinical outcomes and organizations, two additional studies were 
undertaken in this dissertation.  Both studies explored the impacts of HAI reporting 
mandates at the state level, the first reporting on C. difficile events in hospitals and the 
second addressing impacts on organizational climate indicators.   
The second paper in this dissertation examined the association between state HAI 
reporting laws and C. difficile and Methicillin-resistant Staphylococcus aureus blood 
stream (MRSA-BSI) events across a longitudinal sample of hospitals from varying states.  
Building from an analysis previously conducted by Liu and colleagues23,  this paper used 
a quasi-experimental design to determine the effects of reporting mandates on hospital-
onset (HO) C. difficile and MRSA-BSI Laboratory-Identified (LabID) events as defined 
by the CDC’s National Healthcare Safety Network(NHSN).29  These LabID events are 
the common metric used in both state and federal reporting mandates.4,5,30,31  Data from 
the P-NICER survey was used for the primary analysis and included a final sample of 
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219 hospitals was included in the analysis, yielding 4,328 hospital-months of complete 
data.  Outcome events were modeled with respect to effects of mandatory reporting laws 
at varying time distances before and after the laws’ implementation.  This design allows 
for the identification of time trends in infection rates as they related to implementation of 
the law.23   
Early in the analysis phase of this study it was determined that the proposed 
model for MRSA-BSI LabID events would not converge, likely due to a high frequency 
of zero or one event counts in the panel data.  MRSA outcomes were thus not included in 
the final analysis.   Zero-inflated Poisson regression models for C. difficile showed no 
statistically significant effect of public reporting mandates either before or after 
implementation of these laws.  One statistically significant incident rate ratio (IRR) at 18 
to 16 months before the law was significant (p = 0.034) but likely represented a decline in 
a single hospital during that period.  Overall trends in IRRs indicated decreased rates in 
C.-difficile LabID events after implementation of the laws, when compared to 28-to-30 
months prior.  Although these IRRs did not reach statistical significance, findings may 
suggest some impact of mandatory reporting laws. Sensitivity analyses confirmed that the 
rate of change over time in both reporting and non-reporting groups was statistically not 
different, however, and further study is needed to determine the significance of these 
findings.  
To approach the concept of mandated HAI public reporting from a different 
perspective, the third paper in this dissertation aimed to conduct an exploratory data 
analysis and examine the relationship between organizational climate variables and 
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public reporting.  Organizational climate refers to the perception of culture within an 
organization inclusive of specific factors such as leadership, communication and social 
norms.  Data on organizational climate was collected as part of the P-NICER survey and 
reported in a specific subsection of the Leading a Culture of Quality for Infection 
Prevention (LCQ-IP) survey.32  Organizational climate factors included in this survey 
spanned multiple domains and assessed concepts specific to infection prevention.32  Four 
domains emerged from grouping of individual factors related to infection prevention 
organizational climate.  These domains included Improvement Orientation, Psychological 
Safety, Prioritization of Quality and Supportive Work Environment.  Survey questions 
measured factors associated with each domain on a Likert Scale and were coded so 
higher scores indicated more positive organizational climates.  These individual factor 
scores were then summed to generate composite scores for each domain.  These scores 
were then compared across reporting and non-reporting states and linear regression was 
used to determine the impact of reporting laws and various facility-level characteristics 
on organizational climate domains.   
Across all four climate domains, no statistically significant differences were noted 
in composite scores between hospitals in states with HAI public reporting and those 
without.  Additionally, results of multiple linear regression found that the presence of 
public reporting laws had no statistically significant association with organizational 
climate composite scores.  However, in the final models, some key hospital 
characteristics remained significant indicating associations with individual composite 
scores.  The presence of an infection control director was shown to be associated with 
186 
 
higher mean composite scores in the Supportive Work Environment, Psychological 
Safety, and Prioritization of Quality composite scores (p < 0.01).  Similarly, the number 
of infection preventionists certified in infection control was also associated with a higher 
Improvement Orientation score and Prioritization of Quality score (p<0.01, p = 0.02, 
respectively).  While not directly related to public reporting in this study, these findings 
do contribute to the larger body of knowledge regarding organizational climate and 
infection prevention.  Future research will be needed to assess additional relationships 
and potential impacts among public reporting hospitals.   
Together these three papers contribute a well-rounded perspective on HAI public 
reporting and its impacts on organizations and outcomes.  They provide findings from 
empirical investigations and a revised framework gleaned from a substantive review of 
existing literature.  The integration of these findings yields new knowledge regarding 
HAI public reporting mandates and proposes new directions for policy research.   
5.3 Discussion  
 The mandated reporting of HAI performance data is a widely used policy 
intervention that attempts to promote consumer decision-making and healthcare system 
accountability.10,33  Current reporting mandates in the United States span a breadth of 
states, include a variety of HAI reporting requirements, and a promote a diverse 
methodology for data dissemination.5  Most reporting mandates include three key 
legislative or administrative components: the mandate to report HAI data, the mandate to 
report that data to the public, and the inclusion of facility identifiers that link performance 
data to specific healthcare facilities.  In much of the previously discussed literature the 
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publicizing of facility-linked performance data is often thought of the primary motivator 
behind consumer decision-making and changing practices to improve patient care.7,8,10 
Subsequently the primary body of knowledge surrounding HAI public reporting has 
attempted to describe or quantify the effect of these reporting mandates, often with 
diverse and innovative methodologies.  The findings from each of the papers in this 
dissertation contribute significant findings to this body of knowledge.  Yet, as a whole, 
they provide a new direction for future research and innovation needed to understand 
how and why these laws impact healthcare consumers and organizations.   
The revised conceptual framework this dissertation presents is the first updated 
framework to specifically propose pathways between publicly reported HAI data, patient 
outcomes, organizations and consumers.  While it does build from previously proposed  
frameworks7,8, these frameworks were not specific to HAI data.  The importance of an 
HAI-specific framework lies in the need to address the pathways for the process 
improvements, epidemiologic considerations, evidence-based interventions and patient-
related considerations that are unique to HAIs.   Unlike other publicly reported healthcare 
performance data, HAIs are somewhat set apart both because of their implications for 
transmission to other patients within a health system and the medical and environmental 
conditions that put patients at risk for infection.1  Additionally these infections can pose a 
threat to the larger community including patient families, healthcare workers and 
others.34  These distinctive characteristics of HAIs pose a unique challenge to health 
systems attempting to curb their transmission, and often sets them apart from other 
metrics and prevention programs within healthcare settings.  As federal and state policy 
makers have moved public reporting mandates forward, research into how these laws 
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impact these infections and the organizations trying to prevent them, is integral.  The 
revised framework in this dissertation allows investigators to test direct pathways 
between laws and outcomes, or examine specific mediating variables that are evidenced 
in the literature as potentially being impacted by these laws and related to decreased HAI 
rates.  Additionally, the idea that HAI performance data is driving consumer decision-
making is perhaps an intuitive one, but the current available literature suggests that 
consumers are either not aware of the existence of this data22 or have difficulty 
interpreting this data, particularly when metrics are varied or highly statistical and when 
consumers have less eduction.26–28  The framework presented in this dissertation provides 
researchers and policy makers with new pathways for empirical testing and investigation 
of relationships between HAI reporting mandates, outcomes and organizational 
processes.  In addition, it integrates the iterative role consumers play in influencing 
healthcare organizations, while keeping the unique pathways that may prove specific to 
consumers. 
  The two empirical studies in this dissertation tested specific components of this 
revised framework.  The quasi-experimental longitudinal C. difficile and MRSA study 
evaluated the direct association between state reporting mandates and outcomes.  The 
organizational climate study centered on examining the association between these laws 
and specific domains of organizational climate as they relate to infection prevention.    
Although different in aim, methods, and outcomes, these two studies contribute equally 
valuable findings, regarding the broader effects of reporting mandates.   
Understanding the direct impacts of HAI reporting mandates and potential 
mediating factors of these effects is an important component in understanding how these 
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laws impact outcomes.  The revised framework presented in the first paper proposes that 
a directed pathway exists between reporting of HAI data and an improvement in 
outcomes, which is often a reduction in infections.   The evidence from previous studies 
has been mixed regarding this pathway and this dissertation was unable to find a 
statistically significant association.  Although one other study had noted a decrease in C. 
difficile in Canada after implementation of reporting laws16, this paper was the first  to 
examine these associations in the United States.  While this does not confirm or 
strengthen the evidence underlying this pathway, further research will be needed to 
determine how this pathway differs with other types of HAIs, in other policy settings, and 
potentially in other types of care settings.   
This direct pathway, likely has significant mediating organizational influences 
that may contribute to infection outcomes.  These relationships have been explored in 
previous literature, again with mixed findings.14,15,23  However qualitative exploration of 
organizational responses to HAI reporting mandates have shown significant impacts of 
these laws on infection prevention personnel and organizational climate factors.20,21,25   
The exploratory analysis presented in this dissertation is the first to examine 
organizational climate variables specific to infection prevention and attempt to quantify a 
relationship between these variables and public reporting.  While not specifically testing 
for mediation, this paper explores the first pathway from mandated reporting to potential 
impacts on organizations.  Knowledge of this relationship can guide additional inquiry to 
understand how organizations may be impacted by these reporting laws.  If these 
relationships are established, further analyses may show they are a mediating factor for 
decreasing HAIs in response to public reporting.  Organizational climate is an integral 
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component to this pathway as it may not only contribute to better patient outcomes35, but 
it may help policy makers and healthcare administrators understand in what type of 
facilities, these laws may have the biggest impact.     
The findings from this dissertation yield that much remains unknown regarding 
how these reporting mandates impact outcomes and organizations.  Additional study is 
needed to explore these complex relationships presented in these studies and previous 
work.  Examination of theses interrelationships open the door for a significant amount of 
new research and innovative policy directions.  
5.4 New Directions for Nursing Research and Policy  
 This dissertation provides a comprehensive groundwork for additional nursing 
research and new considerations for policy-makers.   In a dynamic policy environment 
both researchers and policy-makers will need to respond to the demand for new inquiry 
and thoughtful policy recommendation and implementation.   
 Nursing researchers have been at the forefront of investigating the effects of HAI 
reporting mandates.  The larger implications for healthcare organizations and personnel 
cannot be understated.  Nurse are often directly involved in the care for those at risk for, 
or affected by HAIs and some HAIs may be nursing sensitive to nursing processes and 
behaviors.36  Although much has been examined regarding HAIs and reporting mandates, 
large gaps in knowledge persist.  One significant paucity in the research is how 
healthcare workers and administrators outside infection control interpret and use publicly 
reported HAI data.  Administrators and front-line staff play significant roles within 
healthcare systems and are often responsible for key decision making, implementing 
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process improvements and conducting patient education.  HAI data is an important tool 
and consideration for many of these staff, yet little is known about if or how publicly 
reported HAI data impacts their roles or their decision-making.  None of the studies 
reviewed investigate the knowledge base or attitudes of nursing or physician personnel, 
outside of infection control departments, regarding publicly reported HAI data and 
whether they can interpret or use the data to effectively.  Additional study is needed 
concerning the impact public reporting continues to have on infection prevention 
personnel and as well as those healthcare workers not directly responsible for data 
submission or surveillance.     
 Nursing research can also play a key role in revealing what specific factors 
contribute to patients understanding of publicly reported HAI data.  Some evidence has 
shown a relationship between educational level, prior healthcare experience and higher 
income levels.22,27,28  Yet many of these studies were conducted on small populations and 
are difficult to extrapolate outside of the study setting.  These findings should be further 
examined in other geographic regions with differing populations to establish and test 
hypotheses about how social determinants of health impact a consumer’s ability to 
interpret data that may guide their decision-making.   
 Finally, there is ample opportunity for nursing researchers to develop novel 
interventions that aim to guide patients through the interpretation of HAI data and 
empower them to use that data to promote safer care environments.  While not every 
consumer has the ability to choose from multiple healthcare institutions, they may still 
benefit from understanding their own hospital’s HAI performance and become advocated 
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for their own high-quality care or that of their family members.  Nurses are uniquely 
qualified to not only educate consumers about this data, but also to advise policy-makers 
and administrators about the best way to organize and disseminate this data to make it 
relevant and applicable across varying sociodemographic and socioeconomic groups.  
In addition to nursing research, the implications of these findings on health policy 
is significant.  Many of current federal policy initiatives centered on improving care 
include a component of mandated and/or public reporting.  The Hospital Inpatient 
Quality Reporting Program (IQR), Healthcare-acquired Conditions Reduction Program 
(HACRP) and Value-Based Purchasing (VBP) are legislative mandates implemented by 
the Centers for Medicare and Medicaid Services (CMS), and require the submission of 
HAI data for various payment incentives and penalties at the healthcare facility 
level.30,31,37  This data is then reported publicly on the Hospital Compare website.  These 
data are received through the NHSN, a primary component of most state-based reporting 
mandates.  Many state mandates require the public dissemination of reported data, 
sometimes in varying formats.   A key consideration for policy-makers is the 
understanding of whether or not the impetus behind these laws’ ability to instigate change 
in healthcare settings is the public reporting component of these mandates.  This is likely 
a consideration for both policy-makers and researchers.  While some studies attempt to 
evaluate the impacts of these public reporting mandate, few delve into what, if any, 
motivators are specific to public reporting.  If the public dissemination of HAI facility-
specific is a stronger motivator than internal reporting, examining the specific 
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mechanisms (i.e. social norms or intrinsic drivers) may be beneficial when applying 
similar policy interventions to other areas of society.   
 An additional policy consideration is the propensity to report outcomes rather 
than process indicators or process measures for HAI improvements.  While some 
hospitals do report certain process measures, including Central Line Insertion Practices 
(CLIPs), most of the metrics required by public reporting mandates are outcome 
measures.  The decision to mandate the implementation of process measures rather than 
outcomes reporting may be based on the feasibility of wide-spread process measure 
implementation.  With the varying sizes, geographical regions, and financial resources 
across hospital settings, broad implementation of targeted process improvements may be 
challenging.  However, the recent passage of mandated antimicrobial stewardship 
programs in California hospitals may serve as a model for future policy initiatives that 
target implementation of interventions rather than simply reporting outcomes.38  
Although some evidence exists that these public reporting mandates have a direct impact 
on infection-related outcomes, the association between process improvements and 
evidence-based prevention programs is more readily understood.   It may prove 
worthwhile for policy makers to develop or promote structured interventions or provide 
funding for participation in broad process improvement initiatives as a means of 
improving HAI-related outcomes.    
Finally, policy makers should would do well consider both the ethical components 
of these mandates and how to best use data to empower consumers across all measures of 
diversity and social determinants of health. Transparency in both the implementation and 
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evaluation of these laws’ utility among consumers is essential to understanding and 
improving methods for effective and fair dissemination.  Understanding the goals of these 
mandates and their effectiveness may guide needed changes in how data is reported and 
shared among multiple stakeholders.  If a critical goal of reporting these data is to help 
consumers make decisions about their care, policy-makers should consider strengthening 
dissemination efforts to make reported data more meaningful.  Data should be publicized 
in a way that acknowledges and is sensitive to the social determinants of health, 
differences in health literacy levels, and health disparities.   
5.5 Conclusion 
 Mandated reporting of HAIs has been a prominent policy initiative in the United 
States for over a decade.   This dissertation aimed to examine associations between these 
policy mandates, HAI outcomes and impacts on organizational climate in acute care 
hospitals.  These studies provide critical foundations for ongoing inquiry regarding the 
effects of these mandates on patient outcomes, organizational characteristics and 
processes and consumer decision-making.  More research is needed to examine the 
important implications of these HAI reporting mandates and determine the mechanisms 
by which they motivate change and improvement in healthcare systems.   
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Appendix A. Integrative Review Matrix/Table of Evidence 
Author(s), 
Year 
Purpose of the 
study 
Stakeholder 
Group/ 
Pathway 
Conceptual 
Framework  
Sample  Data Analysis 
Methods  
Attrition and 
Results  
Significance of 
Findings  
Limitations  
Mansick et.al, 
2015 
To assess the 
interpretability of 
HAI data as 
presented on the 
hospital compare 
website.  
Consumers/ 
Selection 
None 
Specified 
110 
hospitalized 
patients at the 
University of 
Maryland 
Medical 
Center 
selected from 
a list of 
admissions in 
prior 24 hours.  
Cross-sectional 
survey design. The 
mean correct score 
for each task is 
reported as 
percentage.   
Response to 4 
domains was 
evaluated: Written 
description of data, 
written description 
plus SIR, 
IDENTICAL SIR 
descriptions with 
numbers, and only 
numbers.  
Performance of 
hospitals with 
regards to HAIs was 
correctly assessed 
72% of the time 
when plain language 
description of HAI 
rates/SIRs was used.  
Mean percent correct 
decreased as 
complexity 
increased.  Similar 
decreasing trend seen 
among college 
graduates, those who 
were more likely to 
get question 1 
correct, and 
healthcare 
workers/caregivers of 
frequently 
hospitalized persons  
  First quantitative study 
evaluating data 
interpretation specific to 
HAI data.  Outside of 
the experimental 
environment real data is 
likely more difficult to 
interpret.  
No critically ill 
patients, or 
members of the 
non-hospitalized 
population were 
used which 
excludes those 
who had the 
ability to use the 
data for decision 
making 
purposes.   
McGuckin, et. 
al 2014 
To assess 
consumer 
awareness, 
engagement, and 
intention to seek 
information on 
HAI rates.  
Consumers/ 
Selection 
None 
Specified 
Random 
telephone 
sample of 
3000 
consumers 
from the U.S. 
All 18 y.o. 
and older.  
Descriptive 
statistics and 
Pearson Chi-sq tests 
for differences in 
participants from 
public reporting vs. 
non-public 
reporting states.  
3031 respondents 
took the survey, 1895 
lived in states with an 
HAI reporting law 
and at least 1 HAI 
PR. In states with PR 
28% knew this.  Only 
14% of respondents 
stated HAI data as 
one of the top 2 
factors in decision 
While some respondents 
were aware of HAI 
reporting, few listed it as 
a top motivator for 
healthcare decision-
making.   
  Researchers 
don't analyze 
correlation with 
demographic 
variables 
(race/ethnicity) 
as predictors or 
correlates of 
responses.   
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Author(s), 
Year 
Purpose of the 
study 
Stakeholder 
Group/ 
Pathway 
Conceptual 
Framework  
Sample  Data Analysis 
Methods  
Attrition and 
Results  
Significance of 
Findings  
Limitations  
making regarding 
hospital choice with 
recommendation 
from HCW and 
reputation being the 
2 most common 
criteria.   
Mazor & 
Dodd, 2009 
To evaluate 
different 
approaches for 
reporting hospital-
level comparative 
data on HAIs and 
the extent to which 
such data might 
influence hospital 
choice.  
Consumers/ 
Selection/ 
Reputation 
Berwick and 
Hibbard 
Random 
sample of 
residents from 
Worcester 
MA selected 
from city 
clerk's office 
for mailing. 
201 
respondents 
included in the 
final sample.   
Descriptive 
statistics for 
respondent 
characteristics, t-
tests and Chi-2 to 
compare 
respondents to non-
respondents.  IV's 
impact on 
understandability 
were tested with t-
tests and 
multivariate linear 
regression.   
Reponses rate of 
34% (201 total 
respondents of those 
able to respond), 
25% of total 
solicited.  Education 
was associated with 
correctly choosing 
the best and worst 
hospitals (65% of 
those with HS or less 
selecting the best 
hospital compared 
with 83% at least 
some college or 
higher p=.003).  
Understandability 
ratings were also 
associated with 
correct selection.  
Prior experience, 
hospital reputation, 
MD 
recommendation, 
insurance all ranked 
above infection data, 
practice score in 
terms of factors 
affecting hospital 
choice  
Data on HAIs and safety 
ranked lower in 
hierarchy of factors 
affecting hospital choice, 
however reputation was 
the second most 
important factor.  
Overall 
understandability of 
these reports was high 
however there was 
sufficient evidence to 
suggest that education 
plays a role in 
understanding these 
reports.   Numerical data 
were noted to be the 
least comprehensible.  
Aggregate scores were 
most impactful.    
Low response 
rate.  The 
respondents 
were more 
educated than 
the general 
community, so 
generalizability 
may be difficult, 
particularly if 
the goal is to 
evaluate or 
recommend how 
state reporting 
should be rolled 
out.  
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Author(s), 
Year 
Purpose of the 
study 
Stakeholder 
Group/ 
Pathway 
Conceptual 
Framework  
Sample  Data Analysis 
Methods  
Attrition and 
Results  
Significance of 
Findings  
Limitations  
Mazor et. al, 
2009 
To explore 
consumers' 
responses to a 
variety of HAI 
public reporting 
formats and 
content and to use 
the data to develop 
reporting and 
formatting 
recommendations.  
Consumers/S
election 
None 
Specified 
Random 
sample of 
residents from 
Worcester 
MA selected 
from city 
clerk's office 
for mailing. 
59 consumers 
included in the 
final sample   
Describe a range of 
opinions using 
qualitative 
descriptive 
techniques from 
data collected 
through interviews.  
Two themes were 
developed as well 
as subthemes.   
59 interviews were 
completed and 2 
major themes were 
identified: (1) 
responses and 
reactions to reporting 
with 4 subthemes: 
responses to HAIs in 
general, responses to 
specific indicators, 
reactions to different 
modes of reporting, 
and anticipated 
impact of reporting 
on hospital choice. 
(2) recommendations 
with 3 subthemes: 
recommendations 
related to report 
content, recs related 
to report format, and 
recs related to 
dissemination.   
Significant 
recommendations were 
generated including 
recommendations on 
format and content. 
Most indicated other 
factors as paramount for 
selection of hospitals 
including insurance, past 
experience sand 
recommendations. 
Discrepant scores from 
the same institution 
posed a challenge for 
participants  
Little diversity 
in race/ethnicity.   
McGuckin et. 
al, 2013 
To explore the 
hospital 
epidemiologist 
opinions regarding 
HAI public reports 
and their use of 
reports in their 
work with 
consumers and 
HCWs.  
Providers/Ch
ange and 
Consumers/S
election 
None 
Specified 
59 healthcare 
epidemiologist
s frim SHEA 
Research 
Network 
across 40 
states and 30 
of the 32 with 
public 
reporting. 
Descriptive 
statistics of 
responses to survey 
items and open 
ended questions 
(categorized by 
theme) 
36% response rate 
(N=59), 90% were 
from states with 
mandatory reporting.  
93% reported seeing 
the state report, and 
70% used reports 
with administrators 
and HCWs. 
Respondents marked 
consumer awareness 
, understanding, and 
use of data as low 
and 21% suggested 
Supports the notion that 
this public ally reported 
data is used by hospital 
epidemiologists for work 
with administrators and 
other HCWs.  However 
suggests they do not find 
it useful for general 
consumer purposes.  
Small sample 
size of 
epidemiologists. 
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study 
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Pathway 
Conceptual 
Framework  
Sample  Data Analysis 
Methods  
Attrition and 
Results  
Significance of 
Findings  
Limitations  
that more explanation 
of data for consumers 
is needed.  
Larkin et. al, 
2013 
To evaluate the 
association 
between state-
mandated public 
reporting of HAIs 
and perceptions of 
infection control 
process and 
outcome measures 
at their hospitals.  
Outcomes/ 
Change  
None 
Specified 
137 infection 
professionals, 
representing 
hospitals in 35 
states from 
SHEA 
Research 
Network.  
Descriptive 
statistics of sample. 
Chi-sq and t-tests 
for differences in 
reporting groups.  
110 respondents, 91 
hospitals in reporting 
states.  No outcomes 
were found to be 
associated with 
public reporting.  
Most respondents 
stated no increase in 
infection control 
resources and 
perceived risk of 
HAI was slightly 
decreased in the past 
3 years. No perceived 
improved process 
measures or lower 
infection rates 
between two groups 
of hospitals.  
No difference in 2 
groups of hospitals were 
noted in any outcome 
variable.  No 
demographic differences 
noted.  
 Cross-sectional 
design with a 
small and 
homogenous 
sample although 
representative of 
the academic 
medical center 
population. 
Uchida et. al, 
2011 
To conduct in-
depth semi 
structured 
interviews to gain 
insights about the 
experience of the 
infection 
prevention practice 
in California 
Outcomes/ 
Change  
Donabedian 
Framework of 
Healthcare 
Quality 
25 participants 
from 
California 
hospitals 
participating 
in CHAIPI, 
representing a 
range of 
personnel.  
Open coding and 
content analysis.  
Initial set of codes 
developed by two 
coders.  Secondary 
coding completed to 
contextualize the 
phenomena and 
suggest 
meanings/themes  
23 interviews (22 
1:1, 1 with multiple 
personnel) 4 themes 
found (1) mandatory 
reporting/ (2) impact 
of technology for 
surveillance (3) IP 
role expansion (4) 
organizational 
climate.  Mandatory 
reporting yielding an 
Rich qualitative data that 
discusses the impact of 
public reporting and 
regulation on IP 
practices and 
organizations.  These 
laws, while frustrating 
can also help to improve 
the profile and 
importance of IP within 
an organization.  They 
One state only 
included in the 
sample, this state 
had early 
adoption of 
mandatory 
reporting which 
limits external 
validity.    
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Author(s), 
Year 
Purpose of the 
study 
Stakeholder 
Group/ 
Pathway 
Conceptual 
Framework  
Sample  Data Analysis 
Methods  
Attrition and 
Results  
Significance of 
Findings  
Limitations  
increased awareness 
in infection control, 
however fair 
comparison is 
lacking, laws do not 
always address HAI 
of concern, 
significant increased 
workload. With 
regard to 
organizational 
climate subthemes of 
communication, 
organizational values 
and environment 
emerged.    
can stimulate a more 
positive organizational 
climate for IP 
Pegues, 2014 To describe the 
impact of HAI 
Action Plans on an 
academic health 
system in 
California, in 
planning and 
implementing HAI 
prevention 
activities and 
reduce HAI rates 
Outcomes/ 
Change  
Context-input-
Process-
Product 
Model (CIPP) 
Two acute 
care teaching 
hospitals 
within the 
UCLA Health 
System, both 
with dedicated 
infection 
control 
programs 
Description of the 
implementation of 
the HAI action 
within the CIPP 
model.   
Context- at the time 
of HAI action plan 
multiple processes 
already in place for 
HAI reduction, yet 
substantial 
organizational 
barriers as well.  
Inputs - Voluntary 
reporting in place to 
NHSN, yet the 
impact of state public 
reporting drove 
process 
implementation to 
improve HAI rates 
across the system 
(implementation of 
CVC bundle, policy 
development, data 
collection and 
Implementation of 
evidence-based practices 
for HAI prevention can 
be stimulated by 
increased awareness 
from public policy 
initiatives.  However, 
each setting must tailor 
practices to their own 
systems and allocate 
needed resources and 
organizational support.   
Small sample 
size for 
description of 
implementation, 
and not 
generalizable in 
experiences.  
However, 
lessons learned 
may be 
generalizable to 
wider audiences.  
208 
 
Author(s), 
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Purpose of the 
study 
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Conceptual 
Framework  
Sample  Data Analysis 
Methods  
Attrition and 
Results  
Significance of 
Findings  
Limitations  
reporting structure. 
Difficulty with 
implementation, 
given time frame. 
External data 
validation proved to 
be a challenge, but 
spurred collaboration 
internally.   
Reporting lead to 
increases in 
awareness and focus 
in HAI reduction.  
Implementation 
practices for 
evidence-based 
interventions need to 
be tailored to practice 
settings and 
embedded into 
existing processes of 
care 
Stone et. al, 
2015 
To explore the 
impact of federal 
and state HAI 
policy on state 
health 
departments, 
hospital 
stakeholders in the 
USA and to 
explore 
perceptions across 
varying states.  
Organization
s/Change  
Donabedian 
Framework of 
Healthcare 
Quality 
 Purposive 
sample to 
ensure equal 
number of 
states with and 
without HAI 
laws.  5-10 
participants 
were recruited 
after snowball 
sampling. 12 
states were 
selected 6 
with laws, and 
6 without.  
Open coding and 
content analysis.  
Initial set of codes 
developed by two 
coders. Coded data 
were reviewed to 
develop necessary 
themes and evaluate 
differences based on 
the presence of 
public reporting  
90 interviews 
conducted with state 
officials, regulatory 
officials, legal 
counsel, clinicians 
and IP professionals, 
and community 
partners. Four themes 
were identified: 1) 
Increased 
collaboration, 2) 
using public reported 
data for 
benchmarking and 
prioritization, 3) 
Findings suggest that 
laws aimed at mandating 
public reporting of HAIs 
fosters and heightens 
collaboration and 
awareness within the 
acute care setting to 
improve HAI prevention 
efforts.  The 
collaboratives include 
surveillance, 
implementation of 
prevention measures and 
data feedback.  There 
was surprisingly little 
Qualitative 
interviews 
yielded self-
reported 
narrative data.  
The researchers 
report there is a 
potential for bias 
due to social 
desirability.  
Despite efforts 
for a 
representative 
sample, only 12 
states were 
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concerns related to 
public reported data 
and 4) resource 
needs.  Public 
reporting was key in 
focusing importance 
on HAIs within 
hospital settings and 
garnering support for 
initiatives (reported 
by hospital staff).  
This was due to 
reputation and 
accountability of the 
institution.  Data 
validation continued 
to be a concern. 
Resource needs are 
significant 
particularly at the 
hospital level for IP 
staff, but also at the 
state level for 
providing guidance. 
Data validation 
remains a concern.  
variation between 
groups of states. This 
may be due to larger 
federal mandates where 
data is reported.  
included, thus 
generalizability 
may be 
hampered.   
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Stone et. al, 
2011 
To examine the 
impact of federal 
and state HAI 
policy on 
California hospital  
Organization
/ Outcomes/ 
Change 
None 
Specified 
331 hospitals 
in CA with 
adult ICUs 
were eligible 
to participate.  
One staff 
member from 
each hospital's 
infection 
prevention 
and control 
department 
was asked to 
complete the 
web-based 
survey.   
Descriptive 
statistics were 
presented.  Survey 
results pre/post 
were computed 
using t-tests and 
chi-squares. Linear 
and logistic 
multivariate 
regression were 
used to examine 
changes over time 
while controlling 
for hospital 
characteristics. 
Qualitative data was 
coded and content 
analysis preformed. 
207 Hospitals 
completed pre-
surveys and 203 
completed post. At 
time 2, IPs reported 
more time spent on 
surveillance, in 
offices rather than 
other locations, and 
increased data 
mining. Increase in 
CLABSI and CAUTI 
policies increased at 
time 2 as well as SSI 
and VAP-related 
policies. Increased 
adherence noted at 
time 2 to CHG use 
for CVC insertion 
and barrier 
precautions. 
Decreased ICU-
specific rates of 
CLABSI and CAUTI 
were also noted. 
Subthemes gathered 
from mandatory 
reporting included 
increased workload 
and associated 
frustration, variation 
in reporting 
requirements 
between state and 
federal policy, 
increased awakened 
and priority of IP and 
This finding confirms 
previous qualitative 
studies that show similar 
themes with regards to 
mandatory reporting.  
Sample size was large to 
evaluate the state 
hospitals with good 
response rates (>50%).  
Quantitative data capture 
was expansive and 
collected a wide-range 
of data on structure, 
processes and outcomes 
from policy 
implementation.  
  Pre-and post-
measures are 
useful, but 
ultimately self-
reported by 
survey 
respondents.  
Regression 
methods may 
show association 
with public 
reporting and 
outcomes, but 
not clear from 
the models how 
the trends were 
isolated from 
pre-to post 
implementation.  
This data was 
collected from a 
sample of 
hospitals from 
one state and 
may not be 
generalizable to 
experiences of 
other states in 
the U.S.  
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increase use of 
technology and 
associated efficiency.   
Zacharia et. 
al, 2014 
To determine the 
association 
between state legal 
mandates for data 
submission of 
central line-
associated blood 
stream infections 
Organization
/ Outcomes/ 
Change 
None 
Specified 
190 NICUs 
included in the 
study (107 
located in 
states with 
mandates) 
from a 
national 
sample of 
NHSN 
participating 
hospitals and 
associated 
NICU (level 
II/III and level 
III).   
Bivariate analysis 
were used to 
compare 
characteristics of 
NICUs, ANOV and 
Chi-sq were used to 
compare process 
measures and 
outcome measures. 
Multivariable 
logistic regression 
were used to test the 
association between 
mandates and 
process/outcome 
measures.   
190 NICUs were 
included in this study 
(21.8%) of total 
NHSN NICUs.  Over 
half were in states 
with reporting 
mandates.  More 
NICUs in mandatory 
reporting states 
reported >95% 
compliance with all 
prevention practices 
compared to those in 
states with no 
requirement (36.4% 
vs. 16.8%, p=.002).  
No difference in 
NICU CLABSI rates 
overall.  No 
statistically 
significant difference 
in SIR between the 
Compliance with HAI 
prevention practices in 
NICUs appears to be 
associated with reporting 
mandates, yet the impact 
of this on outcomes 
remains unclear.  An 
associated increase in 
compliance was seen 
with increased urgency 
of the mandates.   
Cross-sectional 
design does not 
allow for causal 
inference and it 
may be hard to 
isolate the effect 
of the public 
reporting 
mandate.  Small 
sample size may 
hamper 
generalizability.  
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two reporting groups.  
(Mean SIR 1.6 vs. 
2.7, p = .02).   
Greater than 95% 
compliance with 
prevention practices 
was associated with 
more recent 
mandates which 
compared to states 
with more than 3 
years of mandates. 
CLABSI rates in low 
BW <750g infants 
were significantly 
lower in in states 
with reporting 
mandates.  
Flett et. al, 
2015 
To determine 
whether blood 
culture and 
antibiotic 
utilization changed 
after mandatory 
public reporting of 
CLABSIs 
Clinical 
Processes 
and 
Outcomes/C
hange 
None 
Specified 
Children's 
hospitals that 
report to the 
Pediatric 
Health 
Information 
System 
database 
including 17 
hospitals in 9 
states with 
implemented 
mandated 
reporting and 
4 hospitals in 
4 states 
without.  
Interrupted time 
series using 
generalized linear 
mixed-effects 
models were used to 
look at outcomes as 
adjusted rate 
rations.  Covariates 
were selected for 
inclusion in the 
model after pre/post 
2-sided t-tests 
revealed significant 
differences (p<.2) 
between before and 
after reporting 
implementation.   
Blood culture 
utilization: No 
significant changes in 
rates. PICU Adjusted 
Annual rate ratio 
1.01 [95% CI, 0.90-
1.13], NICU 0.98 
[95% CI, 0.88-1.09].  
No difference found 
in Antibiotic days 
aARR 1.03 [95% CI, 
0.94-1.13] for PICU 
and aARR 0.98 [95% 
CI, 0.88-1.10] for 
NICU.  In hospitals 
without mandatory 
public reporting rates 
of monthly blood 
culture dropped in 
Longitudinal analysis of 
outcomes measures 
overtime.  These 
outcomes were focused 
more on point of care 
decision-making rather 
than broader process 
improvements.  This 
could potentially 
illuminate a new 
pathway for examining 
how these laws work or 
don't work within 
organizations.  
Administrative 
data can be 
subject to 
reporting and 
validity 
weaknesses.  
There may have 
been 
institutional 
differences 
among facilities 
that contributed 
to stable 
prescribing and 
culturing 
practices.   
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both PICU (p<.0001) 
and NICU (p<.0001).  
Antibiotic utilization 
dropped in the PICU 
but the change was 
not statistically 
significant.  Yet was 
significant in the 
NICU, aARR 0.95, 
[95% CI, 0.93-1.01].   
Pakyz & 
Edmond, 
2013 
To evaluate the 
impact of state 
laws on reporting 
of HAIs on 
CLABSI rates 
Outcomes/ 
Change  
None 
Specified 
Administrativ
e data from 
the University 
Health System 
Consortium 
hospitals from 
calendar year 
2011.  159 
hospitals were 
included in the 
study. 34 in 
states with no 
mandate, 92 in 
states with all 
3 legal 
requirements, 
33 in states 
that did not 
meet the 3 
legal 
requirements. 
Ordered probit 
regression model 
used to test 
associations 
between legislation 
and CLABSI rates.  
Secondary analysis 
of state-level SIRs 
and their 
association with 
CLABSI reporting 
legislation using the 
Tukey Kramer HSD 
test.  
 Results of regression 
models showed no 
effect of the presence 
of legislation 
category on hospital 
SIRs.  No difference 
in State-level SIRs 
was noted between 
the three legal 
mandate statutes.  
This was a national 
sample covering 34 
states and examining the 
impact in the differences 
in mandates as well as 
the presence of those 
mandates .  Well 
controlled for case mix, 
academic setting and 
acuity of patients   
Cross sectional 
design makes 
causal 
relationships 
difficult to 
analyze.  The 
sample only 
included 
academic 
medical centers 
and may not 
have been 
powered enough 
to detect an 
association.  The 
cross sectional 
nature of the 
data and analysis 
did not allow for 
temporal trends, 
thus it is 
unknown if rates 
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are similar due 
to a natural trend 
in declining 
CLABSIs.   
Daneman et. 
al, 2012 
To determine 
whether mandatory 
reporting is 
associated with a 
reduction in 
hospital rates of C. 
difficile infection  
Outcomes/ 
Change  
None 
Specified 
All admitted 
patients in the 
study period 
were 
identified with 
broad 
inclusion 
criteria.  
Excluded 
patients were 
those admitted 
to psych, 
rehab/complex 
continuing 
care and non-
acute areas. 
Administrativ
e data from 
the registered 
persons 
database, the 
Ontario 
Health 
Primary analysis 
consisted of 
modeling temporal 
patterns of C. diff 
infection using 
generalized 
estimating 
equations, with the 
unit of analysis as 
the hospital , month, 
and age-group.  
Exponentiated post-
month coefficient 
was the relative 
difference between 
the observed post-
month and the 
predicted post-
month.    
Results from the 
primary analysis 
indicated a 26.7 % 
reduction in c. diff 
cases comparing the 
predicted to the 
observed outcomes. 
This translates to 
5,417 cases observed 
compared to 7, 327 
predicted, or 
8.9/10,00 patient 
days vs. 
12.16/10,000 patient 
days.   (p<.001).  
This trend was seen 
across multiple 
hospital settings.   
This is a well-designed 
longitudinal cohort study 
with significant power 
and high-fidelity models 
to detect the effect of 
mandatory reporting on 
C. diff.  To date this is 
the only study to look as 
C. diff rates as an 
outcome of mandatory 
reporting.  Sensitivity 
analyses were used to 
confirm robustness of 
primary findings.   
All C.difficile 
cases were used 
in this study 
without attention 
to those that may 
have been 
transmitted 
outside of the 
acute care 
setting.  Coding 
data can 
sometimes pose 
challenges 
although the 
authors did 
validate their 
data with public 
reporting 
statistics.  
Temporal 
confounders 
remain a 
challenge in this 
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Insurance Plan 
database, the 
Canadian 
Institute for 
Health 
Information 
Discharge 
Abstract 
Database and 
the Ontario 
Drug Benefit 
database.  
study design, 
and it is difficult 
to isolate the 
primary effect of 
reporting 
mandates.  
Marsteller et. 
al, 2014 
To examine the 
mandatory 
reporting impact 
on participation 
and performance in 
reducing CLABSIs 
in a national 
patient safety 
collaborative.   
Organization
s and 
Outcomes/C
hange 
None 
Specified 
Sample from 
the On the 
CUSP: Stop 
BSI program, 
organized in 
cohorts of 
state-level 
ICUs.  6 
cohorts from 
5/2009 to 
3/2011. 
Hospital 
participation for 
each group tested 
whether unit 
participation rates 
were different 
among each group 
using chi-square.  
Covariates were 
tested using Fisher's 
exact tests.  
Difference-in-
difference design 
was used to 
evaluate the effect 
of each reporting 
group on CLABSI 
56% of hospitals 
joined the national 
program in those 
states where 
mandatory reporting 
started within the 
program period.  For 
those where mandate 
was in effect for <1 
year, participation 
was 50%.  For those 
hospitals with no 
reporting mandate or 
a mandate that was 
>1 year after the 
project, participation 
was low (22% and 
Longitudinal design 
showed some potential 
effect of reporting 
mandates, when 
mandates are newer or 
on the horizon as 
signified by increased 
participation in On the 
CUSP in these states.   
These mandates may 
influence participating 
and improvement 
initiatives within 
hospitals.  Hospitals may 
already see lower 
CLABSI rates states 
with long term reporting.  
No non-
participating 
ICUs were used 
to compare 
impacts of 
public reporting, 
which may be 
different than 
the sample 
provided.  Also 
CMS 
reimbursement 
policy in 2008 
may have been a 
factor in 
changes, yet this 
would have 
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rates.  23%).  Results of the 
regression showed 
voluntary reporting 
(G3)or longer 
duration of 
mandatory reporting 
(G2)  had higher 
baseline CLABSI 
rates (G3 IRR = 1.48, 
95% CI, 1.16-1.89; 
G2 IRR = 1.14, 95% 
CI, 1.01-1.29), but 
greater reductions in 
CLABSI rates during 
the first 6 months of 
the On the CUSP 
program.  Toward the 
end of the program 
period, hospitals in 
states with 
mandatory reporting 
showed a trend 
toward a larger 
reduction in CLABSI 
than those hospitals 
in states without 
reporting (not 
statistically 
significant).  
The presence of a 
mandate is not 
predicative of how well 
these initiatives may be 
implemented however.   
impacted all 
ICUs.  
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Rinke, M et. 
al, 2015 
To test the impact 
of pediatric-
specific public 
CLABSI reporting 
on rates of 
CLABSI as 
defined by the 
AHRQ PQI 12.  
Organization
/ Outcomes/ 
Change 
None 
Specified 
 Discharges 
identified in 
the Kids' 
Inpatient 
Database 
(KID).  States 
were 
identified as 
public 
reporters if 
states had 
facility 
identification 
as part of its 
mandate.  
Patient and hospital 
characteristics 
where compared 
using chi-squared 
statistics and F-test 
for means of 
continuous 
variables.  
Multivariable 
logistic regression 
was used to 
estimate the odds of 
PDI12 during each 
three-year period 
for EACH reporting 
group.  Random 
intercept was 
included to account 
for correlation 
within hospitals 
over time. 
Covariates included 
patient age, sex, 
payer, number of 
diagnosis, hospital 
bed size, location 
(urban/rural), and 
teaching status. 
Odds ratios 
estimated change in 
the PDI12 rates 
over time by 
comparing rates in 
time groups 2006 
and 2009 to the 
2003 baseline.  
Relative OR were 
There 7 states and 
1006 hospitals in the 
2009 reporting 
group, 2 states in 135 
hospitals in the 2006 
reporting group and 
18 states and 2066 
hospitals in the never 
reporting group 
totaling 4,705, 857 
observations. States 
that began reporting 
in 2006 outcome 
rates dropped by 
46% [95% CI, 31%-
68%](2006) and by 
90% [ 95% CI, 83%-
94%], (2009) 
compared to 
baseline.   Those who 
began reporting in 
2009, PDI12 rates 
began decreased by 
35% [95% CI, 30%-
39%] in 2006, 74% 
[95% CI, 72%-76%] 
in 2009.  The never 
reporting group had 
similar decreases 
including a greater 
decrease in PDI12 in 
later reporting 
periods when 
compared to 
reporting begun in 
2009 group (OR .12 
for never reporters, 
This is the first study to 
evaluate pediatric 
CLABSI outcome in the 
advent of public 
reporting.  The results 
indicate that CLABSI 
rates as defined by the 
study decreased across 
all 3 groups, mirroring a 
national trend in 
CLABSI 
prevention/patient safety 
and improvement in 
quality.   
There is some 
potential for bias 
by the data 
indicated in the 
PDI12 database, 
from the way 
that data is 
coded.  Potential 
for 
misclassification 
exists.  The 
public reporting 
in 2006 group 
only had 2 states 
and a subsequent 
low number of 
hospitals.   
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used to compare 
these to the never 
reporting group.    
and OR 0.26 for 
2009 reporters, 
relative OR:2.1 
p<0.001).  
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Black and 
Kim, 2014 
To provide a 
narrative and case 
study description 
of the challenges 
of studying the 
effect of public 
reporting and 
HAIs.  
Outcomes/ 
Change  
None 
Specified 
Data is 
sampled from 
the PA Health 
Care Cost 
Containment 
Council and 
PA Inpatient 
Discharge 
dataset, and 
National 
Inpatient 
Sample.  16 
additional 
states no 
reporting 
laws.   
A difference-in-
difference design 
was used to 
determine the 
impact of state 
mandated public 
reporting policy on 
CLABSI rates, for 
reported rates and 
inpatient rates.  
High rate hospitals 
find that reporting 
decreases inpatient 
data, yet gaming 
(time-inconsistent 
reporting) exists.  
Facilities with higher 
rates experience 
more significant 
drops.  
These findings use a 
quasi-experimental 
design to show a strong 
association between 
public reporting 
implementation and 
decreases in CLABSI 
rates. Differences in 
reported findings also 
include changes in 
reported data vs. 
discharge data, 
suggestive of gaming.  
While a strong 
study design is 
used, only one 
experimental 
group is 
evaluated 
against the 
control.   
Liu et. al, 
2016  
To determine the 
impact of 
mandatory 
reporting laws on 
CLABSI rates in a 
national sample of 
intensive care 
units.  
Outcomes/ 
Change  
Berwick and 
Hibbard 
A total of 244 
hospitals, with 
1,902 ICU 
years. 
Hospitals 
reporting to 
NHSN 
between 2006 
and 2012.  All 
non-VA acute 
care hospitals 
enrolled in 
NHSN were 
eligible to 
participate.   
Variant of a 
difference-in-
difference design, 
using a fixed effects 
Poisson regression 
model of CLABSI 
counts for each ICU 
month at a given 
time interval.  
Sensitivity analysis 
with CLABSIs by 
central line days 
and time spent by 
infection 
preventionists 
(#hours per 100 
hospitals beds per 
week) on 
surveillance.   
When compared to 
25 months or more 
prior to the law’s 
implementation, 
notable decreases in 
CLABSIs are seen 
both in anticipation 
of the law (IRR = 
0.66 , p<.001) and 
long after the laws 
went into effect 
(IRR=0.343, p=.009) 
These findings use a 
quasi-experimental and 
multi-state longitudinal 
analysis to show an 
impact of public 
reporting on CLABSI 
outcomes. This is the 
first study to use 
surveillance data from 
NSHN to examine 
CLABSI in adult ICU 
across the country.  
Findings also show 
longitudinal and 
sustained impacts of 
these laws on CLABSI 
rates.  
There is a 
potential for 
selection bias as 
well as changes 
in the CLABSI 
definition, 
however this 
would have 
affected all 
hospitals within 
the sample.  
Process 
improvements 
and point of care 
decision-making 
were not 
evaluated.   
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McKibben et. 
al, 2006 
To conduct a 
systematic review 
of the available 
literature to 
determine the 
ability of public 
reporting laws to 
improve care.  
Outcomes/ 
Change  
None 
Specified 
Of the 450 
papers 
selected for 
review with 
inclusion/excl
usion criteria. 
10 papers in 
the final 
analysis.  
Systematic review 
of empirical 
evidence presented 
in the papers.  
No significant 
empirical evidence 
was found supporting 
the recommendation 
that public reporting 
may improve HAI 
outcomes or improve 
care.  
First systematic review 
to focus on HAI related 
empirical evidence for 
the purposes of policy 
recommendations.   
Potential for 
publication bias 
as with any 
systematic 
review.  
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Appendix B. List of State Abbreviations  
Appendix B. U.S. State Abbreviations 
AL  Alabama MI  Michigan UT  Utah 
AK  Alaska MN  Minnesota VA  Virginia 
AR  Arkansas MO  Missouri VT  Vermont 
AZ  Arizona MS  Mississippi WA  Washington 
CA  California MT  Montana WI  Wisconsin 
CO  Colorado NC  North Carolina WV  West Virginia 
CT  Connecticut ND  North Dakota WY  Wyoming 
DC  District of Columbia NE  Nebraska UT  Utah 
DE  Delaware NH  New Hampshire VA  Virginia 
FL  Florida NJ  New Jersey   
GA  Georgia NM  New Mexico   
HA  Hawaii NV  Nevada   
IA  Iowa NY  New York   
ID  Idaho OH  Ohio   
IL  Illinois OK  Oklahoma   
IN  Indiana OR  Oregon   
KS  Kansas PA  Pennsylvania   
KY  Kentucky PR  Puerto Rico   
LA  Louisiana RI  Rhode Island   
MA  Massachusetts SC  South Carolina   
MD  Maryland SD  South Dakota   
ME  Maine TN  Tennessee   
MI  Michigan TX  Texas   
 
